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Abstract 
 
The increased incidence of allergies to cow’s milk proteins (CMP) in newborns enhanced the production of 
infant formula based on either soy proteins and/or hydrolysates of CMP. These formula, although having a 
good nutritional value, can be affected by the presence of peptides with a size stimulating the immunological 
response in predisposed subjects and/or an unpleasant taste for the infant consumers. Recent clinical studies 
indicated that patients with CMP allergy and also intolerant to these formula, showed a high tolerance 
towards the donkey milk, due to its greater quantitative similarities to human milk than cow’s milk. 
Specifically, although the mechanism of this tolerance has not yet been clarified, it is reasonable to 
hypothesize that the reduced allergenic properties of donkey milk can be related to structural differences of 
its protein components with respect to cow’s milk. 
At present, compared with cow’s milk, the characterization of donkey milk proteins (whey proteins and 
mainly caseins) is at a relatively early stage of progress, and only limited data are related to their 
heterogeneity. In this PhD thesis the complexity and specifically the qualitative and quantitative  
heterogeneity of donkey milk proteins of 77 animals reared in Italy was investigated using a proteomic 
approach. This analytical procedure for structural analysis of protein fractions is based on the combination of 
highly efficient separation techniques, such as one-dimensional electrophoretic techniques (PAGE pH 8.6, 
UTLIEF, PAGE-SDS) or, more efficiently, the two dimensional (2-DE) electrophoresis, coupled either to 
Coomassie Brilliant Blue staining or immunospecific staining with polyclonal antibodies, to chromatography 
analysis (RP-HPLC), interfaced to structural Mass Spectrometry analysis (LC/ESI/MS, MALDI/TOF/MS, 
ESI q-TOF/MS).  
For donkey caseins, these combined methodologies allowed the contemporary identification of the four 
casein fractions (αs1-, αs2-, β- and κ-CN) in donkey milk together with their related heterogeneity due to post-
translational phenomena such as the different phosphorylation degree of the caseins (αs1-, αs2-, β-CN) and the 
high glycosylation level of κ-CN, incorrect splicing of primary transcript in mRNA (non allelic deleted forms 
of αs1-, αs2-, β-CN) and genetic polymorphism of αs1- and β-CN (one or more variants in individual 
samples). At this regard, for the first time the primary structure of a new αs1-CN variant was determined, as 
well as and the amino acid sequences of three new genetic variants of β-CN (B, C, D) were characterized, 
using the known common αs1- and β-CN phenotype from donkey as reference, respectively. 
From a quantitative analysis, β-CN was always present in all analyzed donkey milk samples, as in human 
milk, representing the most abundant casein fraction followed by αs-CN complex. The αs1-CN showed an 
high variability in its expression level (0.2-2 g/L), confirming a quantitative polymorphism at this locus as in 
goat milk. The minor expression of αs1-CN together with the absence of αs2-CN in some donkey milk 
samples, as in the human milk, confirms the compositional similarity of two milks and represent a scientific 
basis for donkey milk’s use in nutrition of infants with CMP allergy. 
The screening carried out on the individual whey protein samples by the proteomic approach revealed a 
monomorphism either for α-La (A) and for β-Lg I (B). β-Lg II was instead polymorphic, for the occurrence 
of four variants (A, B, C, D) already known in literature and for the identification of a new variant E. The 
primary structure of β-Lg II E was determined and differs from β-Lg II D for D Asp2/E Asn2, D Arg18/E 
Lys18, D Val25/E Ala25 amino acid substitutions with a Mr18256 Da. Moreover a quantitative polymorphism 
seemed to affect the donkey β-Lg II locus since different phenotypes, with a relative quantitative percentage 
respect to total whey protein ranging from 0% to 3.34%, were detected by RP-HPLC. This quali-quantitative 
polymorphism at donkey β-Lg II locus seems to affect donkey milk composition and therefore, its allergenic 
properties. Moreover, the achieved results also highlighted that all examined samples have a high lysozyme 
content (∼ 2 g/L) which together with lactoferrin is important from an immunological point of view and for 
the shelf life of the milk.  
Finally, the donkey milk samples were shown to be poor in the total proteins (1.48%) as human milk, and 
specifically they were characterized by a lower casein content (35-40%) with allergenic properties and a 
higher whey protein content (50-60%) with biological activities, compared to bovine milk, with a CN/WP 
ratio <1. However, in analyzed donkey milk samples, an individual variability either of each casein or whey 
protein amounts suggests further studies in this direction aimed at a selection of animals producing milk with 
a composition “qualitatively and quantitatively” more similar to human milk, and “functionalized” for infant 
feeding. 
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Abstract 
 
L’incremento di allergie nei confronti delle proteine del latte vaccino (PLV) nei neonati ha incrementato la 
produzione di formulati per l’infanzia basati essenzialmente sulle proteine della soia e idrolizzati estensivi in 
PLV. Queste formule, pur avendo un buon valore nutrizionale, possono contenere peptidi in grado di indurre 
una risposta immunitaria nei soggetti predisposti e/o avere gusto sgradevole per il piccolo consumatore. 
Recenti studi clinici hanno mostrato che pazienti allergici alle PLV e refrattari anche a questi formulati, sono 
in grado di tollerare il latte di asina per la sua composizione quantitativa più simile al latte umano piuttosto 
che al latte vaccino. Specificamente, sebbene questo meccanismo di tolleranza non è chiaro, è ragionevole 
ipotizzare che le ridotte proprietà allergeniche del latte di asina possono essere correlate alle differenze 
strutturali dei suoi componenti proteici rispetto a quelli del latte di vacca.  
Ad oggi, rispetto al latte di vacca, la caratterizzazione delle proteine asinine (sieroproteine e soprattutto 
caseine) è ancora agli stadi iniziali, con pochi dati disponibili a causa soprattutto della loro eterogeneità. In 
questa tesi di dottorato, la complessità e specificamente l’eterogeneità quali-quantitativa delle proteine del 
latte di asina prodotto da 77 animali allevati in Italia è stata investigata mediante un approccio proteomico. 
Questa metodologia analitica per l’analisi strutturale delle frazioni proteiche è basata sulla combinazione di 
tecniche di separazione altamente efficienti, come le tecniche elettroforetiche mono-dimensionali (PAGE pH 
8.6, UTLIEF, PAGE-SDS), o più efficientemente, l’elettroforesi bidimensionale (2-DE), con la doppia 
colorazione al Blue Coomassie e con anticorpi policlonali specifici, all’analisi cromatografica (RP-HPLC), 
interfacciata all’analisi di Spettrometria di Massa (LC/ESI/MS, MALDI/TOF/MS, ESI q-TOF/MS).  
Per le caseine asinine, la combinazione di queste tecniche ha permesso la contemporanea identificazione 
delle quattro frazioni caseiniche (αs1-, αs2-, β- and κ-CN) nel latte di asina assieme alla loro eterogeneità 
compositiva dovuta ai processi post-traduzionali come il differente grado di fosforilazione delle caseine (αs1-, 
αs2-, β-CN) e l’alto livello di glicosilazione della κ-CN, incorreto splicing del trascritto primario in mRNA 
(forme delete non alleliche dell’αs1-, αs2-, β-CN) e polimorfismo genetico dell’αs1- e β-CN (una o più 
varianti nei latti individuali). A tal riguardo, per la prima volta è stata determinata la struttura primaria di una 
nuova variante dell’αs1-CN, cosi come sono state caratterizzate le sequenze aminoacidiche di tre nuove 
varianti di  β-CN (B, C, D) utilizzando i comuni noti fenotipi di αs1- e β-CN di asina, come riferimento. 
Da un punto di vista quantitativo, la β-CN è sempre stata presente in tutti i campioni di latte di asina 
analizzati, come nel latte umano, rappresentando anche la frazione caseinica più abbondante, seguita dal 
complesso αs-CN. L’αs1-CN ha mostrato un’elevata variabilità nel livello di espressione (0.2-2 g/L), 
confermando il polimorfismo quantitativo a tale locus, come nel latte di capra. Il minor livello di espressione 
dell’αs1-CN, insieme all’assenza dell’αs2-CN in alcuni campioni di latte di asina, come nel latte umano, 
conferma la similarità compositiva dei due latte e rappresenta una base scientifica per l’utilizzo del latte di 
asina nell’alimentazione di bambini con allergia alle PLV. 
Lo screening effettuato sui campioni individuali di sieroproteine mediante l’approccio proteomico, ha 
mostrato un monomorfismo sia per α-La (A) che per la β-Lg I (B). La β-Lg II è risultata invece polimorfa, 
per l’identificazione delle quattro varianti (A, B, C, D) già note in letteratura e di una nuova variante E. La 
struttura primaria della β-Lg II E (Mr18256 D) è stata determinata e differisce dalla β-Lg II D  per le seguenti 
sostituzioni aminoacidiche: D Asp2/E Asn2, D Arg18/E Lys18, D Val25/E Ala25. Inoltre un polimorfismo 
quantitativo sembra condizionare il locus della β-Lg II in quanto differenti fenotipi, con una percentuale  
quantitativa relativa rispetto alle sieroproteine totali compresa tra 0 e 3.34%, sono stati identificati mediante 
RP-HPLC. Questo polimorfismo quali-quantitativo al locus della β-Lg II sembra condizionare la 
composizione del latte di asina e perciò, le sue proprietà allergeniche. Inoltre i risultati ottenuti hanno anche 
evidenziato che tutti i campioni analizzati mostrano un alto contenuto di lisozima (∼ 2 g/L) che assieme alla 
lattoferrina è importante da un punto di vista immunologico e per la shelf life del latte.  
Infine, i campioni di latte di asina hanno mostrato, come il latte umano, un basso contenuto di proteine totali 
(1.48%). Specificamente, essi sono stati caratterizzati da un più basso contenuto (35-40%) di caseine 
allergeniche e un più alto contenuto di sieroproteine (50-60%) con attività biologiche, mostrando un rapporto 
CN/SP <1. Comunque, nei campioni analizzati, un’elevata variabilità nelle quantità di ciascuna caseina o 
sieroproteina, suggerisce futuri studi in questa direzione, finalizzati a una selezione di animali produttori di 
un latte con una composizione “ qualitativa e quantitativa” più simile al latte umano, e “funzionalizzato” per 
l’alimentazione pediatrica. 
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0 Preface 
 
The production and wider use of donkey milk suggests the potential economic value of donkey breeding, 
providing an economic justification for breeding donkey and preserving their natural environment, mostly 
represented by marginal and hilly areas, helping to protect certain donkey breeds from extinction in 
industriazed countries. 
Donkey milk, having an organoleptic and compositional characteristics very similar to human milk, may 
become an important food in the feeding of infants with cow’s milk protein allergy, frequently refractory to 
other treatments, also allowing the development of a normal and complete immune system in the newborn. In 
addition to its use for infants, some researchers (Carroccio et al., 2000a; Monti et al., 2007) have reported 
that donkey milk has an effect on the osteogenesis process, as well as in arteriosclerosis therapy, for 
rehabilitation of patients with coronary heart disease or premature senescence, and in hypocholesterolemic 
diets. 
Today, the production of donkey milk has also an economic interest, not only for human consumption, but 
also in the pharmaceutical and cosmetic industries and in rehabilitation of patients with psycho-physical 
deficits (Vita et al., 2007; Tesse et al., 2009).  
So, the biological and nutritional value of donkey milk urges a deep knowledge of this milk which could be 
used as a breast milk substitute and as a new dietetic-biofood. 
In this context, since the knowledge about the genetic profiles of donkey “proteome” (caseins and whey 
proteins) of animals reared in Italy is very scarce, as well as there are few experimental evidences of the 
expression level of each individual milk proteins, the present research was aimed to filling this gap and to 
relating it to the milk nutritional quality by a proteomic approach.  
A classic proteomic approach provides, after the extraction of proteins from a food, the separation of the 
protein mixture (e.g. by electrophoresis or chromatography) and identification of proteins combining 
techniques of classical biochemistry (immunospecific staining, enzymatic hydrolysis) to the mass 
spectrometry methods, followed by bioinformatic analysis of the data.   
However, the proteome is the set of proteins expressed in a cell, in a tissue and therefore in an organism. The 
science which allows the depth study of the proteome is called the “proteomics”. This science allows the 
study of the proteins both in the forms just transcribed by the genes and in the isoforms (due to alternative 
splicing) or post-translational modifications which may occur in the cell after transcription (after translation). 
The study of the isoforms or any post-translational modifications allows the comprehension of the 
interaction’s mechanisms between the proteins; these mechanisms enable the activity and function of 
proteins. So, the proteomics is a science which seeks to investigate and determine the identity, quantity, 
structure and bio-chemical and cellular functions of all proteins of a tissue, cellular or sub-cellular 
compartment, describing how these properties are variable in time, in space and in certain physiological 
states. 
All the information obtained from the proteomic studies, correlated with those obtained in the genome’s 
study, could help to establish the actual role of the proteins, as well as the relationship between genotype and 
phenotype.     
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1 STATE OF THE ART 
 
1.1 The history of donkey’s milk through the centuries 
 
The domestic equid species (horse and donkey) belong to the taxonomic order Perissodactyla, family 
Equidae, genus Equus, specie asinus. The domestic donkey could derive from African widcat donkey which 
still lives along northern and eastern coasts of Africa, Syria, Persia, Tibet and Mongolia. The donkey was 
domesticated for the first time, at the end of Neolithic period in ancient Egypt, in the Nile valley, and later in 
Europe, in southern Italy (Bonadonna, 1976). The donkey has always been a cult object in East countries and 
in Africa, and it has always been used for work, for the production of mule, meat (fresh and sausages) and 
milk (also used for the production of fermented alcoholic beverages as koumiss). Today the donkey is still 
used for trekking but also for rehabilitation of disabled people (onotherapy). At this regard, the donkey still 
occupies a large place in folklore, art and literature of European and extra-European countries.  
Since Erodoto (V century BC), the donkey was known for nutritional and beneficial properties of its milk; in 
fact, the curative recipes based on donkey’s milk and spread by Plinio were very famous, as well as 
Cleopatra, Egypt queen, kept her youth and beauty of the skin immersing herself in donkey’s milk; these 
healthy benefits required a herd of about 700 donkey every day. The Romans also used donkey’s milk 
because of the great healing powers; Poppea, Nerone’s wife, used this precious liquid in order to preserve the 
splendour and the elasticity of the skin; even Messalina, Rome Empress, cured her face with masks made of 
bread soaked in donkey’s milk (Salimei et al., 1996a; Andena, 2007).  
It is in Renaissance, that was the first scientific consideration of the donkey’s milk, by the king of France, 
Francis I, which exhausted by wars and excesses, used this milk against stress and physical fatigue. In the 
nineteenth century, in the European countries, it was easy to find merchants who carried the donkeys. The 
elegant society of that period regularly consumed this precious drink, while poor families reserved the rare 
elixir only to stick children and to the weak and tired elderly. During this same period, donkey’s milk began 
to be used for breastfeeding; the donkey lend itself to nurse infants that are submitted directly to the breast. In 
fact, also in France in the nineteenth century, Dr .Parrot of Hospital des Enfants Assistès spread the practice 
of bringing babies motherless directly to the donkey’s nipple (Bullettin de l’Acadèmie de mèdicine, 1882). 
The donkey’s milk was then sold until the twentieth century to feed orphaned infants and to cure delicate 
children, the sick and the elderly. For this reason, in Italy, Belgium, Germany, Switzerland many donkey 
farm born. Today there is a renewed interest towards the donkey’s milk because of its peculiar characteristics 
of composition (The story of donkey’s milk through the centuries in www.eurolactis.com). 
However, asinine breeds-populations are few and have a variability not very accentuated, except for the 
morpho-functional characteristics, such as height that in some breeds, is equal to 160 cm and in other breeds 
reduced less than one meter (Balasini, 1990). Breeding is mostly present in the countries of southern Europe 
(Spain, France, Italy and Balkan Peninsula) and in Africa, from which this species is originated. In Europe, 
there are asinine breeds in France (Poitou donkey), Spain (Catalan donkey), but especially in Italy where 
there are many breeds: Martina Franca donkey, Sardinian donkey, Romagnolo donkey, Viterbese donkey, 
Asinara donkey, Armata donkey, Pantelleria donkey and Ragusan donkey (Baroncini, 1987). 
In 1950, donkeys were almost one million in Italy, but their consistency has dwindled over the years. Only, 
since 2000, a rapid ascent is started and many local breeds were saved from the extinction (Paolicelli, 2010) 
(Fondiz). In fact, today, there are about 55000 donkeys in Italy (www.anagrafeequidi.it). 
The Italian region, which has preserved the good tradition of donkey is Sicily, which has the highest number 
of asinine farms (donkeys breeding) together with Abruzzo, Lombardia, Campania and Lazio. Generally, a 
donkey farm (breeding), aimed at milk’s production, is composed of 20/25 dams with 1 or 2 stallions. The 
donkey breeds, reared for milk production, are heavier ones, such as Amiata (Toscana), Martina Franca 
(Puglia) and Ragusana (Sicilia) breeds. They are shown more adequate in terms of efficacy, because the 
produced milk is related to the animal’s mole (Paolicelli, 2010).   
In Italy, the protected asinine breeds are: Armiata (1614 animals), Martina Franca (964 animals), Ragusan 
(2017 animals), Sardinian (1349 animals), Romagnolo (461 animals), Asinara (70 animals), Pantesco (76 
animals) and Viterbese (131 animals), for a total number of about 6682 donkeys officially reported in the 
populations’ register (www.anagrafeequidi.it). In the last years, the loss of asinine genetic patrimony and the 
demand of a hypoallergenic and nutritionally adequate milk, have stimulated the interest of many farms, 
mainly in the inner areas of the Italy, which have rediscovered the donkey breeding, as important for 
environment and biodiversity. The preservation of asinine breeds is due to donkey’s reintegration in 
programs of social and economic interest, such as, onotherapy, onodidactics, onotourism and onomilk (milk 
production). In fact, donkey’s milk, is a natural product attributable to category of pharmafood/nutraceuticals 
useful for children and adults (Gatti, 2007).            
   
1.2 Donkey milk production   
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Donkey milk production differs greatly from that of conventional dairy species, especially in terms of milk 
supply. The equid mammary gland has a low capacity (max 2,5 L) so that milking may be carried out two or 
three hours after separation from the foal (Doreau, 1991; Drogoul et al., 1992). Kinetics of milk ejection 
shows two peaks: the first represents the emission of the cisternal milk, while the second represents the 
emission of alveolar milk (75-85%) as natural response to oxytocin release during milking, which is often 
insufficient for complete milk removal from the udder of donkey. As a consequence, low fat contents are 
reported for donkey milk, whereas residual milk, accounting on average for 30% of total milk extracted, is 
the richest fraction in fat (Salimei et al., 2004b). However, when foals are not physically present, the milking 
routine is more manageable in terms of both human and animal safety, and for an optimal milk extraction 
(Simoni et al., 2004). Due to the small amount of milk per milking and depending on the wavering consumer 
demand, mostly limited by local availability and lack of communication, donkeys, as mares, may need to be 
milked many times a day (Doreau, 1991; Drogoul et al., 1992). In donkeys, although manual milking could 
be efficient in terms of quantity of milk extracted per milking, production varies less when donkeys are 
machine milked (Salimei, 2011) and the risk of contamination, a crucial issue, can be significantly reduced 
compared with manual milking (Sorrentino et al., 2010).  
Milking routine is crucial in donkeys with regard to the specific management of the dams that live with their 
suckling foals until natural weaning (> 7 months of age). Donkeys should be milked from 20 to 90 d after 
foaling, three times a day, following a strict milking preparation and routine consisting of 3 h physical 
separation from foal, udder massage and teat cleaning (Bayle-Labouré, 2007; Doreau & Martin-Rosset, 
2011). In general, the presence of foal during milking does not affect milk ejection in donkeys which always 
showed a quick adaption to the milking procedure (Salimei et al., 2000), which is a significant advantage 
compared with horses and allows the modification of the milking parlour, routine and facility.  
Donkeys adapt quickly to the routine (including udder massage, teat cleaning, approaching and leaving the 
parlour) that requires about 3 min per animal (Simoni et al., 2004).  
However, the variability of donkey milk production is due to many factors, such as individual milk ability 
(individual features of breast apparatus) also related to genetics (donkey breed), nutrition (type of forage) 
(donkey body condition), but also management of reproduction and milking management (Salimei & Fantuz, 
2012). In donkey, the changes during lactation include both qualitative and quantitative aspects, and the 
definition of these trends is important for the nutritional characterization of milk, as well as aspects 
concerning the production process (D’Alessandro, 2007). Studies on donkey milk showed an highly variable 
productions between manual (466 ± 260 mL) (Guo et al., 2007; Alabisio et al., 2009) and mechanical milking 
(772 ± 148 mL) (Salimei et al., 2004a; Simoni et al., 2004; Fantuz et al., 2007; D’Alessandro et al., 2009; 
Giosuè et al., 2008; Fantuz et al., 2010). In fact, Salimei et al. (2004a) have demonstrated that average milk 
yield per mechanical milking was about 740 mL, even if it was significantly higher during the second year of 
lactation (606,5 mL vs 854,3 mL), attributable to the adaption of donkeys and (operator) to mechanical 
milking. However, the milk yield per machine milking is less rich in fat, being the residual milk after 
oxytocin injection about 37% of the total milk produced, and milk fat is the main retained milk component 
(Salimei et al., 2004b), consistently with the data on mares (Doreu et al., 1986). Considering the different 
milk yield obtained when donkeys were milked twice a day, in the morning and in the afternoon (Salimei et 
al., 2004a), the average milk yield of the morning milking was found to be statistically lower than that 
observed for the afternoon milking (549,2 mL vs 949,3 mL). The observed higher milk production during the 
middle part of the day, as also reported in dairy mares (Dell’Orto et al., 1994), supports the hypothesis of a 
coadaption of the dam to the suckling rhythm and activity pattern of the foal, although a circadian rhythm for 
suckling was not noted in horses. 
D’Alessandro & Martemucci (2007) have investigated on the effects of daily milking number and frequency 
on donkey milk production: the results obtained in that study demonstrated that the highest milk yield 
corresponded to three milking per day every three hours, while daily milking regimen of 5-6 milking per day 
did not increase milk production and had a negative influence on the health of the mammary gland. Also 
Alabisio et al. (2006) have demonstrated that the highest milk yield can be obtained with three milking per 
day compared to two milking per day, with an increase fat content, too. Outside the milking hours, the 
sucking of breast milk to foal should be instead allowed, which is essential for milk secretion (Salimei, 
2001).   
Variability in milk yield could be related could be related also to genetic diversities and therefore to the 
breeds, even though Blasi et al. (2005) defined genetically similar Romagnola, Ragusana and Martina Franca 
populations; the Authors also showed reciprocal influences confirming the hypothesis formulated by Gandini 
& Rognoni (1997). However, the lactation, for dairy donkeys, shows high individual variability, explained by 
the total absence of any form of genetic selection of the animals; starting at 30 d post partum milk yield 
constantly decreases up to 4th – 5th  month of lactation (Salimei et al., 2005). This trend is substantially 
confirmed by data on Ragusana and Martina Franca populations (Alabisio et al., 2005), also showing   
seasonal variation of milk yield, presumably due to foaling period and the related different availability of 
pasture at the onset of lactation (Giosuè et al., 2008).  
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In fact, the asinine species is considered a seasonal polyestrous one, but the latitude in which the farm is 
located can greatly influence the reproduction cycle; considering a recent investigation runned in the south of 
Italy, specifically in Sicily, the local latitude determined small photoperiod oscillations between the different 
seasons, and under these conditions the donkeys have a continuous reproductive cycle, the same was 
observed in sheep. In Sicily it is in fact possible to obtain donkey milk throughout the year by adequately 
planning the reproductive seasons; results showed that donkey foaling in winter and in summer produced 
more milk than those foaling in the other seasons (Giosuè et al., 2008).       
However, individual variation is high in dairy donkeys, suggesting that the adoption of adequate selection 
programmes and reproductive management would lead to a substantial improvement in milk production, as 
already experienced with dairy horses (Doreau & Martuzzi, 2006).    
 
1.3 Gross composition of donkey milk  
 
The composition of donkey’s milk differs considerably from that the milk of the principal dairying species 
(cow, buffalo, goat and sheep). In comparison with bovine milk, donkey’s milk contains less fat, protein and 
inorganic salts but more lactose, with a concentration close to that human milk (Table1.1). 
Both genetic and environmental factors affect the gross composition of milk, including the breed of mammal, 
individuality of animals, stage of lactation, frequency and completeness of milking, maternal age, health and 
type of feed.  
The pH value, ranging from 7.14 to 7.22 (Salimei et al., 2004a; Guo et al., 2007), does not vary significantly 
throughout the lactation period as in mare’s milk (Mariani et al., 2001), and this suggests that the pH value is 
not influenced by breed or stage of lactation. The average pH value (7.18) of donkey’s milk is higher than 
that of cow’s milk (6.6 - 6.7) and it is associated with a low average titratable acidity. These data may be 
explained by the lower casein and phosphate contents in donkey’s milk than cow’s milk (Salimei et al., 
2004a). During the lactation, the density of donkey’s milk also remains constant at 1.032. This value,  
because of the lack of fats, is higher than human and cow milk.  
 
Table 1.1. Average percentage composition (g/100g) found in donkey’s milk, compared with other domestic 
species (Polidori, 1994; Salimei et al., 2000). 
 
 Fat Proteins Lactose Dry matter Ashes 
Donkey 0.38  1.72  6.88  8.84  0.39 
Human 3.83 1.25 6.81 12.20 0.21 
Mare 1.36 2.10 6.16 10.04 0.42 
Cow 3.70 3.20 5.00 12.70 0.80 
Goat 4.00 3.10 4.25 12.05 0.80 
 
The fat content, according to Salimei et al. (2004a) and Guo et al. (2007) shows marked variability (1.82-
0.20%) indicating that could be affected by breed, breeding area and forage, milking technique, interval 
between milkings and mainly stage and year of lactation as also reported by Fox (2003), with a negative 
trend throughout lactation. Due to the high variability observed in milk fat content, the variation in energy 
value appeared to show much similarity to that of the fat content (Salimei et al., 2004a; Guo et al., 2007). 
The lactose content of donkey’s milk is similar to that human and mare milk (table 1.1) and is much higher 
than that of cow milk. According to Guo et al. (2007) the lactose content is constant throughout the lactation, 
because lactose is responsible for about 50% of the osmotic pressure of milk, which is equal to that of blood. 
The lactose content in donkey’s milk is unaffected by breed, milking time, year and stage of lactation, as 
observed by Salimei et al. (2004a). In donkey’s milk, the high lactose content not only makes this milk 
pleasant in taste, but also stimulates the intestinal absorption of calcium, that is essential for bone 
mineralization and for nervous system development in infants (Schaafsma, 2003). Moreover, the high lactose 
content suggests using donkey’s milk also for probiotic purpose (Coppola et al., 2002) because it is an ideal 
substrate for a correct development of intestinal lactobacilli and, from a technological point of view, makes 
donkey’s milk an ideal matrix for the preparation of probiotic drinks following the incubation with 
Lactobacillus rhamnosus strains (Coppola et al., 2001). 
Despite the high lactose content of donkey’s milk, the average energy content is lower (1,708Kj/Kg) 
compared with human milk (2,60 Kj/Kg). According to Oftedal & Jennes (1988) the low energy content of 
donkey’s milk is related to its low fat content and to the large amounts of milk secreted to meet the 
nutritional requirements of the foal for its rapid growth. The hypolipid content of donkey’s milk (table 1.1) 
must be taken into account from a nutritive point of view: for this purpose, when used in infant nutrition, 
donkey’s milk is usually supplemented with vegetal oil (4mL/100mL) to conform to human milk energy 
(Iacono et al., 1992). In donkey’s milk significant positive correlations between milk yield and total solids or 
fat content were observed. These results confirm that higher milk fat is associated with a more complete 
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udder evacuation in dairy donkey. Moreover, total solids were positively correlated to protein, fat and ash 
content, whereas the protein content was directly related with fat and ash contents but negatively correlated 
to lactose (Salimei et al., 2009). According to circadian studies, milk lipid and lactose contents have been 
observed to peak in donkey during the night, whereas the protein content peaked during the day (Piccione et 
al., 2008). However, internal rhythms are known to be affected by environmental factors, such as 
management of feeding and the light-dark cycles.      
 
1.4 Donkey milk proteins 
 
The seasonal trend in the protein’s percentage showed a richer milk during spring season, and because the 
breeding system of donkeys provides a wide grazing period especially during the spring and summer months, 
when the forage’s availability is maximum, it is hypothesized that in the period from March to June the high 
proportion of protein in diet positively influences milk proteins. The abundant forage supply provides to 
donkeys an amount of proteins, often not fully utilized by nitrogen metabolism, which are then excreted also 
as urea in the milk (Conte, 2007).   
The protein content of donkey milk is similar to that human milk and was much lower than that cow’s milk 
(table 1.1) (Salimei et al., 2004a). Although it is not significantly influenced by milking times and breed, 
varies during lactation, with a negative trend, as already described for milk yield and its fat percentage. 
However, during lactation both in donkey and in human a decreasing trend of the protein level (1.72g/100g) 
was showed (Salimei et al., 2004a). Similar trends were observed in mare’s milk (Mariani et al., 2001) and 
cow’s milk (Fox, 2003). This shows that the total protein percentage in donkey’s milk is affected by the stage 
of lactation, consistent with the finding of Fox (2003) in cow’s milk. This may be related to the differential 
expression of milk proteins genes during lactation (Demmer et al., 1998). 
The study of protein fraction has an essential role, because it is presumably responsible for hypoallergenicity 
of donkey’s milk, entering in tolerance’s mechanism of this milk. Casein, whey protein and NPN contents do 
not vary significantly throughout the lactation period and appear not be influenced by breed or milking time 
(Salimei et al., 2004a; Guo et al., 2007). 
The non-protein nitrogen (NPN) accounts for an average of 10-16% of total nitrogen in mare and donkey 
milk, which is lower than values reported for human milk but higher than those of domestic ruminants 
(Uniacke-Lowe et al., 2010; Salimei, 2011). The average content of NPN is lower in winter, tending to 
increase during the summer, because in the summer the protein content of feed intake becomes excessive 
compared to the physiological requirements of the animal (Tidona et al., 2011). The nutritional and biological 
significance of this milk fraction (0,29g/100g milk) which includes urea, uric acid, creatinine, amino acids, 
nucleic acids and nucleotides is still far from being completely understood, but seems to be related to the 
development of the infant (Emmet & Rogers, 1997).   
The average content in casein and whey proteins are very similar (Table 1.2), but while casein content has a 
decreasing trend, the whey protein content remains constant during the lactation (Alabisio et al., 2005). There 
is a similarity between donkey milk and mare milk in nitrogen distribution. The whey protein content of 
donkey milk (0,68g/ 100g milk) is close to that of human and mare milk (Doreau et al., 2002; Malacarne et 
al., 2002), instead the average casein content (0,87g/100g) is resulted higher than human milk (0,53g/100 g 
milk) but it is lower than equine (1,11g/100g milk) and ruminant milk (2,42 g/100g cow milk; 2,40g/100g 
goat milk) (Travia, 1996). Moreover, the average ratio of casein to whey protein in donkey’s milk (0,94) is 
intermediate between the lower value of human milk and the higher value of cow’s milk, consistent with the 
finding reported by Travia (1986). In fact, in the milk of ruminants this ratio is four times higher than 
donkey’s milk, and seven times higher than human milk (Polidori and Vincenzetti, 2007). 
 
Table 1.2. Average percentage composition of the nitrogen component of donkey milk, compared with other 
domestic species (Polidori, 1994; Salimei et al., 2000). 
 Proteins 
(g/100m) 
NPN (x6.38) 
(g/100 mL) 
WP 
(g/100mL) 
%WP 
 
Casein 
(g/100m) 
CN/WP 
Donkey 1.72 0.29 0.68 38.4 0.87 0.94 
Human 1.25 0.16 0.71 56.8 0.38 0.53 
Mare 2.10 0.20 0.79 37.50 1.11 1.40 
Cow  3.20 0.18 0.60 18.50 2.42 4.03 
Goat 3.12 0.14 0.58 18.59 2.40 4.14 
 
The high whey protein content of donkey’s milk make it more favorable for human consumption (Curadi et 
al., 2001; Iacono et al., 1992). With reference to the protein content, it is important not to ignore the fact that 
patients who experience an intolerance to cow, goat, or sheep milk are able to tolerate donkey and mare milk 
(Businco et al., 2000; Carroccio et al., 2000a; Curadi et al., 2001). Although the mechanism for tolerance to 
donkey’s milk is still unclear, it may be related to the specific levels of major allergenic components in the 
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milk. Among the potentially allergenic milk components, β-Lg is, in fact, probably the major milk allergen 
among infants and children, whereas casein is considered the predominant milk allergen among adults 
(Carroccio et al., 1999). Lara-Villoslada et al. (2005) found that the balance between casein and whey protein 
played an important role in the sensitization capacity of cow milk and showed that cow milk with a CN:WP 
ratio of 40:60 was less allergenic than native cow milk. As a result, it may be of interest to use donkey milk 
for infant feeding. The donkey milk may be a valid substitute for human milk and also an alternative for 
feeding children who experience an allergy to cow milk.           
 
1.5 Donkey caseins 
 
Casein micelles are primarily a source of amino acids, calcium, phosphate and bioactive peptides for 
neonates (Shekar et al., 2006). Although the mechanism of tolerance of donkey’s milk has not yet been fully 
clarified, it is reasonable to hypothesize that the reduced allergenic properties of this milk can be related to 
structural differences of its protein component with respect to cow’s milk.  The lower casein concentration in 
donkey’s milk (about 50% of total protein) compared with bovine milk (80% of total protein) (Zicker & 
Lonnerdal, 1994) and the relevant percentage of essential aminoacids make this milk a new dietetic food and 
a promising breast milk substitute (Guo et al., 2007). 
The traditional method for separating caseins from whey proteins is isoelectric precipitation of the caseins at 
pH 4.6. The casein fraction of most milk types consists of four gene products synthesized in the mammary 
gland in response to lactogenesis hormones and other stimuli: αs1-, αs2-, β-, and κ-caseins, of which the first 
three are calcium-sensitive. They showed an high heterogeneity due to post-translation phenomena 
(phosphorilation, glycosylation), genetic polymorphism (one or more variants in individual samples, much 
more in bulk milk), non allelic deleted forms and proteolysis by action of endogenous proteases. All caseins 
display a distinct lack of secondary structure, which led to classify them as rheomorphic proteins (Holt & 
Sawyer, 1993). The lack of secondary structure may be attributed, at least partially, to the relatively high 
level of proline residues in casein. As a result, caseins do not denature or associate on heating (Paulson & 
Dejmek, 1990). The biological function of the caseins lies in their ability to form macromolecular structures, 
casein micelles, which transfer large amount of calcium to the neonate with a minimum risk of pathological 
calcification of the mammary gland. 
However, compared with cow’s milk, the characterization at molecular level of donkey milk caseins is at a 
relatively early stage and limited data are available for its genetic polymorphism.   
 
1.5.1 alpha-s1 casein (αs1-CN) 
 
Donkey αs1-CN contains 202 amino acids (aa) and has a molecular mass (Mr) 24406 Da prior to post-
translational modifications; as such, it is considerably larger than its cow (199 aa) and human (170 aa) 
counterpart (Table 1.3) (Cunsolo et al., 2009a). According to Miranda et al. (2004), equidae αs1-CN gene, as 
cow and other mammals, is constituted by 19 exons (Fig. 1.1 and 1.2) mapped on chromosome 6, even if the 
first and the last two exons represent 5’ and 3’ UTR (untranslated region, respectively). Moreover, the 
alignment with the other species revealed the absence of exon 5 in the equine αs1-CN cDNA, which resulted 
in the total of 18 exons in the longer form of the equine αs1-CN transcript (using the number of the bovine 
gene). This assumption is consistent with cDNA sequences published by Milenkovic et al. (2002) and Lenasi 
et al. (2003), who reported alternative spicing and cryptic splice site usage. 
 
Table 1.3: Properties of Equine, Bovine, Human and donkey αs1-CN. Values were calculated from the amino 
acid sequences of the mature protein provided on SWISS-PROT database (http://au.expasy.org/tools).    
 
 
Protein 
 
Species 
Primary 
Accession 
Number 
Amino acid 
residues 
Molecular 
Mass (Da) 
 
pI 
 
GRAVY
 
Cys residues 
 
αs1-CN 
Equine - 205 24614.4 5.47 
−1.127 0 
Bovine P02662 199 22974.8 4.99 
−0.704 0 
Human P47710 170 20089.4 5.17 
−1.013 3 
Donkey P86272 202 24406.4 5.95 
−1.115 0 
 
The αs1-CN primary structure displays polymorphic patterns, due to alternative splicing processes leading to 
casual exon skipping events involving exons of the gene coding for the protein. In fact Cunsolo et al. (2009a) 
identified and completely characterized four donkey αs1-CN components, using mare’s αs1-CN as reference. 
The two donkey’s αs1-CNs with a Mr 23786 (197aa) and 23658 Da (196aa) differ in the absence of a 
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glutamine residue at position 83 in the shorter form (196aa), which explains the difference of 128 Da in their 
molecular mass. In addition, they show two amino acid substitutions (Q8→ H and H115→Y) with respect to 
the homologous mare’s αs1-CN. The other two αs1-CN components with Mr 24406 (202 aa) and 24278 Da 
(201), which also differ in the presence of a glutamine residue at position 88 in the full-length component, 
show the insertion of the pentapeptide HTPRE between Leu33 and Glu34, which accounts for the increase of 
620 Da in their observed molecular masses. Taking into account the exon modular structure of the αs1-CN in 
the other species and in mare (Lenasi et al., 2003; Miranda et al., 2004), it is reasonable to assume that the 
pentapeptide HTPRE between Leu33 and Glu34 is encoded by the exon 5, which is constitutively spliced as in 
mare’s αs1-CNs, where it should express the sequence SIPREVRK (Lenasi et al., 2003). On the other hand, 
the existence of the two non-allelic deleted forms lacking a glutamine residue, which is the first amino acid 
encoded by exon 11, is probably related to an alternative splicing event occurring during primary transcript 
processing. On the other hand, the existence of a cryptic splice site occurring at the first codon (CAG) of 
exon 11, encoding this glutamine residue, has already reported for ewe (Ferranti et al., 1995), goat (Ferranti 
et al., 1997), cow and water buffalo (Ferranti et al., 1999) αs1-CNs. The two αs1-CNs bearing the 
pentapeptide insertion are named variant A (202 aa; Mr 24406) and A1 (201 amino acids; Mr 24278), 
whereas the two αs1-CNs without the pentapeptide are named variants B (197 aa; Mr 23786) and B1 (196 aa; 
Mr 23658) (Table 1.4). 
 
Table 1.4: Proposed nomenclature for the full-length and deleted donkey’s αs1-CNs (Cunsolo et al., 2009a). 
 
Nomenclature of the isoforms Calculated Mr  Amino acid differences 
A 24406 - 
A1 24278 
−Q88 
B 23786 
−H34TPRE38 
B1 23658 
−H34TPRE38; −Q83 
 
The absence of pentapeptide HTPRE confers to αs1-CNs components, B and B1, a more acidic nature 
(theoretical pIs of 6.01) with respect to the components A and A1 (theoretical pIs of 6.12). The existence of a 
full-length component and deleted forms in αs1-CN protein show genetic polymorphism in donkey milk and 
reflect the complex exon/intron structure of αs1-CN, which consists of many short exons and allows 
alternative splicing of shorter exons from pre-mRNA (Lenasi et al., 2003). 
αs1-CN’s primary structure from donkey milk has been characterized by Cunsolo et al.(2009a) who did not 
mention the possible phosphorilation degree of the protein, but looking its primary structure it can contains 
six potential phosphorylation sites (http://au.expasy.org/tools) (Ser18, Ser73, Ser74, Ser76,Ser77 and Ser78), as 
mare αs1-CN (Ser18, Ser75, Ser77, Ser79,Ser80 and Ser81) (Lenasi et al., 2003; Mateos et al., 2009b), which are 
very close approximately and can thus form a phosphorylation centre, which is important in structure of 
casein micelles. Regarding mare’s αs1-CN, Mateos et al. (2009b) revealed the existence of a full-length 
protein and deleted forms resulting from posttranscriptional modifications; that is exon skipping involving 
exon 7, exon 14 or both and use of cryptic splice site encoding a glutamine residue. According to Mateos et 
al. (2009b) the full length αs1-CN existed in equine milk, even if, additionally, the major components of αs1-
CN were ∆7 and ∆7,14 splicing variants, suggesting that the mechanism of alternative splicing mainly 
involved exon 7. Exon skipping is frequently observed in αs1-CN of other mammalian species as human 
(Johnsen et al., 1995), caprine (Ferranti et al., 1997) and ovine milk (Passey et al., 1996), and it is not only 
restricted to ruminants (Martin et al., 2002). The formation of several splicing variants could be explained by 
the αs1-CN gene structure that is divided into many short exons (19) (Martin et al., 2002). Equine αs1-CN and 
human αs1-CN (Johnsen et al., 1995) are the only αs1-CNs for which exon 7 can be alternatively spliced and 
for the latter, the removal of exon 7 leads to the formation of a protein with 162 AA (Mr 19158 Da) for the 
expulsion of sequence D61-Q68. For each component of αs1-CN, including the full-length component, a 
shorter component lacking a glutamine residue was characterized. This supported the occurrence of an 
alternative splice mechanism using a cryptic splice site located at the beginning of exon 11 and 
corresponding to Gln-91 (Lenasi et al., 2003). The deletion of the first codon of exon 11 (in mare αs1-CN) is 
a rather frequent phenomenon occurring in other species (Martin et al., 2002) including ewe (Ferranti et al., 
1995), goat (Ferranti et al., 1997), cow and water buffalo (Ferranti et al., 1999). In the human, the first codon 
of exon 6’ (a supplementary exon in the gene of human αs1-CN between exon 6 and exon 7) encoding a Gln-
37 residue is spliced (Johnsen et al., 1995), with the formation of a deleted form with 169 AA and a 
molecular weight lower of 128 Da than the corresponding full-length protein. According to Martin et al. 
(2002), the loss of a Gln residue could be explained by a splicing error by the spliceosome. The codon CAG 
(encoding a Gln residue) at the beginning of an exon could be confused with the AG splice acceptor site of 
the adjacent intron and could be used alternatively (Smith et al., 1993).  
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Mateos et al. (2009b) also determined the different phosphorilation level of  mare αs1-CN, which varies from 
two to six or eight phosphate groups depending on the loss or conservation of exon 7 which encodes for an 
amino acid sequence with two potential phosphorilation sites (Ser58 and Ser61).     
In comparison, bovine αs1-CN contains eight or nine phosphorilation sites (Swaisgood, 2003), while goat and 
ewe αs1-CNs lead from 7 to 10 phosphate and from 5 to 11 respectively, where the highest phosphorilation 
level depends on the type of genetic variant considered. In contrast, the human αs1-CN is resulted less 
phosphorylated than the other mammals, because in the sequence Ser70-Glu78, which is a phosphorylation 
cluster common to all ruminant αs1-CNs, no trace of phosphate group has been found (Sorensen et al., 2003). 
In human αs1-CN, Ser18 and Ser26 encoded by 3 and 5 exons of αs1-CN gene and not always present in 
ruminants, are essentially phosphorylated. However, the human protein contains only four identified 
phosphorilation sites (Ser18, Ser26, Ser73 and Ser75), despite the presence of 9 potential phosphorilation sites 
(Kjeldesen et al., 2007). Moreover human αs1-CN (170 aa) is in mature milk as an heteropolymers with κ-
CN, because it has three cysteines at position 75, 99 and 104. Two of these amino acids form an 
intramolecular disulphide bond, instead the other free cysteine forms an intermolecular disulphide bond with 
κ-CN (Johnsen et al., 1995).  
Moreover, donkey (-1.115), mare (-1.127) and human (-1.013) αs1-CN have comparable GRAVY scores 
(hydropathicity index), which are lower than that of cow αs1-CN, indicating an overall higher hydrophobicity 
for the latter (table 1.3). 
 
The heterogeneity of αs1-CN is due to genetic polymorphism and therefore to identification of several 
variants of this protein in cow milk (A, B, C, D, E, F, G, H); instead for human αs1-CN two variants were 
found, with only silent amino acid substitution (A112→V). To date, no information is available on genetic 
polymorphism of αs1-CN  in equidae milk (mare and donkey).  
 
In bovine milk, αs1-CN is a major structural component of the casein micelle and plays a functional role in 
curd formation (Walstra and Jennes, 1984). The relatively low level of αs1-CN in equid milk (mare and 
donkey) compared with bovine milk may be significant and, coupled with the low protein content, may be 
responsible for the soft curd produced in the infant stomach and the foal. Goat milk lacking αs1-CN has poor 
coagulation properties compared with milk containing αs1-casein (Clark and Sherbon, 2000).  
 
1.5.2 alpha-s2 casein (αs2-CN) 
 
The complete amino acid sequence of equine αs2-CN is unknown but Ochirkhuyag et al. (2000) published the 
sequence of N-terminal 15 amino acid residues (Lys-His-Lys-Met-Glu-His-Phe-Ala-Pro???-Tyr-???-Gln-
Val-Leu), and only five of these amino acids (Lys-His-Asn-Met-Glu-His-Arg-Ser-Ser-Ser-Glu-Glu) were 
confirmed by Miranda et al. (2004). Bovine αs2-CN is the most highly phosphorilation casein, usually 
containing eleven phosphorylated serine residues, with lesser amounts containing ten, twelve or thirteen 
phosphate groups (Swaisgood, 2003). There are no reports on the presence of αs2-CN in human milk. 
Donkey αs2-CN, as cow, is encoded by a gene (CSN1S2 I) constituted by 19 exons mapped on chromosome 
6 which showed an identity of about 74% with corresponding bovine sequence and encodes for a predicted 
protein of 221 amino acids. Cosenza et al. (2010) also sequenced a donkey αs2-CN cDNA sequence (CSN1S2 
II) (16 exons) which encodes for a predicted peptide of 168 amino acids. So, in donkey’s milk, the cDNA 
deduced amino acid sequences of two αs2-CNs (GenBank Acc. Nos CAV00691.1) (221 aa) (Ramunno, 2008) 
and  (GenBank Acc. Nos CAX65660.1) (168 aa) (Ramunno, 2009) have been reported. At this regard, for the 
first time, the primary structure of the expressed protein corresponding to the only available donkey αs2-CN 
cDNA sequence was determined using a proteomic approach (Chianese et al., 2010). Its structural 
characterization confirmed for the first time the correctness of the cDNA-derived sequence reported by 
Ramunno (2008). The main properties of bovine and donkey αs2-CN are reported in Table 1.5  
  
Table 1.5: Properties of Equine, Bovine, Human and donkey αs2-CN. Values were calculated from the amino 
acid sequences of the mature protein provided on SWISS-PROT database (http://au.expasy.org/tools).    
 
 
Protein 
 
Species 
Primary 
Accession 
Number 
Amino 
acid 
residues 
 
Mr (Da) 
 
pI 
 
GRAVY
 
Cys residues 
 
αs2-CN 
Equine -      
Bovine P02663 207 24348.5 8.34 
−0.918 2 
Human -      
Donkey B7VGF9 221 26030.1 5.74 
−0.908 2 
 14
 
Saletti et al. (2012) have reported the identification and direct sequence determination of  the primary 
structure of four αs2-CN isoforms (Fig. 1.4) as internally (non-allelic) deleted donkey’s αs2-CN forms using 
the amino acid sequence of the known full-length donkey’s αs2-CN as reference (GenBank Acc.No. 
CAV00691). In detail, the protein with Mr 25429 Da (A1) differs from the full length αs2-CN (A) for the 
deletion of the Asn 176-Gln180 pentapeptide, whereas in the protein with Mr 21939 Da (A1∆4,5,6), in addition to 
the same peptide, the sequence Asp12-Glu42 is also suppressed. In the third non-allelic deleted form (Mr 
25203 Da) (A2), the Tyr212-Leu218 heptapeptide is absent in comparison with the full-length αs2-CN, whereas 
in the primary structure of the component with Mr 21713 Da (A2∆4,5,6), both the heptapeptide Tyr212-Leu218 
and the sequence Asp12-Glu42 are missed. Taking into account the exon modular structure of the donkey’s 
αs2-CN (Cosenza et al., 2010), it can be observed that the sequence Asn176-Gln180, absent in the components 
with Mr 25429 (A1) and 21939 Da (A1∆4,5,6), represents the first five amino acids encoded by the exon 17; the 
sequence Asp12-Glu42, absent in the primary structure of the components with Mr 21939 (A1∆4,5,6) and 21713 
Da (A2∆4,5,6), is encoded by exons 4, 5, and 6; the heptapeptide Tyr212-Leu218, absent in the primary structure 
of the components with Mr 25203 (A2) and 21713 Da (A2∆4,5,6), is the terminal part of the sequence encoded 
by the exon 17. As evidenced by these data, it can be hypothesized that exons 4, 5 and 6 are completely 
skipped in some events. On the other hand, cryptic 5’ and 3’ splicing sites inside exon 17 may determine the 
absence of the starting five amino acids or the final seven amino acids encoded by this exon in the final 
products. In light of these consideration, the full length donkey’s αs2-CN and the four internally (non-allelic) 
deleted forms can be named as reported in Table 1.6. 
 
Table 1.6: Proposed nomenclature for the full-length and the internally deleted donkey’s αs2-CNs (Saletti et 
al., 2012). 
 
Nomenclature of the isoforms Calculated Mr  Amino acid differences 
A 26028 - 
A1 25429 -Asn 176-Gln180 
A1∆4,5,6 21939 -Asp12-Glu42; -Asn 176-Gln180 
A2 25203 -Tyr212-Leu218 
A2∆4,5,6 21713 -Asp12-Glu42; -Tyr212-Leu218 
 
The existence of a full-length αs2-CN (221 AA and Mr 26028) (Chianese et al., 2010) and its four different 
deleted forms resulting from differential splicing events, is analogous to what was already noted for the αs1-
type CNs (Cunsolo et al., 2009a). This polymorphism seems to be correlated with the complex intron/exon 
modular structure of the genes encoding these proteins, consisting of a large number of short exons, that may 
undergone differential splicing events during primary transcript processing, thus originating protein 
components with different amino acid lengths (Lenasi et al., 2003). Comparative analysis of the primary 
structure of the αs2-CN from donkey and other mammalians reveals that the differential splicing events 
involving the exons 4,5,6 and the last seven amino acids encoded by exon 17 seem unique of donkey species, 
whereas the first five amino acids (N176KINQ180) encoded by exon 17 are also constitutively spliced in the 
αs2-CN from mare (NCBI Acc. No. NP_001164238) (Martin et al., 2009). Moreover it is interesting to note 
that the amino acid sequences absent in the internally deleted αs2-CN forms from donkey are traits of some 
IgE-binding epitopes of bovine αs2-CN. In particular, the NKINQ sequence absent in the deleted forms 
A1and A1∆4,5,6 from donkey and constitutively spliced in the αs2-CN from mare is a trait of two major IgE-
binding epitopes of bovine αs2-CN an therefore could be related to the already demonstrated low allergenic 
properties of donkey’s milk. 
Regarding αs2-CN genetic polymorphism, only four variants (A, B, C, D) are known for bovine αs2-CN, 
while to date no information is available on genetic polymorphism of αs2-CN  in equidae milk (mare and 
donkey).  
 
1.5.3 Beta-casein (β-CN) 
 
According to Lenasi et al. (2003), the number and approximately length of individual exons in horse (as in 
donkey) are most probably the same as in the majority of other species. By aligning equine β-CN cDNAs 
with corresponding cDNAs of other species, 9 exons mapped on chromosome 6 were found in equine β-CN, 
where the first and the last two exons represent 5’ and 3’ UTR (untranslated region, respectively) (Fig. 1.3).  
β-CN’s primary structure from donkey milk has been characterized completely (Cunsolo et al., 2009b), using 
mare’s β-CN derived from cDNA as reference reported by Lenasi et al. (2003) and revised by Girardet et al. 
(2006). It is constituted of 226 amino acids and it has a molecular weight of 25529 Da. Human, cow and 
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mare β-CN contain 211, 209 and 226 amino acid residues, respectively (Table 1.7). However donkey β-CN 
primary structure displays polymorphic patterns, due to alternative splicing processes leading to casual exon 
skipping events involving exon 5, as occurring in the mare’s β-CNs used as reference and reported by 
Miranda et al., 2004.  
In fact Cunsolo et al. (2009b) also identified an deleted component of β-CN, which has a molecular weight of 
24406 Da. So the two donkey β-CNs differ by the presence of the domain E27SITHINK34 in the full-length 
component, as occur in the mare’s β-CNs used as references, which explains the mass difference of 923 Da. 
 
Table 1.7: Properties of Equine, Bovine, Human and donkey β-CN. Values were calculated from the amino 
acid sequences of the mature protein provided on SWISS-PROT database (http://au.expasy.org/tools).    
 
 
Protein 
 
Species 
Primary 
Accession 
Number 
Amino acid 
residues 
 
Mr  (Da) 
 
pI 
 
GRAVY
 
Cys 
residues 
 
β-CN 
Equine Q9GKK3 226 25511.4 5.78 
−0.415 0 
Bovine P02666 209 23583.2 5.13 
−0.355 0 
Human P05814 211 23857,8 5.33 
−0.289 0 
Donkey P86273 226 25529,3 5.54 
−0.406 0 
 
In view of theses analogies, the same nomenclature of mare’s β-CNs was adopted to name the new donkey β-
CN variants. Therefore, the full length (226 amino acids) β-CN was named variant A, whereas the β-CN 
lacking the region 27-34 (218 amino acids) encoded by exon 5 was termed variant A∆5 (Table 1.8). 
 
Table 1.8: Proposed nomenclature for the full-length and the deleted donkey’s β-CN (Cunsolo et al., 2009b). 
 
Nomenclature of the isoforms Calculated Mr  Amino acid differences 
A 25529 - 
A∆5 24406 -Glu 27-Lys34 
 
The two donkey β-CNs differ from the homologous mare’s β-CNs by the  presence of  nine amino acid 
substitutions: L→S37, R→H52, S→N81, P→V84, L→V91, R→Q203, P→L/I206, L→F210, and A→P219. Taken 
together, this substitutions account for the increase of 18 Da in the Mr of the donkey’s β-CNs in comparison 
with the mares counterparts. 
The primary structure of the full-length donkey β-CN contains seven potential phosphorilation sites (Ser9, 
Ser15, Ser17, Ser18, Ser23, Ser24 and Ser25), together with two other potential phosphorilation sites located at 
Thr12 and Thr207, analogously to the homologous mare’s β-CN. The Ser-Xxx-Glu/SerP and Ser-Xxx-Xxx-Glu 
motifs are the recognition sequences characterized for cow mammary gland casein Kinase I (Mercier, 1981) 
and II (Kuenzel et al., 1987), whereas studies on the specificity of mammary gland casein kinase have shown 
that the sequence motif Thr-Xxx-Glu is a poor substrate for the mammary gland enzyme and is usually not 
phosphorylated (Bingham & Groves, 1979; Sorensen & Petersen, 1994). Moreover the mRNA of donkey’s 
β-CN, as mare’s β-CN contains an additional exon (exon 4’ corresponding to the 21-26 region), which is not 
observed in the other mammals, and seems specific to equidae (Miranda et al., 2004). This additional exon 4’ 
encodes a region containing a phosphorilation cluster with three potential sites and, hence, is partly the cause 
of the high content in SerP of equine and donkey β-CN. The presence of exon 4’ in equidae would largely 
compensate for the substitution of a SerP residue of the –SerP-SerP-SerP-Glu- cluster, that is usually found 
in the exon 4-encoded region (residues 12-20) of numerous mammals, by an Asn residue in position 19. 
Therefore the analysis of the donkey phosphorylated β-CNs demonstrated that the full-length variant A 
consist of three components carrying from five to seven phosphate groups, whereas no data were obtained 
about the phosphorilation level of the short β-CN variant A∆5. 6P and 7P isoforms of the variant A occur with 
comparable relative abundances whereas the 5P protein is present as a minor component, revealing that this 
protein is more phosphorylated (Cunsolo et al., 2009b) than the homologous mare’s β-CN, in which the 
predominant phosphorylated components carries five phosphate groups even if its maximum degree of 
phosphorilation is 7P (Girardet et al., 2006). According to Mateos et al. (2009a), in equine milk the short β-
CN variant A∆5 also carries five phosphate groups even if its maximum degree of phosphorilation is 7P. Also 
cow β-CN contains four o five phosphorylated serine residue (Swaisgood, 2003), instead human β-CN has up 
to six phosphorilation level (Sood & Slattery, 2000) and the phosphate groups are located in a cluster 
sequence near the amino terminus, within the first ten residues of this protein (Greenberg et al., 1984). 
Moreover, unique to equine milk and apparently absent from the milk of other mammals (including 
ruminants) is a low molecular mass β-CN protein which accounts for 4% of the casein content (Miclo et al., 
2007). This short protein (94 amino acid residues) is an internally truncated form of the full length equine β-
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CN (226 residues), in which a large internal peptide sequence (132 residues) is lacking. According Miclo et 
al. (2007), this large deletion (residues 50-181) might be due of an alternative donor splice site, identified in 
the terminal part of the nucleotide sequence encoding exon 7. Such a cryptic splice site usage should result in 
RNA forms that lacked the first 396 nucleotides of exon 7. Deletion of the basic 50-181 region conferred to 
this short protein a more acidic nature than corresponding full-length β-CN. Seven phosphorilation were 
identified with one to seven phosphate groups, even if the major isoforms carry five and six phosphate 
groups. Moreover, no spontaneous deamidation of this low molecular mass form of β-CN has been found, 
and the preferential site of hydrolysis by plasmin (Lys55-Ile56) in β-CN sequence was lost after truncation of 
exon 7, whereas the highly sensitive peptide bond toward chymosin (Leu198-Tyr199) was preserved (Miclo et 
al., 2007). 
Equine β-CN is a good substrate for plasmin associated to equine caseinate, where the Lys47-Ile48 bond of β-
CN is readily hydrolysed leading to the production of γ-like caseins, whereas no cleavage of a corresponding 
bond Lys48-Ile49, in bovine β-CN occurs (Egito et al., 2003). In bovine milk, plasmin activity on β-CN results 
in production of γ1-, γ2-, γ3-CNs (fragments 29-209, 106-209 and 108-209 of bovine β-CN, respectively) and 
of their complementary amino-terminal peptides, components 5 of proteose peptone (PP5), components PP8-
slow, and component PP8-fast (fragments 1-105/107, 29-105/107, and 1-28 of β-CN, respectively). In bovine 
β-CN, Lys28-Ile29 is readily cleaved by plasmin but the equivalent, Lys28-Ile29 in equine β-CN is insensitive 
(Egito et al., 2002). Other plasmin cleavage sites in equine β-CN are Lys103-Arg104 Arg104-Lys105 and Lys105-
Val106 (Egito et al., 2002). Equine β-CN is readily hydrolysed by chymosin at Leu190-Tyr191 (Egito et al., 
2001) and the two fragments generated seemed to be resistant to further hydrolysis by chymosin at pH 6.5.     
Equine, bovine, human and donkey β-CN have a very hydrophilic N-terminus, followed by a relatively 
random hydropathy distribution in the rest of the protein, leading to an amphiphilic protein with a hydrophilic 
N-terminus and a hydrophobic C-terminus (Table 1.7).   
 
Regarding β-CN genetic polymorphism, this phenomenon is quite complex in cow’s milk, due to the high 
variability and to the presence of a large number of cases not characterized or not well clarified variants. 
However for cow β-CN, in addition to already identified genetic variants (A1, A2, A3, B, C, D, E), new 
variants have been identified (F, H1, H2 and I). According to Greenberg et al. (1984), there is also the 
existence of genetic polymorphism in human β-CN, but probably the substitution involving uncharged amino 
acids make difficult to demonstrate this phenomenon. To date no information is available on genetic 
polymorphism of β-CN in equidae milk (mare and donkey).  
 
1.5.4.1 Kappa casein (κ-CN) 
 
The presence of κ-CN in equine milk was an issue of debate for several years, with several authors (Ono et 
al., 1989; Visser et al., 1992; Ochirkhuyag et al., 2000) reporting its absence, even if other studies (Malacarne 
et al., 2000; Egito et al., 2001; Iametti et al., 2001) showed its presence, albeit at low concentration. The 
primary structure of equine κ-CN has been derived (Iametti et al., 2001; Lenasi et al., 2003; Miranda et al., 
2004); it contains 165 amino acid residues, four less than bovine κ-CN but three more than human casein 
(table 1.9). The molecular mass of equine κ-CN, prior to post-translation modification is 18847.7 Da. Equine 
and human κ-CN have a considerably higher isoelectric pH than bovine κ-CN (table 1.9), and they have a net 
positive charge at physiological pH, whereas bovine κ-CN has a net negative charge. In fact, equine κ-CN 
contains 11 negatively charged residues and 14 positively charged residues compared with 16 and 14, 
respectively, in the bovine protein. This distribution is reflected in the calculated pI values (equine: 9.02; 
bovine: 5.93). The particular composition of equine κ-CN is similar to that found in κ-CN from monogastric 
species, such as human κ-CN (11 negatively charged residues; 13 positively charged residues, pI 8.68), or pig 
κ-CN (15 negatively charged residues; 17 positively charged residues; pI 8.68) (Iametti et al., 2001). The 
GRAVY score of bovine κ-CN is considerably lower than that of equine κ-CN (Table 1.9), indicating that 
equine κ-CN is less hydrophilic than its bovine counterpart. Bovine κ-CN is characterized by a hydrophilic 
C-terminus, which is very important for the stabilization of bovine casein micelles, but a comparison of the 
hydropathy distribution of bovine and equine κ-CNs indicates that the C-terminus of equine κ-CN is far less 
hydrophilic, particularly as a result of the absence of a strong hydrophilic region at residues 110-120. Equine 
κ-CN appears to be more like human than bovine κ-CN in terms of  the distribution of hydropathy along the 
polypeptide chain. 
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Table 1.9: Properties of Equine, Bovine, Human κ-CN. Values were calculated from the amino acid 
sequences of the mature protein provided on SWISS-PROT database (http://au.expasy.org/tools).    
 
 
Protein 
 
Species 
Primary 
Accession 
Number 
Amino acid 
residues 
 
Mr (Da) 
 
pI 
 
GRAVY
 
Cys 
residues 
 
κ-CN 
Equine P82187 165 18844.7 8.03 
−0.313 2 
Bovine P02668 169 18974.4 5.93 
−0.557 2 
Human P07498 162 18162.6 8.68 
−0.528 1 
 
1.5.4.2 Glycosylation of κ-CN  
κ-CN is the only glycosylated member of the casein family and exhibits micro-heterogeneity due to the level 
of glycosylation (Saito & Itoh, 1992). Oligosaccharides consisting of N-acetylneuraminic acid (NANA), 
galactose and N-acetylgalactosamine are attached to κ-CN via O-glycosidic linkages to threonine residues in 
the C-terminal portion of the molecule (glycomacropeptide, GMP, region). Human κ-CN contains 
approximately 5 times more sugars (around 55%) than cow. Not only galactose, NANA and N-
acetylgalactosamine, but also fucose and N-acetylglucosamine were identified (Fiat et al., 1980). 
Glycosylation degree is higher in colostrum than in milk, and increases during mastitis infection (Dziuba & 
Minkiewicz, 1996). Although no direct information is available, lectin binding studies indicate that equine κ-
CN is glycosylated (Iametti et al., 2001), probably at residues Thr123, Thr127, Thr131, Thr149, Thr153 (Lenasi et 
al., 2003), although these glycosylation sites are not fully in agreement with those proposed by Egito at al. 
(2001). In equine κ-CN, nine threonine residues were possible O-glycosylation sites Thr116, Thr123, Thr127 
Thr131, Thr150, Thr153 Thr154, Thr155 andThr159 (Egito et al., 2001). Equine κ-CN might thus be more 
glycosylated than bovine κ-CN which has six glycosylated threonine residues. In general, κ-CNs of Group II 
are more glycosylated than κ-CNs of Group I (as will be seen later). About two-thirds of bovine κ-CN 
molecules are glycosylated at one of six threonil residues, i.e., Thr121, Thr131, Thr133, Thr135, Thr136 (only in 
bovine κ-CN variant A) or Thr142 (Pisano et al., 1994). Human κ-CN have seven glycosylation sites Thr113, 
Thr123, Thr128, Thr131, Thr137, Thr147 and Thr149 (Fiat et al., 1980). To date, no non-glycosylated κ-CN has 
been identified in equine milk (Martuzzi & Doreau, 2006). 
No direct information is available on the phosphorilation state of the equine protein. However, three putative 
phosphorilation sites, namely Thr127, Thr150 and Ser160, may be suggested based on the sequence similarity 
studies with other κ-CNs and on prediction analyses (Iametti et al., 2001).  
κ-CN is located mainly on the surface of the casein micelles and is responsible for their stability. The 
presence of a glycan moiety in the C-terminal region of κ-CN enhances its ability to stabilize the micelle, by 
electrostatic repulsion, and may increase the resistance by the protein to proteolytic enzymes and high 
temperature (Dziuba & Muzinska, 1996). Biologically, NANA residues have antibacterial properties and act 
as a bifidogenic factor (Dziuba & Muzinska, 1996). κ-CN is thought to play a major role in preventing 
adhesion of Helicobacter pilori to human gastric mucosa (Stromqsit et al., 1995). It is likely that heavily 
glycosylated κ-CN provides protection due to its carbohydrate content and breast-feeding infants is thought 
to provide some protection, especially Helicobacter pilori infection is occurring in increasingly younger age 
(Lonnerdal, 2003). In spite of some peculiarities, some of which also occur in other monogastric species, 
equine milk κ-CN appeared to have all the properties found in other κ-CNs and associated with the role of 
this protein family in the formation and stabilization of the micellar structure of casein in milk (Iametti et al., 
2001).    
 
1.5.4.3 Hydrolysis of κ-CN  
The hydrolysis of bovine κ-CN by chymosin at Phe105-Met106 leads to the production of the hydrophobic 
(non-glycosylated) N-terminal para-κ-CN and the hydrophilic, highly charged (O-glycosylated) C-terminal 
caseinomacropeptide (CMP) (Walstra & Jennes, 1984). Release of CMP causes destabilisation of the casein 
micelles, resulting in their coagulation. The insoluble para-κ-CN remains in the coagulum, whereas CMP is 
released into the soluble phase (Jollès et al., 1972) Calf chymosin hydrolyses the Phe97-Ile98 bond of equine 
κ-CN (Egito et al., 2001) and slowly hydrolyses the Phe105-Met106 bond of human κ-CN (Plowman et al., 
1999). However as summarized in Table 1.10, the CMPs released from equine or human κ-CN are 
considerably less hydrophilic than bovine CMP.  
 
Table 1.10: Properties of Equine, Bovine, Human para-κ-CN and CMP. Values were calculated from the 
amino acid sequences of the mature protein provided on SWISS-PROT database (http://au.expasy.org/tools).    
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Protein 
 
Species 
Amino acid 
residues 
 
Mr (Da) 
 
pI 
 
GRAVY
 
 
Para-κ-CN 
 
 
CMP 
Equine 1-97 11693.3 8.96 
−0.675 
Bovine 1-105 12285.0 9.33 
−0.617 
Human 1-105 11456.9 9.63 
−1.004 
Equine 98-165 7169.3 4.72 0.203 
Bovine 106-169 6707.4 4.04 
−0.370 
Human 106-169 6723.7 4.24 0.182 
 
The sequence 97-116 of κ-CN is highly conserved across species, suggesting that the limited proteolysis of 
κ-CN and subsequent coagulation of milk are of major biological significance (Mercier at al., 1976). A 
grouping system for mammals based on κ-CN structure and the site of cleavage by chymosin has been 
suggested. Group I species (cow, goat, sheep, buffalo) have a high content of dicarboxylic amino acids and 
low hydrophobicity and carbohydrate content and κ-CN is cleaved at Phe105-Met106, while Group II species 
(human, mouse, pig, rat) have a high proline content, less dicarboxylic amino acids and a much higher 
hydrophobicity and carbohydrate content and are cleaved at Phe97-Ile98 or Phe105-Leu106. Cleavage of equine 
milk at Phe97-Ile98, as well as other characteristics of its κ-CN (i.e., zebra), place the horse in Group II. The 
divergence between species into Groups I and II could account for differences in the clotting mechanism of 
ruminant and non-ruminant milk (Herskovitis, 1966). In addition to differences in cleavage sites, the 
grouping system also divides species based on the number of O-glycosylation sites. As equine and human κ-
CNs are considerably more highly glycosylated than bovine κ-CN and non-glycosylated κ-CN has not been 
found in equine milk (Egito et al., 2001), equine and human κ-CN belong to the same group. The level of 
glycosylation does not affect micelle structure but it does affect the susceptibility of κ-CN to hydrolysis by 
chymosin, with susceptibility decreasing as the level of glycosylation increases (Addeo et al., 1984; 
Zbikwoska et al., 1992). Therefore, equine milk probably has a different chymosin-induced clotting 
mechanism than bovine milk.    
The proportion of κ-CN in equine milk appears to be lower compared to that cow’s and human milk (Egito et 
al., 2001). Also in donkey’s milk this protein might be in minute, and therefore undetectable quantities,, 
making their characterization difficult (Vincenzetti et al., 2008). However Chianese et al. (2010) identified 
this protein in donkey milk, thanks to the recent advances in proteomic technology. The results obtained by 
Chianese et al. (2010) showed, also for this protein, a high heterogeneity due to its different glycosylation 
level. However, to date the knowledge of donkey κ-CN is scant and only the primary structure of κ-CN, 
deduced from corresponding cDNA, has been reported (Di Gregorio, 2011). κ-CN cDNA have been 
characterized in several species and its structure is very similar among them. Regarding κ-CN (CSN3) gene 
in horse, it consists of 5 exons mapped on chromosome 6, even if  the mature κ-CN is only encoded by part 
of the exon 3 and the entire exon 4 (Hobor et al., 2006). The first and the last exons  represent 5’ and 3’ UTR 
(untraslated region), respectively, while the signal peptide encoded by exon 2 does not also transated (Lenasi 
et al., 2003). Moreover, the κ-CN gene was postulated to be not evolutionary related to the genes encoding 
the calcium sensitive caseins, but evolutionary to fibrinogen gene family whose cleavage by thrombin results 
in blood clotting (Jolles et al., 1978). This hypothesis is sustained by the structural and functional similarities 
between the proteins, and by nucleotide sequence similarities between κ-CN and fibrinogen cDNAs.  
The genetic polymorphism of κ-CN is also of interest, since some variants could be more beneficial from the 
point of human nutrition or be associated with milk quality, composition and technological characteristics 
(Yahyaoui et al., 2003). In case of cow’s milk, B allelic variant of CSN3 gene is preferable and animals with 
genotype BB produce milk with better cheese making ability and shorter rennet time.        
To date no information is available on genetic polymorphism of κ-CN in equidae milk (mare and donkey) 
and specifically for donkey κ-CN, its primary structure was not determined.  
 
 
 
 
 
 
 
 
 
 
 
 
 19
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.1 Primary structure of donkey αs1-CN (202 aa since exon 7 outspliced). IN RESULTS AND 
DISCUSSION, the insertion of exon 7 which encodes for octapeptide DTSNESTE as in homologous mare 
αs1-CN, determines the formation of donkey αs1-CN with 210 aa long. With the insertion of exon 7 and 
skipping of first codon CAG of exon 11, donkey αs1-CN is 209 aa long. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.2 Primary structure of mare αs1-CN (exon 5 outspliced). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RP NEQDSRE KLPHRHPEIIQ KVLKERKFPSFAL HTPRE EYINELNR 
QRELLKEKQKDEHK DTSNESTE EYLIEDPE QQESSSTSSSE EVVPINTE 
QKRIPREDMLYQHTL EQLRRLSKYNQLQL QAIYAQ EQLIRMKENSQ 
EQAYFYLE RKPMRVVNQ PFQPSYQLDVYPYAAWFHPAQIMQHVAYSPFHDTA 
KLIASENSEKTDIIPEW 
EXON 2 EXON 3 EXON 3’ EXON 4 
EXON 5 
EXON 6 
EXON 6’ EXON 7 EXON 8 EXON 9 EXON 10 
EXON 11 EXON 12 EXON 13’ EXON 14 
EXON 15 EXON 16 EXON 17 
EXON 17 
1 34 38 
47 61 68 
96 
142 
194 210 
Skipping/insertion exon 7 
Skipping/insertion  exon 5 
RP NEQDSRKLPHRQPEIIQ KVLKERKFPSFAL EYINELN QRELLKEKQKDEH
DTSNEST EYLIEDPE QQESSSTSSS EVVPINT QKRIPREDMLYQHT
EQLRRLSKYNQLQ QAIHAQ EQLIRMKENS EQAYFYLE RKPMRVVNQ 
PFQPSYQLDVYPYAAWFHPAQIMQHVAYSPFHDTAKLIASENSEKTDIIPE
EXON 2 EXON 3 EXON 3’ EXON 4 EXON 6 EXON 6’ 
EXON 7 EXON 8 EXON 9 EXON 10 EXON 11 
EXON 12 EXON 13’ EXON 14 EXON 15 EXON 16 
EXON 17 
1 
Skipping/insertion exon 7 
Skipping/insertion exon 14 
56 63 
106 126 136 
154 205 
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Fig. 1.3: Primary structure of donkey and mare β-CN. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.4: Primary structure of donkey αs2-CN. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RE TVESLSSNE KEELNVSSE PDSSE ESITHINK EEKSQKFKHEGQQQRE 
VEHQDHKISRFVQPQVVYPYAEPVPYAVVPQNILVLAQPPIVPFLQPEIMEVSQAKETILPK 
EXON 2 EXON 3 EXON 4’ EXON 5 EXON 6 
EXON 7 
1 
Amino acid substitution present in donkey β-CN 
with respect to mare’s counterparts 
Skipping/insertion  exon 5 
EXON 4 
RKVMPFLKSPIVPFSERQILNPTNGENLRLPVHLIQPFMHQVPQSLLQTLMLPSQPVLSPPQ 
SKVAPFPQPVVPYPQRDTPVQAFLLYQDPQLGLTGEFDPATQPIVPVHNPVI 
226 
V 
27 34 
EXON 8 
KH NMEHRSSS DSVNISQE KFKQEKYVVIPTS ESICSTSCE 
EATRNINEM ESAKFPT VYSSSSSSE ESAKFPT
LNKINQFYEKLNFLQYLQALRQPRIVLTPWDQTKTGASPFIPIV NTEQLFTSE 
EIPKKTVDM ESTEVVTE 
NKINQYYEKFTLPQYFKIVHQHQTTMDPQSHSKTNSYQIIPV
KTELTEEEKNYLKLL 
EXON 2 EXON 3 EXON 4 EXON 5 EXON 6 
EXON 7 EXON 8 EXON 9 EXON 10 
EXON 12 EXON 13’ 
EXON 14 EXON 15 EXON 16 
EXON 17 
1 
91 
144 
176 221 
REEKEVEEKHHLKQ 
EXON 11 
EXON 18 
RYF 
42 
43 
143 
90 
175 
Skipping exon 4 
Skipping exon 5 
Skipping exon 6 
Skipping initial part of exon 17 
Skipping final part of exon 17 
A1 
A2 A2∆4,5,6 
A1∆4,5,6 
12 
180 218 212 
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1.6 Donkey whey proteins 
 
Donkey’s milk whey proteins represent the 35-50% of the nitrogen fraction whereas in bovine milk only the 
20% (Herrouin et al., 2000). The most important whey proteins in donkey’s milk are α-Lactalbumin (α-La), 
β-Lactoglobulin (β-Lg) and lysozyme (Lyz), as demonstrated by Fantuz et al. (2001). In Table 1.11, a 
comparison of the concentration of total caseins, whey proteins and non-casein proteins in human, mare’s 
and donkey’s milk is shown. 
 
Table 1.11 : Comparison of the concentration of total caseins, total whey proteins and of the relative amounts 
of non-casein proteins in human, mare’s and donkey’s milk (Malacarne et al., 2002; Miranda et al., 2004). 
 
 Human (mg/ml) Equine (mg/ml) Donkey (mg/ml) 
Caseins 5.8 10.3b-14.0a 6.60 
Whey proteins 2.1 8.03a-7.40b 7.50 
Lysozyme 0.50a 1.10a 1.00 
β-Lattoglobulin  3.00a 3.75 
α-Lactalbumin 1.60a 3.30a 1.80 
 
In contrast to bovine milk proteins, only limited data are available for genetic polymorphism of donkey whey 
proteins. 
Similar to α-La of bovine, caprine, ovine, camelid, human and mare’s milk, donkey α-La contains 123 amino 
acids.  
In horse milk, Godovac-Zimmermann et al. (1987) showed the occurrence of three genetic variants of α-La 
named α-La A, B and C, which differ by only a few single amino acids, whereas only one α-La genetic 
variant was reported in donkey milk, even if apparent heterogeneity of the protein was observed (Giuffrida et 
al., 1992) for the identification of two isoforms (A and B) both of them glycosylated (Bertino et al., 2010).  
Donkey α-La is closely related to the horse A-type variant according to the amino acid sequence alignment. 
The percentage of sequence identity between the two proteins is 99.2%, whereas it is 96,7% with horse B/C 
type variants. Bovine α-La occurs as two, or possibly three, genetic variants (Bell et al., 1981) and human α-
La has two genetic variants, one of which has been identified only recently (Chowanadisaia et al., 2005). The 
primary structures of mare, bovine, human and donkey α-La differ only by a few single amino acid 
replacements, and the proteins have similar properties (Table 1.12) 
 
Table 1.12: Properties of equine, bovine, human and donkey α-La. Values were calculated from the amino 
acid sequences of the mature protein provided on SWISS-PROT database (http://au.expasy.org/tools).    
 
Species Variant AA residues Molecular Mass 
(Da) 
pI GRAVY 
 score 
Disulphide 
 bridges 
Equine A 123 14223.2 4.95 -0.416 4 
 B 123 14251.2 4.95 -0.503 4 
 C 123 14249.3 5.11 -0.438 4 
Bovine  123 14186.0 4.80 -0.453 4 
Human  123 14078.1 4.70 -0.255 4 
Donkey  123 14222.3 5.11 -0.416 4 
  
Equine α-La A, B, and C have an isoelectric point at pH 4.95, 4.95 and 5.11, respectively, as donkey α-La 
(5.11), whereas bovine and human α-La have pIs at pH 4.80 and 4.70, respectively (Table 1.12). The 
GRAVY scores of equine, bovine and donkey α-La are comparable, whereas that of human α-La is distinctly 
higher (Table 1.12), indicating a lower hydrophobicity. The eight cysteine residues of bovine and human α-
La form four intra-molecular disulphide bonds (Cys6-Cys20, Cys28-Cys111, Cys61-Cys77,  Cys73-Cys93). Based 
on the very high similarity between equine, bovine human and donkey α-La, as well as the α-La from other 
species, it is highly likely that equine and donkey α-La also contains four intra-molecular disulphide bridges, 
at the aforementioned positions.   
According to Vincenzetti et al. (2008), the  donkey α-La content showed a marked increase three month after 
parturition to reach the value of  1.8 mg/mL, that remained almost stable during the remaining lactation 
period (Table 1.13). This value obtained for donkey’s milk is in good agreement with the α-La content in  
human milk (1.6 mg/mL) but is very low to the mare α-La content (3.3 mg/mL), which is instead very close 
to the α-La content in bovine milk (Table 1.11). 
 22
However, α-La, a unique protein in the milk of mammals, is homologous with the well characterized c-type 
lysozyme. It is a calcium metalloprotein, in which Ca2+ plays a crucial role in folding and structure. The 
determination of calcium amount bound to the A and B isoforms showed that A α-La binds less Ca2+ than B, 
so its apparent heterogeneity is due to different ability to bind Ca2+, missing in the α-La A (Conti et al., 1989; 
Herrouin et al., 2000). Moreover, α-La is synthesized in the rough endoplasmic reticulum, from where it is 
transported to the Golgi apparatus, where it has a regulatory function in the synthesis of lactose. Together 
with β-1,4 galactosyltranferase, which is the catalytic component of the lactose synthetase, α-La enhances 
affinity for glucose 1000-fold in the final step of lactose synthesis, when glucose is linked to galactose 
(Neville, 2009). 
β-Lg is the major whey protein in the milk of ruminants, and is also present in milk of monogastrics and 
marsupials, but not in that of humans and rodents (Hambling et al., 1992).  It is a member of the superfamily 
of hydrophobic molecule transporters or Lipocalins which have a strong affinity for hydrophobic molecules. 
The physiological function of this protein is unclear, though it is suspected to be involved in retinol and fatty 
acids transport (Pérez & Calvo, 1995). Bovine β-Lg is very resistant to peptic digestion and can cause 
allergenic reaction on consumption, even if the resistance to digestion is not uniform among the species and 
this is important considering the potential application of donkey’s milk as a hypo-allergenic dairy product 
(El-Zahar et al., 2005). 
The donkey β-Lg content proved to be stable during the different stages of lactation with a mean value of 
about 3.75 mg/mL (Table 1.13) (Vincenzetti et al., 2008) which is very close to that of bovine milk (3.3 
mg/mL) and mare’s milk (3.0 mg/mL), whereas in human milk the β-Lg content is absent (Miranda et al., 
2004) (Table 1.11). 
 
Table 1.13: Quantitative determination of α-La, lysozyme, β-Lg in different stage of lactation  (Vincenzetti 
et al., 2008). 
 
Days after parturition Lysozyme (mg/mL) β-Lg (mg/mL) α-La(mg/mL) 
60 1.34 Non deter. 0.81 
90 0.94 4.13 1.97 
120 1.03 3.60 1.87 
160 0.82 3.69 1.74 
190 0.76 3.60 1.63 
 
In ruminants β-Lg is encoded by a single gene, although the presence of a β-Lg pseudogene has been 
described in the cow (Passey & MacKinlay, 1995) and goat (Folch et al., 1996). In the milk of these species, 
β-Lg exists predominantly as a dimer. Bovine β-Lg occurs mainly as two genetic variants A and B, both of 
which contain 162 amino acids and differ only at position 63 (Asp in variant A, Gly in variant B) and 117 
(Val in variant A, Ala in variant B); a further eleven, less common genetic variants of bovine β-Lg have also 
been reported (Sawyer, 2003). In donkeys milk as in horse, dogs and dolphins, two structurally different 
monomeric β-Lgs exist, called β-Lg I and β-Lg II. The presence of third  protein in milk (β-Lg III) has been 
described only in cats, where β-Lgs exhibit a high polymorphism (Halliday et al., 1993). 
In donkey’s milk, β-Lg I is the major component and represents about 80% of total β-Lg, instead β-Lg II is 
the minor component (about 20% of the total protein) (Godovac-Zimmermann et al., 1990). β-Lg I is 162 
amino acids long (4 cysteines) and two genetic variants named A (18524 Da) (Godovac-Zimmermann et al., 
1988a) and B (18510 Da) (Herrouin et al., 2000) with a molecular mass difference of 14 Da due to three 
amino acid substitutions E36→S, S97→T e V150→I (Table 1.14). The homology of donkey β-Lg I A with B 
variants accounted for 98.1% and each of them, was 98.8% and 99.4%, identical to horse counterpart, 
respectively. In the same way the homology of β-Lg I with donkey β-Lg II and cow counterpart accounted 
for 65.6% and 56.0% respectively (http://au.expasy.org). 
β-Lg II presents 163 amino acids for the additional glycine residue between 116-117th aa as in mare’s milk. 
Four genetic variants of donkey β-Lg II named A (Godovac-Zimmermann et al., 1990), B (Herrouin et al., 
2000), C (Herrouin et al., 2000) and D (Cunsolo et al., 2007) have been identified and characterized (Table 
1.14).  
Unlike ruminants β-Lgs and donkey β-Lg II A (each having five cysteine residues), only four cysteines were 
found in asinine species. Specifically, donkey, equine and bovine β-Lg contain two intra-molecular 
disulphide bridges, linking Cys66-Cys160 and Cys106-Cys119 in equine and donkey β-Lg I, Cys66-Cys161 and 
Cys106-Cys120 in equine and donkey β-Lg II and Cys66-Cys160 and Cys106-Cys119 or Cys121 in bovine β-Lg A 
and B (Cunsolo et al., 2007). At this regard, unlike bovine β-Lgs, equine and donkey β-Lg lack a sulphydryl 
group, which has large implications for denaturation and aggregation of the protein. Also, unlike bovine β-
Lg, equine and donkey β-Lg do not dimerize (Sawyer, 2003).   
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Table 1.14: Physico-chemical characteristics of donkey β-Lg I and β-Lg II genetic variants. 
 
Protein Genetic 
variant 
Amino acid  
Substitutions 
Amino 
acid 
residues 
Molecular 
mass 
 (Da) 
Number and 
positions of 
disulphide bridges 
pI 
β-Lg I A E36     S97          V150 162 18528 2 (66-160; 106-119) 4.79 
 B S36     T97        I150 “ 18514 “ 4.85 
β-Lg II A D2   R18   V25   D96   fC110   M118   G162 163 18263 2 (66-161;106-120) 4.70 
 B                                P110    T118 “ 18227 “ 4.70 
 C                       E96    P110    T118 “ 18241 “ 4.72 
 D                                P110              D162 “ 18311 “ 4.64 
 
The two β-Lgs (β-Lg I and β-Lg II), each containing 162 and 163 amino acid respectively, were also found 
in equine milk (Halliday et al., 1991). The main characteristics of bovine, equine and donkey β-Lg were 
reported in Table 1.15, where bovine β-Lg A and B have a GRAVY score of −0.167 and−0.162, respectively, 
and are, therefore, considered to be less hydrophilic than equine and donkey β-Lg I and β-Lg II.    
 
Table 1.15: Properties of equine, bovine, human and donkey β-Lg. Values were calculated from the amino 
acid sequences of the mature protein provided on SWISS-PROT database (http://au.expasy.org/tools).    
 
Species Variant AA residues Molecular Mass 
(Da) 
pI GRAVY 
 score 
Disulphide 
 bridges 
Equine I 162 18500.1 4.85 -0.386 2 
 II 163 18261.6 4.71 -0.300 2 
Bovine A 162 18367.3 4.76 -0.167 2 
Bovine B 162 18281.2 4.83 -0.162 2 
Donkey I 162 18528.2 4.79 -0.404 2 
Donkey II 163 18262.6 4.70 -0.265 2 
 
1.6.1 The donkey lysozyme  
 
Lysozyme (Lyz) is known to be a natural antimicrobial agent (very resistant to acid and protease 
gastrointestinal digestion) since it catalyses the hydrolysis of glycosidic bonds of mucopolysaccharides in 
bacterial cell walls (Chiavari et al., 2005), and so inhibiting many pathogens bacteria development makes the 
milk somewhat selective with regards to the bacteria it can host. So this enzyme, together with other factor 
including immunoglobulins, lactoferrin and lactoperoxidase could be one of the most important component 
of the immune system of children and it may function in the infant’s digestive tract to reduce the incidence of 
gastrointestinal infections (Businco et al., 2000). According to Vincenzetti et al. (2008), the Lyz content in 
donkey’s milk varied considerably during the different stages of lactation (Table 1.13), with a mean value of  
1.0 mg/mL, and proved to be higher  with respect to that in bovine (traces), human (0.12 mg/mL) and goat’s 
milk (traces), whereas, it was very close to mare’s milk (0.79 mg/mL), as observed by Stelwagen, (2003). 
Two genetic variants of donkey Lyz are known: A (14680) (Godovac-Zimmermann et al., 1988b) and B 
(14631) (Herrouin et al., 2000) with three amino acid substitutions in comparison with Lyz A N49 →D, 
Y52→S and S61→N, which explain the loss of 48 Da in the molecular mass of Lyz A. However, donkey Lys 
B showed 97.7% identity with donkey Lyz A. In comparison with horse Lyz, the donkey Lyz B has a greater 
percentage identity than donkey Lys A (98.4% vs. 97.7%) (Table 1.16) 
 
Table 1.16: Donkey Lyz genetic variants in comparison with horse Lyz. 
 
Lyz    49    52    61 86 
A Donkey Asn (N) Tyr  (Y) Ser  (S) Asp (D) 
B Donkey Asp (D) Ser  (S) Asn (N) Asp (D) 
Horse Asn (N) Ser  (S) Asn (N) Glu (E) 
 
The large amount of Lyz in donkey milk may be useful not only to prevent intestine infections in infants, but 
also responsible for the low bacterial count as reported by Salimei et al. (2004a), giving to the donkey’s milk 
the peculiarity to preserve their organoleptic and microbiological characteristics unchanged for a long time. 
In fact it has been observed in a donkey milk sample stored at refrigeration system for over 10 days that the 
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organoleptic characteristics, pH and microbial flora showed no significant changes (Polidori & Vincenzetti, 
2007). At this regard, Zhang et al. (2008) showed that the absence of Salmonella and Shighella strains and a 
growth reduction of S. choleraus and S. disenteriae in donkey’s milk can be attributed to the activity of Lyz 
and other antimicrobial molecules as LPS, lactoferrin, immunoglobulin and free fatty acids. Also Tidona et 
al. (2009) showed antimicrobial effect of donkey’s milk on selected pathogenic bacteria with a significant 
reduction growth of E. coli during its stationary phase and inhibition of L. monocytogenes 2230/92 in a dose 
dependent way. 
The interest for Lyz is also motivated by its role in mitigating the inflammation of the epidermis and scalp, 
which justifies the dermatological use of donkey’s milk carried out since ancient Rome (Cotte, 1991). 
In addition, Lyz has also other physiological functions, including inactivation of certain virus, 
immunoregulatory activity, anti-inflammatory and anti-tumor activity (Ibrahm & Aoki, 2003). In fact, in Mao 
et al. (2009) study, an high content of Lyz in donkey’s milk may contribute to its anti-proliferative and anti 
tumor effects on A549 human long cancer cells in vitro. 
Donkey milk active components, as Lyz, reduced the viability of A549 cells in dose-dependent and time 
dependent manners either directly by apoptosis or indirectly through the secretion of molecules responsible 
of  lymphocytes and macrophages activation. 
Considering the numerous benefits of donkey milk, including its healthy-promoting characteristic and 
probiotic effect, Chiavari et al. (2005) and Coppola et al. (2002) suggested the possibility of using donkey’s 
milk for probiotic purposes. Donkey’s milk could be valorised as a very good base for a fermented milk 
beverage, since it proved to be a good growth medium for probiotic lactobacilli (L. rhamnosus and L. casei) 
because of its initial low microbial count, high lactose content and mainly high Lyz content (Coppola et al., 
2002). In fact it must be noted that Lyz can be considered an indirect “bifidogenic factor” and so a vehicle for 
the consumption of probiotic bacteria. However the high Lyz content in donkey’s milk seems did not affect 
the probiotic strains viability during the storage and so, only partially it influenced the growth of the strains 
tested without also any significant effect on their acidifying activity (Coppola et al., 2002). According to 
Chiavari et al. (2005), in a fermented beverage with lactobacilli, a Lyz activity unchanged in comparison 
with initial values, also after pasteurization carried out at 63°C for 30 min and after 30 days shelf life. 
These results confirmed the possibility of producing a probiotic infant formula with favorable beneficial 
properties using donkey’s milk as a raw material (Chiavari et al., 2005). 
 
1.7 The mineral content 
 
The intense neonatal pace of foal growth also requires an adequate mineral content in donkey’s milk which is 
unaffected by breed (Mariani et al., 2001), even though it varies, with a continuous decline, during lactation. 
In fact, the milk produced in the first month of lactation, when milk is the only nutritional source for the foal, 
contained the highest levels of mineral elements, which may be related to the considerable requirements of 
the young foal at the first fast growth stage. Afterward, the mineral supply decreased considerably 
(Doreu,1994).   
The mean ash content in donkey’s milk (0.39g/100mL), as in mare’s milk, is resulted higher than that of 
human milk and lower than that of ruminants milk (Table 1.17) (Polidori & Vincenzetti, 2007). The values of 
mineral composition are closer to human milk than other milks except for the higher absolute levels of 
calcium and phosphorous. In fact, in donkey’s milk, Ca/P ratio, ranging averaged 1.48, lies between the 
lower values of cow’s milk and the higher values of human milk (Salimei et al., 2004a; Polidori & 
Vincenzetti, 2007). The mean content of potassium in donkey’s milk is slightly lower compared to that of 
human milk. As regards chlorine and magnesium, the mean concentrations in donkey’s milk are resulted 
similar to that of human milk, while the sodium content is detected slightly higher than that of human milk. 
The calcium, chlorine, potassium, sodium and magnesium contents in cow’s and goat’s milk, appear to be 
about three times higher than in the human milk, and for phosphorous, even six times higher than human 
milk. Also in goat’s milk, the content of chloride is very high. However it is considered that, in close 
connection with the feeding, even the ash content decreases during autumn (Polidori & Vincenzetti, 2007; 
Salimei et al., 2004a).  
From a nutritional point of view, it must be noted that the renal load of solutes,  mainly determined by the 
amount of inorganic substances and proteins in the diet, is very similar in both breast-fed infants and those 
fed donkey’s milk, excluding the absolute calcium and phosphorous contributions (Iacono et al., 1992). From 
a dermatological point of view, the minerals contained in donkey’s milk are useful for cleaning the skin; 
they, in fact, allow to sweep away dead skin cells, leaving on skin surface only live cells. They may also 
influence cell growth. 
 
Table 1.17: The mean content of minerals in donkey’s milk compared than that of other species (Belli 
Blanes, 2001). 
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Minerals 
(g/100mL) 
Ca  
(mg/Kg) 
P 
(mg/kg) 
Ca/P K  
(mg/Kg) 
Cl  
(mg/Kg) 
Na 
 (mg/Kg) 
Mg  
(mg/Kg) 
Donkey 0.39 676.7 487 1.48 497 336.7 218.3 37.3 
Human  0.21 340 140 2.4 530 379 133.8 38.8 
Mare 0.35 900 700 1.29 550 450 135  
Cow 0.71 1170 900 1.3 1448 999.5 491 121 
Goat 0.80 1260 970 1.3 1844 1600 380 130 
 
1.8 Lipid Composition 
 
The mean fat content of donkey’s milk (0,3-1,8%) is similar to values observed in mare’s milk (0,3-0,5%) 
and it is much lower than in the other mammal milks (human 3,5-4%; cow 3,5-3,9%) (Guo et al., 2007; 
Polidori et al., 2009). The lower total donkey lipid content than other mammals reflects in its lower caloric 
content (408 Kcal/L donkey milk, vs 690 Kcal/L human milk and 660 Kcal/L cow milk) (Gastaldi et al., 
2010) and there are different factors that influence fat content, such as, breed, breeding area and forage and 
milking technique (Fox, 2003).  
Milk lipids consists mainly of triglycerides (98%). Other constituents are mono- and diglycerides, 
phospholipids, sterols and free fatty acids (FAs) (Fox & McSweeney, 1998). The triglycerides are composed 
of FAs of different length and saturation. The diameter of donkey milk fat globules varies from 1 to 10µm, 
showing a dimensional distribution consistent with that reported by cow’s milk (Salimei, 2011). With regard 
to milk FAs composition, its profile in mammal milks is indicative and can also vary, because influenced by 
factors like breed, diet, state of lactation, individual factors, health issue and environmental factors (Chiofalo 
et al., 2004). 
 
Table 1.18: Average composition of fatty acid classes (% of the total) in the lipid fraction of the donkey milk 
(mean ± standard deviation SD) (Chiofalo et al., 2003).  
 
Fatty acids Mean (g/100g) ± SD 
Saurated  67.57±2.78 
Monounsaturated 15.82±0.95 
Polyunsaturated ω3 7.45±1.15 
Polyunsaturated ω6 8.65±1.07 
Polyunsaturated 16.60±2.33 
 
In donkey milk FAs identified are (Table 1.19): 22 saturated linear FAs from C4 to C22, 9 monounsaturated 
FAs from C10 to C20 and 13 polyunsaturated FAs from C18 to C22, of which 3 of ω6 series and 8 of ω3 
series, containing from 2 to 6 double bonds (Table 1.19) (Chiofalo et al., 2003; 2004). 
Compared to monounsaturated and polyunsatured classes (table 1.18), saturated milk fatty acids SFA are the 
most represented (67,57%): these results, consistent with those reported for mare’s milk (Martuzzi et al., 
1998), were found lower than those in ovine (73%) (Chiofalo et al., 1994) and caprine (77%) (Chiofalo et al., 
1996). SFAs found in greater quantity were: caprilic (C8:0), caprinic (C10:0) and palmitic (C16:0). Among 
the FAs of nutritional interest and found in modest amounts, the high concentrations were observed for the 
miristic acid (C14:0), while the lowest levels for the stearic acid (C18:0) was similar to those (1,55%) in 
mare’s milk, as observed by Chiofalo & Salimei 2001 and by Chiofalo et al., 2003. The relatively high 
content of FAs with 16 and less carbons could be due to a synthesis of these FAs from acetate and 3-
hydroxybutirate, as in ruminants, and not from glucose, as monogostrics (Duroe & Boulot, 1989). Among 
SFAs, medium chain fatty acids (MCFAs) together with palmitic acid represent about the totality of SFAs. 
From the nutritional standpoint, (MCFAs) undergo preferential intestinal absorption vs long chain fatty acids 
LCFAs, which are present in very small quantitaties in donkey’s milk and in much higher quantitaties in 
cow’s milk (Beermann et al., 2003). 
Monounsaturated fatty acid MUFA found in greater quantity was oleic acid (C18:1) (Chiofalo et al., 2003; 
2004) with anti-atherogenic and protective effects on endothelial cells (Massaro et al., 2002) as seen also in 
the milk of Martina Franca donkeys (Pinto, 1998). The caproleic (C10:1) and palmitoleic (C16:1ω7) acids, 
showed lower quantity (2,20% and 2,37% respectively) (table 1.19) than milks of different breeds, however 
these acids reach higher levels in comparison with those of the different asinine races (Pinto, 1998), and the 
highest levels in comparison with those of other animal species (Chiofalo et al., 1996). The sum of the 
MUFAs percentages was 15,82% (Table 1.18), lower than that of each other species both non ruminant and 
ruminant (Chiofalo, 2001).  
 
Table 1.19: Fatty acid composition (%) of donkey milk (mean ± SD) (Chiofalo & Salimei, 2001). 
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Fatty Acids Mean SD Fatty Acids Mean  SD 
Saturated   Monounsaturated   
C4:0 0.60 0.29 C10:1 2.20 0.16 
C6.0 1.22 0.22 C12:1 0.25 0.10 
C7:0 Tracce  C14:1 0.22 0.05 
C8:0 12.80 0.59 C16:1 ω7 2.37 0.57 
C10:0 18.65 0.91 C17:1 0.27 0.05 
C12:0 10.67 0.49 C18:1 ω9 9.65 0.70 
C13:0r 0.22 0.05 C20:1 ω11 0.35 0.10 
C13:0 3.92 0.90 Polyunsaturated ω3   
C14:0r 0.12 0.05 C18:3:3 6.32 1.02 
C14:0 5.77 0.33 C18.4:3 0.22 0.10 
C15.0r 0.07 0.01 C20:3:3 0.12 0.05 
C15:0 0.32 0.05 C20:4:3 0.07 0.01 
C16:0r 0.12 0.05 C20:5:3 0.27 0.05 
C16:0 11.47 0.59 C22:5:3 0.07 0.01 
C17:0r 0.20 0.08 C22:6:3   0.30 0.08 
C17:0 0.22 0.05 Polyunsaturated ω6   
C18:0 1.12 0.24 C18:2:6 8.15 0.94 
C20:0 0.12 0.05 C18:3:6 0.15 0.03 
C22:0 0.05 0.01 C20:2:6 0.35 0.10 
 
Among polyunsaturated fatty acids PUFAs, in absolute quantitaties, ω3 PUFAs contained in donkey’s milk 
(746 mg/L) are slightly higher than human milk (689 mg/L) and much higher than cow’s milk (280 mg/L); 
this is one of the chief point of interest in this milk. However, in terms of percentage FA composition, 
PUFAs content of donkey’s milk is higher than that of human milk and, particularly, of cow’s milk (Gastaldi 
et al., 2010). In donkey’s milk PUFAs showed a similar distribution of the ω3 (7,45%) and ω6 PUFAs 
(8,65%). Among these acids, the linolenic (C18:1ω3 = 6,32%) and the linoleic (C18:2ω6 = 8,15%) acids 
(Table 1.19) are the most represented components of the polyunsaturated class, which reached the value of 
16,60% (Table 1.18) (Chiofalo et al., 2003; 2004). FA levels of this class in comparison with those of other 
animal species, except mare, showed the higher values. Among the essential FAs, the linolenic and linoleic 
acids show higher values than those observed in the ruminants (C18:1ω3 = 0,7-1%) (C18:2ω6 = 1,8-2,1%) 
(Chiofalo et al., 1996), but are comparable with those (C18:1ω3 = 5-19%) (C18:2ω6 = 5-10%) found in 
mare’s milk (Duroe & Boulot, 1989). These data confirm that in monogastric herbivora, like equidae, the 
amount of unsaturated long chain FAs in milk is related to the amount consumed with forages: the absence of 
saturation and  hydrogenation of FAs in the digestive tract before absorption, as occurring in ruminants, can 
in fact explain the high content in linoleic and linolenic acids (Duroe & Boulot, 1989). In donkey’s milk, the 
PUFAs class showed small amounts of eicosapentanoic (EPA) and docosahesaenoic (DHA) acids, whose 
involvement is necessary in myelination process (Chiofalo et al., 2003). However the unsaturated fatty acids 
UFAs content was 32,42% (Chiofalo et al., 2003; 2004), lower than that reported by Pinto (1998)  in Martina 
franca donkey’s milk (50,69%) but higher than that observed in ruminant’s milk (19-26%) (Chiofalo et al., 
1994; 1996). In donkey milk, no significant difference was observed for SFAs and MUFAs, while PUFAs 
showed a significant variability during the lactation, probably to changes between ω6 PUFAs than ω3 
PUFAs, which instead showed stable values throughout the lactation period (Chiofalo et al., 2004). 
The ω3/ω6 PUFAs was 0,86 (Table 1.20) and it is similar to that observed in the equine species (0,84) 
(Salimei et al., 2006); however these species showed higher ratio than that found in ruminants’ (0,44-0,45) 
(Chiofalo et al., 1996) and human’s milk (0,07) (Pinto, 1998). It is interesting to note that in lactating 
donkeys, the transfer from blood to milk of ω3 PUFAs was found to be more efficient than that of ω6 
PUFAs; this could probably be related to the other destination of ω6 PUFAs during the metabolic cycle 
(constituents of adipose tissue, of tryglicerides as well as of membranes phospholipids), and from a dietetic 
point of view, this transfer enhances the nutritional characteristics of the milk (Chiofalo et al., 2007). The 
unsaturated/saturated ratio in donkey’s milk (0,48) (Table 1.20) is similar to mare’s milk (0,65) (Martuzzi et 
al., 1998) and higher than that found in the ruminants’ milk (0,26-0,38) (Chiofalo et al., 1994; 1996). 
 
Table 1.20: Fatty acid ratio of donkey milk (Mean± SD) (Chiofalo & Salimei, 2001). 
 
 Mean SD 
Ratio ω3/ ω6  0.86 0.07 
Ratio UFA/SFA 0.48 0.06 
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Donkey milk FAs profile also reflects dietary pattern and with the fresh forage vs hay administration the 
level of ω3 PUFAs are significantly higher, while ω6 PUFAs showed no significant differences between 
treatment (Chiofalo et al., 2006b). This phenomenon can be attributed that, in some polygastric animals occur 
anaerobic fermentation involving the rumen hydrogenation of UFAs, resulting in saturation and formation of 
SFAs; instead, in monogastric herbivora, like equidae, the amount of unsaturatated long chain FAs in milk is 
related to the amount consumed with forages: the absence of saturation and hydrogenation of FAs in the 
digestive tract before absorption, as occurring in ruminants, can in fact explain the high content in linoleic 
and linolenic acids (Duroe & Boulot, 1989).  
Consequently, the quality indices, Atherogenic IA (0,86-0,81) and Thrombogenic IT (0,64-0,79), are 
correlated to pathological phenomena such as the formation of atheroma and/or thrombosis, therefore 
expression of animal welfare, despite being higher than in the vegetable oils, appeared significantly lower 
than those of cow’s milk. For these reasons, donkey’s milk can be considered a “functional food” (Chiofalo 
et al., 2003; 2004). In fact, compared with ruminants’ milk, a low content of SFAs which together with an 
high UFAs content found in donkey’s milk, make it extremely useful in prevention of cardiovascular, 
autoimmune and inflammatory diseases (Chiofalo & Salimei, 2001). The significant content of the ω3 
PUFAs can counteract the above-mentioned pathologies through the synthesis of anti-inflammatory, 
antiaggregant and non immunosuppressant substances, like lipidic mediators (eicosanoids), prostaglandins 
(PGE3) and leukotrienes (LTB5), cytokines, interleukins and tumor necrosis factors. These ω3 PUFAs 
characteristic constituents of the fish oils, could also have an interesting role on the outcome of the grafts, on 
some kinds of tumor, on the bodily and neuropsychic development (William, 2000). Besides, the 
considerable percentage of MCFAs influences the vasodilation phenomena and, together with the SCFAs, 
determine an increase of the anti-oxidative defences of the organism. In this direction, some Authors pointed 
out the role of donkey’s milk in the osteogenesis process and in the atherosclerosis dietotherapy, in the 
rehabilitation of the patients with coronary hearth disease (Chiofalo, 2001). However donkey’s milk has 
limits which, if supplemented by appropriate nutrients, could optimize its role of “functional food”. The 
major limit is represented by its low fat content (Salimei & Chiofalo, 2006), and it is also characterized by 
the low presence of some LCFAs as coniugated linoleic acids (CLA) (Doreau et al., 2002), responsible for 
the wide variety of beneficial effects (anticarcenogenic, antiatherosclerotic, antidiabetic effects) as well as 
arachidonic (C20:4ω6) and DHA (C22:6ω3) acids, particularly represented in the membranes of nervous 
cells, in the external segments of the retinal photoreceptor and in the acrosome of the spermatozoa, therefore 
essential during the neonatal development of the nervous tissues as well as of retinal tissue and reproductive 
apparatus (Cocchi, 2000). It must be noted that dietary supplementation with vegetable or marine oils 
changes the FAs profile of donkey milk, even thought it has a negative o null effect on the milk fat 
percentage (Salimei et al., 1996). Increased intake of soluble fibre also affect the donkey milk FAs 
percentage and reducing the total ω6 PUFAs content (Chiofalo et al., 2006a;b). So, levels of ω6 and ω3 
PUFAs should be in the same range as those found in human milk to ensure the best effects on growth, 
cognitive development and visual acuity and to limit the side effect due to the lack of balance between ω6 
and ω3 (Gastaldi et al., 2010).  
 
1.8.1 Donkey milk Triglycerides 
 
The knowledge of the composition of milk lipids, in terms of molecular species of triglycerides (TAGs) is 
fundamental in order to explain the physical properties, nutritive and organoleptic characteristics and the 
biosynthetic pathways of milk fat (Morera Pons et al., 1998). The little literature at disposal (Dugo et al., 
2005) underline some quali-quantitative differences in the FAs typology that form the donkey’s milk TAGs 
in comparison with those of human and cow milk. 
The peculiar TAGs distribution of donkey’s milk as well as mare’s milk is largely due to the high presence of 
capric acid that is recovered in 18 TAGs out of 55 TAGs identified. Moreover, the milk fat of donkey shows 
a TAG pattern with 30-54 acyl carbon atoms, as well as mare’s milk, in relation to the high content of 
medium and long chain FAs. The most frequent TAG components found in donkey milk are: palmitic-oleic-
linoleic (6.69%), palmitic-oleic-oleic (6.22%), palmitic-palmitic-oleic (5.25%), capric-palmitic-oleic 
(4.63%), palmitic-oleic-linoleic (4.48%) and palmitic-palmitoleic-oleic (4.18%) (Dugo et al., 2005). The 
composition of the TAG fraction of human milk shows that the main components are: Palmitic-oleic-oleic 
(24%) and palmitic-oleic-linoleic (19%), followed by palmitic-palmitic-oleic, palmitic-palmitoleic-oleic and 
linoleic-oleic-oleic present in amounts ranging from 3 to 8% (Morera Pons et al., 2000). These results show a 
certain degree of qualitative similarity in the TAG fraction of these two products, both very dissimilar from 
the composition of cow’s milk, where the main components are butyric-palmitic-oleic, butyric-palmitic-
palmitic and butyric-myristic-palmitic and where TAGs containing PUFAs (linoleic and linolenic acids) are 
not found (Gresti et al., 1993). This observation could be explained by the absence in donkey small intestine 
of isomerisation and hydrogenation processes of FAs prior to absorption and esterification in the blood; it 
also could confirm the nutritional value of donkey milk fat composition in relation to human health. 
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Moreover, according to Morera Pons et al. (2003), the trend of TAGs in donkey’s milk during the lactation 
(Chiofalo et al., 2006a) show a certain degree of similarity with that of TAGs profile in human milks; in fact 
during the lactation, some TAG species (caprylic-oleic-linolenic, caprylic-palmitic-oleic, oleic-linoleic-
linolenic and capric-palmitic-oleic) also recovered in human milk, show relatively constant levels and could 
thus be considered as markers of donkey milk TAG profile. It has also to be noted that concentrations of 
other TAG species (capric-caprylic-palmitic, capric-palmitic-palmitic, and palmitic-palmitoleic-oleic) vary 
considerable (Chiofalo et al., 2006a) and consequently these may be understood to be especially affected by 
external factors such as dietary intake, nutritional status etc. (Morera Pons et al., 2003) which could have 
changed the availability of some FAs involved in the TAG synthesis in the mammary gland.   
In donkey’s milk, the position of FAs on glycerol backbone is very similar to that of human milk: this fact, in 
conjunction with the relatively high content of medium chain triglycerides (MCT), makes this lipids in 
donkey’s milk, through quantitatively modest, highly bioavailable. Palmitic acid is present in donkey’s milk 
in position 2 of the glycerol (72.9% of the total), as observed in human milk (74.8%), whereas for the cow’s 
milk the position 2 of the glycerol is esterified by the oleic acid (Gastaldi et al., 2010). It has been reported 
that an high 2-palmitoyl TAG content in the lipid fraction increases fat absorption. For the specificity of the 
pancreatic lipase towards the primary ethereal bonds, the digestion of donkey and human milks permits a 
greater absorption of the palmitic acid like monoacylglycerides, while, during the digestion of the cow’s 
milk, the palmitic acid, set free from the glycerol, bind itself to the calcium present in the intestinal lumen, 
precipitate as calcium soap, and therefore is excreted through the faeces with consequent a twofold 
nutritional damage: the loss of palmitic acid and of calcium (Fidanza & Liguori, 1988) from the body. 
However, the low lipid content, together with a low percentages of EPA, DHA and AA make donkey milk 
inadequate as an exclusive food in infants for the first year of life; nevertheless, the better quality of the lipid 
pattern in donkey’s milk versus cow’s milk might make this milk a better substrate to produce formulas 
(starting or follow on) to be used for feeding of newborns and infants in the early months of life. In this case, 
the defattening process usually applied for cow’s milk, would not be necessary and a formulation would just 
require a slight increases of DHA, EPA and AA, which are especially necessary for adequate growth, 
neurological development and cardiovascular health (Aldamiz-Echevarria et al., 2008).    
 
1.9.1 Use of donkey’s milk in pediatric diet: the role of donkey’s milk in the treatment of allergy to 
cow’s milk protein 
 
The term allergy or hypersensitivity is used for immune-mediated reactions, and the term intolerance for non 
immune-mediated reactions (Pelto et al., 2003). Immune-mediated reactions may be immunoglobulin (IgE)-
mediated or non-IgE-mediated, whereas intolerance may be enzymatic, pharmacologic, metabolic 
deficiencies and food poisoning. The terms allergy and hypersensitivity are used variably in literature: 
normally the term allergy is used in infants and children, while hypersensitivity is used in adults for adverse 
clinical reactions based on any type of abnormal immune response to milk as an allergen. The ubiquity of 
fresh dairy products and the availability of milk powder resulted in significant increase in protein cow’s milk 
intake and this has probably increased the number of patients allergic or intolerant to these proteins. The 
protein content of cow’s milk is higher than human milk (3.2% vs 1%) and the proteins are mainly 
represented by caseins (80%) and in lesser amount by whey proteins (20%) (against 40% and 60% 
respectively in human milk). Cow’ milk proteins are the first source of foreign proteins given in large 
quantities to an infant, and in the immature intestine it may provoke allergic reactions (Sampson, 1999). 
Cow’s milk contains several proteins known to be potential antigens: they can be generally classified in two 
major groups: caseins and whey proteins (Restani et al., 2002). Because β-Lg is absent from human milk, it 
has long been considered the most important of cow’s milk allergens (Savilahti & Kuitunen, 1992), but 
several studies have demonstrated that the casein fractions, too, have an important allergic potential (Muraro 
et al., 2002). Moreover, the heat treatments, as pasteurization, and the homogenization do not eliminate the 
allergenicity of cow’s milk proteins (CMP) (Host, 1994; Chiarelli & Di Michele, 2007).  
Cow’s milk protein allergy (CMPA) is a common disease occurs in infancy and childhood involving 
approximately 3% of children below the age of three years (Host & Halken, 2004; Sampson, 2004); the 
incidence of CMPA ranges from 0.3 to 7.5% in population based studies in different countries. However, in 
most cases this allergy does not last a lifetime, since during the years the child can acquire the tolerance to 
milk and its active ingredients. Although the majority of children (80-85%) allergic to CMP acquires 
tolerance by fifth year of life, approximately 15% of patients with IgE-mediated CMPA keep this allergy also 
in the second decade of life, and 35% of patients will show allergic reactions also to other foods. In these 
patients APLV, from infancy to schooling years, becomes a serious problem of food security which (for 10% 
of cases) may evolve into a state of multiple food allergy (Sampson, 2004). 
Symptoms of CMPA can appear immediately or start seven hours or even days after the intake of moderate to 
large amount of cow milk. CMPA can cause symptoms of variable severity which can affect the skin (atopic 
dermatitis, urticaria, angiodema), gastro-intestinal tract (food refusal, status-weight growth retardation, 
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gastro-esophageal reflux, diarrhea, vomit, persistent constipation, gastritis, eosinophilic gastroenteritis, 
enterocolitis). All this may determine histopathological lesions of the intestinal mucosa which are very 
similar to those found in celiac disease (intestinal villous atrophy) with repercussions on health until the 
malabsoprtion. Other symptoms concerning the respiratory system (chronic rhinitis, pneumonia, asthma, 
hypotension and anaphylactic shock) (Murch & Walker-Smith, 1988; Carroccio et al., 2000a; Iacono & 
D’Amico, 2001). 
The therapy for CMPA consisting in eliminating CMP from the child’s diet, which has to be replaced with 
appropriate substitute. It is very important to remove from the diet of children allergic to CMP also foods 
containing hidden sources of these proteins which are often used as additive in many foods such as biscuits, 
ham, soups. The elimination of allergenic protein from nurse diet is important in breast feeding children 
because traces of CMP were found in human milk if the mother follows a free diet (Cant et al., 1985; Host et 
al., 1990). Since the nutritional needs of the child in the first two years of life (and especially in the first 
year), when human milk is unavailable or insufficient, are satisfied by cow’s milk, pasteurized or adapted 
formula, and by its derivates, since the child satisfies the 50% of the nutritional and energy requirements 
(especially with regard to the calcium requirement which is very high in this age) with these foods, it 
becomes necessary to choose an alternative formula, which should ideally have the characteristics of: 
• hypoallergenicity (protein contained in the milk substitute should not be recognised as “enemy” by 
immune system which would not cause any type of allergenic reaction after ingestion; 
• non cross-reactive with cow’s milk (the proteins in milk substitute should not be structurally similar 
to those of cow milk, otherwise the immune system react against them);  
• nutritional adequacy; 
• palatability (pleasant taste is an important requirement in view of the young age of  patients); 
• low cost. 
At present the ideal formula, meeting all these requirement at once, does not exist, and nor is there an 
international consensus for which formula should be considered first choice in treating CMPA when mother’s 
milk is not available. 
Hypoallergenic alternative to breast milk have been proposed through the years and include extensively 
hydrolysed formulas (eHF), amino acid formulas (AAF) and soy formulas. 
eHF, industrial milk protein – based products treated with proteolitic enzymes, are recommended worldwide 
as first choice for CMPA treatment (or for the dietotherapy of CMPA patients) by the European Society for 
Paediatric Allergology and clinical Immunology (ESPACI), the European Society for Paediatric 
Gastroenterology, Hepatology and nutrition (ESPGHAN) (Host et al., 1999) and the American Academy of 
Pediatrics (AAP) (American Academy of Pediatrics Committee on Nutrition, 2000).  
These formulas are currently the most used substitutes of CMP. They derived from hydrolysis of casein and 
whey protein of cow’s milk but are not tolerated by all patients with CMPA because they may contain 
residual allergenic epitopes (Hill et al., 1995). As regard their nutritional adequacy, even thought they are 
able to ensure an appropriate height-weight growth, their palatability is low, being inversely proportional to 
the hydrolysis degree. In the first months of life, this does not represent generally a problem but in later life 
unpleasant and bitter taste can cause a complication in taking these formulas. Furthermore, their costs are 
high, even if lower than the amino-acid formulas (Carvalho et al., 2001; Host & Halken 2004).  
According to ESPACI-ESPGHAN guidelines, only amino acid formulas (AAF) can be considered 
completely hypoallergenic, because the immune system can not recognize the protein from which the amino 
acids are derived. They are therefore indicated in several clinical manifestation of CMPA and of multiple 
food allergy, including soy and eHF. As regards the nutritional value, the AAF ensure a normal height-
weight growth; their palatability is similar to that of eHF, because their flavour is unpleasant, that children 
especially the older ones, but sometimes even infants over six months refuse to assume them even though 
sweetened or mixed with fruit. Another problem is the cost, which is significantly higher than eHF (Host et 
al., 1999; Sampson, 2004; Host & Halken, 2004). 
Soy-protein-based formulas (SF) have been subject to several discussion during the years, especially for the 
risk of allergy to their proteins, which occurs with a rate ranging from 8% to 14% of children with IgE-
mediated CMPA. ESPACI-ESPGHAN does not generally recommend its use for the initial treatment of 
infant and young children with CMPA, in whom soy protein allergy has been reported with frequencies 
between 17% and 47% (Host et al., 1999; Host & Halken 2004). SF are also contraindicated for the treatment 
of infants with some forms of non IgE-mediated CMPA with gastrointestinal sympthoms as in enterocolitis, 
enteropathy and in proctolite (AAP, 2000). According to AAP, if tolerated, these SF represent an effective 
alternative to cow’s milk in infants older than six month. In fact, several studies have shown its nutritional 
adequacy, as well as a normal height-weight growth and a regular bone mineralization in term infants, even if 
they are used for long periods. On the other hand, the SF are contraindicated in preterm infants, in whom they 
can cause poor growth; the high aluminium content contraindicates its use in both preterm subjects and in 
patients with renal disease. These formulas also contain from two to six times the concentration of 
manganese compared to cow’s milk which may have potential long-term effects on the central nervous 
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system; in these formulas some physiologically active substances are also present, as phytoestrogens, whose 
long term effects are not yet clear. Palatability and discrete costs, are instead in favour of SF (Muraro et al., 
2002).   
Today, the continuing danger of allergic reactions also even to those foods considered apparently safe, their 
high costs and unpleasant taste have made necessary the search for alternative foods.  
For these reasons, in the last years other non-bovine mammalian milks (goat, sheep, mare, camel, donkey) 
has been studied to identify the best natural substitute for human milk (Belloni-Businco, 1999; ; El-Agamy et 
al., 1997; Businco et al., 2000; Muraro et al., 2002; Restani et al., 2002). 
As regards goat’s milk, it has been shown that this milk with a lower alpha casein content is less allergenic 
than cow’s milk. This protein could act as a carrier for other allergenic proteins in cow’s milk, as β-Lg, 
which closely linked to casein micelles, is more difficult to digest. The low content of alpha casein in goat’s 
milk ensures, therefore, a better digestion of β-Lg and other allergens (Bevilacqua et al., 2001; Di Pillo et al., 
2011). However many studies (Muraro et al., 2002; Infante et al., 2003; Pessler et al., 2004) have shown that 
goat’s and sheep milk are contraindicated as their proteins have shown, for common epitopes presence, 
extensive cross-reactivity (>90%) with CMP both in vitro and in vivo. In goat milk, the high content of 
protein and minerals, particularly calcium, phosphorus, sodium and potassium than human milk could result 
in excessive solute load for the infant’s kidney. In addition, goat milk is nutritionally inadequate, because 
deficient in folic acid, B6 and B12 vitamins and iron (with a consequent risk of anemia for extensive use) 
(Restani, 2004). No data is available on the palatability, but this is better than hydrolysates. The cost varies, 
because there is no a global market for this milk (D’auria et al., 2010).   
In many part of the world (North-East Africa, Middle East, Arabian Peninsula and China) camel milk is used 
as a substitute of human milk in bottle fed babies. Camel’s milk contains only 2% of fat, especially 
polyunsatured fatty acids and it is rich in micronutrients. As human milk, camel’s milk does not contain β-
Lg, allergenic whey protein present in ruminant milk and for low or no in vitro cross-reactivity with CMP 
represents a valid alternative to cow’s milk for children CMPA above the two years of age. No data is 
available on the palatability, but it is reasonably more pleasant than hydrolysates. However, this milk has 
main disadvantage, the difficult of supply in Italy (Di Pillo et al., 2011).   
Mare’s milk appears to be more promising as in composition it is much closer to human milk than cow milk 
(Muraro et al., 2002; D’Auria et al., 2005) and it has been found to be tolerated by some children (24/25 
patients - 96% tolerability) with severe IgE-mediated CMPA (Businco et al., 2000). However there are few 
clinical studies concerning the allergenicity and tolerability of goat’s and mare’s milk and their results are 
controversial (Iacono et al., 1992; Belloni-Businco et al., 1999; Businco et al., 2000) and for mare’s milk its 
availability is limited and collection is difficult.  
Donkey’s milk, as mare’s milk, has a chemical composition and organoleptic characteristics more similar to 
human milk than cow’s milk (Guo et al., 2007; Salimei et al., 2004a; Vincenzetti et al., 2008). So, it was 
found to be a valid alternative to both IgE and non IgE-mediated CMPA and to multiple food allergy also at 
soy and eHF formulas, with favourable effects on palatability and weight-height gain in an increasing number 
of clinical trials (Iacono et al., 1992; Carroccio et al., 2000a; Monti et al., 2007; Vita et al., 2007; Tesse et al., 
2009), although the mechanism of this tolerance likely related to the protein composition, has not yet been 
fully clarified.  
Donkey’s milk is more available than mare’s milk in Italy; it was evaluated initially in 1992 by the group of 
Prof. Iacono, in a clinical study performed on 9 infants with multiple food allergies, for whom human milk 
was not available. This food was well tolerated by all patients (9/9- 100% tolerability), who have continued 
to tolerate donkey’s milk for the entire duration of follow-up (15-20 months).The authors have also reported 
in this study the good palatability and nutritional adequacy of the milk (Iacono et al., 1992). In a second 
study, donkey’s milk was evaluated in 2000 by the group of Prof. Carroccio, in a clinical study performed on 
21 children with severe IgE-mediated CMPA and multiple food allergies also to eHF and amino acid 
formulas. This food was tolerated by 18-21 patients (86% tolerability), who have continued to tolerate this 
milk for the entire duration of follow-up (1-8 years) without any allergic reaction and resumption of growth 
parameters. Moreover, in this clinical study, donkey’s milk was well tolerated by patients with intolerance to 
goat’s milk and sheep’s milk, confirming the possibility of lack of cross-reactivity between natural milks of 
different origin (Carroccio et al., 2000a). In 2007 the group of Prof. Vita published a study on the use of 
goat’s milk and donkey’s milk in 26 children (age 6 months-3 years) with atopic dermatitis (AD) and CMPA. 
The children were randomized to goat and donkey’s milk for 6 months, then switched to the other milk for 
further 3 months. At the end of the study, 23 of 26 children did not tolerate goat’s milk, while only one of 26 
children did not tolerate donkey’s milk with 88% of tolerability for this milk. So this study report that 
Equidae milk could be an appropriate alternative to cow’s milk, but is the first demonstration that donkey’s 
milk is better tolerated than goat’s milk, which is in turn still largely used (Vita et al., 2007). Similarly, Monti 
et al. (2007) demonstrated the tolerance of donkey’s milk (82.6%) in a selected population of  children (38/46 
patients, age 12-149 months) with CMPA, for whom it was not possible to use any cow’s milk substitute and 
because of their concomitant multiple food allergies, required a substitute food that was palatable and 
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tolerated, as well as being nutritionally valid. In Monti’s study, the efficacy of donkey’s milk in treating 
highly problematic children with cow’s milk allergic was valuated also in vivo and the degree of cross-
reactivity with donkey’s milk proteins was very weak and aspecific. Recently in 2009, the group of Prof. 
Tesse also investigated the tolerance and nutritional adequacy of donkey’s milk in 30 children (age 6 months-
11 years) with IgE and non IgE mediated CMPA. 24/25 patients (96% tolerability) tolerated this milk and 
showed an adequate increase in weight and length stature. Auxological data also resulted improved by the 
end of the study in all patients, while biochemical and metabolic parameters did not vary during the follow-
up (4-6 months) (Tesse et al., 2009). These authors, as Monti et al. (2007), concluded that the effect on 
growth of donkey’s milk is related to its ability to fill some nutritional gaps present in the diet of the subjects 
treated. 
Other authors, as D’Auria et al. (2011) have found a case of growth impairment and nutritional deficiences in 
a five-month infant fed by unmodified donkey’s milk, for its low lipid content and a low caloric value in 
addition to a very low iron content. However, there are no clinical studies with an adequate statistical design 
to evaluate the nutritional efficacy of donkey’s milk, at least in the first year of life.  
These clinical studies evaluated donkey’s milk tolerability that seems quite good, even if it did not achieve 
the 90% tolerability value required to define a hypoallergenic formula. If in a multicenter study, donkey’s 
milk was tolerated by at least 90% of children with CMPA, it could be considered a natural “hypoallergenic” 
food for CMPA therapy, in accordance with the international guidelines. In this way, donkey’s milk may be a 
valid alternative, especially for children with multiple food allergies, with clear advantages in terms of cost 
and palatability in relation to the only alternative available for these patients, represented by amino acid 
formulas. If it were possible to optimize the production, the milk’s cost could be lower: in fact, the use of this 
milk is today limited by the high cost, intermediate between eHF and AAF cost, and by difficulty of finding. 
The use of donkey’s milk for therapeutic purposes is also hampered by other factors, such as the extinction of 
asinine species, reluctance for use by parents, medical risk related to the administration of unconventional 
therapy, risk of infection related to hygiene of the food (animals not controlled for human consumption).      
 
1.9.2 Use of donkey’s milk in the prevention of cardio-vascular and autoimmune diseases 
 
The donkey’s milk is characterized by a low fat content, where the lipid fraction contains elevated amounts 
of essential fatty acids (EFAs). These fatty acids are found in donkey’s milk in concentrations higher than 
those ruminants, perhaps due to the absence of hydrogenation, a biochemical process of the rumen activity 
(Chiofalo et al., 2003). Polyunsatured fatty acids entering into the composition of cell membranes, influence 
the oxidation and transport of cholesterol, reducing its concentration. They facilitate the enzymatic activity 
and the production of biologically active substances, eicosanoids and cytokines, which in turn regulate 
interactions among cells. The EFAs are involved in the synthesis of prostaglandins, which have a key role in 
various bodily functions such as hormone synthesis, vasoconstriction, regulation of pain and inflammation. 
Moreover, these EFAs, in particular those belonging to ω3 and ω6 classes have a fundamental role in 
preventing and inhibiting either cardiovascular and autoimmune diseases because: 
• they avoid the accumulation of more unsafe lipids (cholesterol and triglycerides) on the arteries, 
blocking the hardening of blood vessels; 
• they protect the cardiovascular system: the blood made more fluid, better circulates, removing the 
risk of coronary heart disease, hypertension, atherosclerosis and thrombosis; 
• they attenuate inflammatory reactions such as rheumatoid arthritis and other inflammation and 
asthma; 
• they promote the vitality of central nervous system’s cells, with antidepressant functions, but also 
of the retina and of the reproductive functions; 
• they enhance the immune system and reinforce the skin’s defences; 
• they aid in the treatment of psoriasis and other skin diseases; 
• they act on the microcirculation (useful for cellulite and edema); 
• they facilitate the anti-inflammatory response for injuries or infections.  
Several studies have also shown that lysozyme in donkey milk has many physiological functions, including 
inactivation of certain virus, immuno-regulatory activity, anti-inflammatory and anti-tumour activity 
(Ibrahim & Aoki, 2003; Salimei et al., 2004a; Zhang et al., 2008). In fact, Ye et al. (2008) investigated the 
anti-tumour and anti-angiogenesis effects of newly isolated marine lysozyme both in vitro and in vivo, and 
showed that marine-derived lysozyme specifically inhibited the proliferation of endothelial cells (EVC304), 
and markedly inhibited tumour growth in mice bearing either sarcoma 180 and hepatoma 22. In Mao et al. 
(2009) study, an high content of lysozyme in donkey milk may contribute to its anti-proliferative and anti-
tumour effects on A549 human lung cancer cells in vitro. Donkey milk active components, (whey protein 
fractions with a Molecular Mass > 10KDa), as lysozyme, reduced the viability of A549 cells in dose-
dependent and time-dependent manners either directly by apoptosis or indirectly through the secretion of 
molecules (with anti-tumour activity), responsible of lymphocytes and macrophages activation. Activated 
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macrophages are considered as the pivotal immunocytes of host defence that inhibit tumour growth. The 
tumoricidal activity of macrophages is mediated mainly through nitric oxide, cytokines, interleukins and 
tumour necrosis factors.  
Mao et al. (2009) study has shown that donkey milk active fractions could stimulate cytokine production 
from lymphocytes and macrophages in vitro. These cytokines are contributory to an immune response and 
are influential upon the maturation, anti-proliferation and differentiation of A549 tumour cells. In fact, the 
significant suppressive effect of donkey milk on the proliferation of A549 tumour cells is partly attributed to 
the promotion of differentiation of A549 cells into normal cells. However, donkey milk whey protein, which 
possesses potent anti-proliferative activity, may have potential in the treatment of lung cancer, although in 
vivo evidence would be required to determine any such possible actions. 
 
1.9.3 Digestibility of donkey milk protein and its use for gut regulation, particularly for the defence of 
the low immune system of children, elderly and the convalescent 
 
In vivo digestion of milk protein is initiated in the stomach by pepsin and, in young animals, by chymosin. 
Coagulation of milk in the stomach delays the degradation of proteins and allows for their better assimilation 
by the body. Degradation of casein is slow but extensive and while β-Lg is relatively resistant to gastric 
proteolysis, α-La is readily hydrolysed when the gastric pH is 3.5 (Savalle et al., 1988). The structure of the 
coagulum formed in the stomach depends on the casein content of ingested milk; high casein milk yields 
firm, tough clots. Species that nurse their young at frequent intervals (horses, humans, donkeys) produce 
dilute milk with a casein content <60% of the total protein and the coagulum formed in the stomach is soft 
and disintegrates quickly (Oftedal, 1980). The physico-chemical differences between human and bovine 
caseins result in the formation of different types of curd in the stomach and because the protein profile of 
equidae milk (horse and donkey) is quite similar to that human milk, equidae milk may be more appropriate 
in human nutrition than bovine milk. Turner (1945) compared the digestibility of equine, human and bovine 
milk based on the average percentage conversion of acid-insoluble protein to acid-soluble protein during 
digestion. Equine and human milk have a much lower buffering capacity than bovine milk and, while equine 
milk is very digestible, it was slightly less so than human milk but significantly better than bovine milk. 
Turner (1945) concluded that both equine and human milk form soft curds in the stomach which pass through 
the digestive tract more quickly than bovine milk curd. Kalliala et al. (1951) also reported that the overall 
digestibility of equine and human milk (by in-vitro experiments) appeared quite similar and both were easier 
to digest compared to bovine milk. Human milk forms fine, soft flocs in the stomach with an evacuation time 
of 2-2.5h, whereas bovine milk forms compact hard curds with a digestion time of 3-5 h. 
Digestion of milk proteins from different species, as donkey, has been also studied in vitro through a two step 
simulation using human gastric and duodenal enzymes (Ingligstad et al., 2010; Tidona et al., 2011). These 
studies showed that the overall digestibility of casein is high and comparable for horse, donkey, cow, goat 
and human milk, the percentage of undigested caseins after gastric and duodenal steps being 4%, 7%, 4%, 
6% and 5% respectively. However, after gastric digestion the percentage of undigested caseins was almost 
double for cow and goat caseins compared with horse and human milk (Ingligstad et al., 2010). The low 
protein and casein content of donkeys and mares’ milk might be the reason for the last digestible caseins 
compared with high casein predominant milk of other species such as cow and goat. In human milk, the 
casein degradation during the gastric step was also fast at low pH (Iinglingstad et al., 2010). Lactoferrin in 
milk from the same specie is also highly digested; however, similarly to cow and goat β-Lg, horse and 
donkey β-Lg is resistant to gastric enzymes although after digestion with human duodenal enzymes only 25% 
and 30% of β-Lg remain intact respectively in horse and donkey milk, compared with the high concentration 
observed for cow (64%) and goat (62%) milk. The reason of major digestibility of this protein in horse and 
donkey milk is that, β-Lgs are present as monomers in equidae at normal milk pH compared with the 
corresponding dimeric form in ruminant milk (Ingligstad et al., 2010; Tidona et al., 2011). In Equid, as well 
as cow and human, α-La were very resistant to gastric and duodenal digestion, with a percentage of intact 
protein at the end of the process ranging from 91% to 95% (Ingligstad et al., 2010; Tidona et al., 2011). 
Lysozyme from equid milk is also relatively resistant to digestion with 64% and 75% of undigested protein in 
horse and donkey milk, respectively (Ingligstad et al., 2010; Tidona et al., 2011). There is a close correlation 
between the vivo digestion of human milk proteins and in vitro digestion with human neonatal gastric juice. 
Differences in digestibility of potential milk allergens (Ingligstad et al., 2010; Tidona et al., 2011), in amount 
and distribution of nitrogen components (Uniacke-Lowe et al., 2010; Salimei, 2011), and in primary structure 
of milk proteins (Cunsolo et al., 2011) may help explain the hypoallergenic properties of equid milk 
compared with milk from conventional dairy species. 
 
Donkey milk provides an array of defence factors (proteins), such as lactoferrin, lactoperoxidase, 
immunoglobulins and lysozyme that confer high hygienic qualities (Coppola et al., 2002; Zhang et al., 2008) 
to the milk, contributing to its low bacterial concentration (104 CFU/ml). In the same time they also have the 
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capability to kill or inhibit a large spectrum of pathogen microorganism (Salmonella cholerous, Scighella 
dysenteriae) (Zhangh et al., 2008), (Bacillus cereus, Staphilococcus aureus, Enterococcus faecalis and 
Escherichia coli pathogenic strains) (Nazzaro et al., 2010; Tidona et al., 2011), providing the neonates an 
immune protection against infections (Baldi et al., 2005), mainly diarrhea. 
These occurrences are generally much lower in breast-fed infants that in formula fed infants. However, 
according to Tidona et al. (2011) the antimicrobial activity of donkey milk might result from a synergistic 
effect of substances, possibly peptides released by gastrointestinal enzymes together with undigested 
proteins, as lysozyme. Lysozyme in donkey milk ranges from 100mg/100mL (Vincenzetti et al., 2008), 
which is consistent with data on horse milk (Doreau & Martin Rosset, 2011), whereas only traces were found 
in bovine milk (Salimei et al., 2004a; Guo et al., 2007). Lysozyme in equid milk is highly thermo-stable 
(Coppola et al., 2002; Di Cagno et al., 2004) and its activity is intense against Gram-positive bacteria and 
much weaker on Gram-negative bacteria, as described by Kato (2003). Moreover, donkey milk lysozyme is 
very resistant to acid and protease digestion, playing in this way a significant role in the intestinal immune 
response (Tidona et al., 2011). According to Nazzaro et al. (2010) and Tidona et al. (2011), donkey milk 
contains many antimicrobial components further than lysozyme. They are essentially functional peptides, 
released from caseins (β- and αs1-CN) and whey proteins (β-Lgs) during a simulated digestion process or 
fermentation in vitro. These bio-molecules released during the digestive proteolysis could have important 
nutritional values and physiological roles (antihypertensive, immuno-modulating, oppioide, antithrombotic) 
as well as contributing to the antimicrobial activity of donkey milk (Nazzaro et al., 2010; Tidona et al., 
2011).  
In a vitro study simulating gastrointestinal digestion of donkey milk, Bidasolo et al. (2011) identified one β-
CN derived peptide with potent angiotensin converting enzyme (ACE)-inhibitory activity. Small proteolytic 
fragments of both bovine and human lactoferrin have been shown to exhibit antimicrobial (bactericidal) and 
bacteriostatic activities, the latter of which was thought to deprive microorganism of iron (Tomita et al., 
1994). 
In conclusion, donkey milk contains different protective antimicrobial factors, including peptides released 
during the digestion process, that can exert a beneficial impact on gut health, particularly for the low immune 
defence system of children, elderly and the convalescent, which cannot be fed either with the human milk 
and are also allergic to other milks (Nazzaro et al., 2010; Tidona et al., 2011).          
 
1.9.4 Use of donkey’s milk in geriatric diet 
 
The low fat content of donkey’s milk, the highest whey protein content (easily assimilated by the immune 
system), minerals, probiotics, growth factors, hormones and the high lactose content (important in facilitating 
the calcium absorption) have led to postulate its use in the defined “healing” feeding of the elderly.   
It found that the consumption of cow’s milk and its derivates in adulthood is greatly reduced, partly because 
of gastrointestinal disturbances, and although the most common cause is considered to be the deficit amount 
of the enzyme lactase, which hydrolyzes lactose, the presence of allergy in elderly patients should not be 
excluded. The milk and derivatives have an important role in human nutrition for the prevention and 
correction of osteoporosis. Atherosclerosis and osteoporosis, which have a high incidence in the elderly, 
perhaps seen in bad nutrition (diet poor in products containing calcium and rich in saturated fats), the more 
important reason.  
The inability to digest lactose, the main milk sugar, by the involved enzymes (for lactase deficiency, which 
can affect 10-60% of the population), especially in adulthood, leads to limit or abolish the use of bovine milk 
and derivatives. The patients complain of abdominal pain and tension, flatulence and diarrhea when the milk 
is consumed. However, recent studies have found that many patients who do not consume milk and dairy 
products for these disorders, have a normal ability to digest lactose (Carroccio et al., 2000a; D’Amico et al., 
2007). 
It was assumed therefore, that the protein content of cow milk could be responsible for the symptoms 
experienced by patients who self-define intolerant to milk. So it should be considered in the elderly, the 
possibility that there is an allergy to CMP, a frequent condition in children, who, with increasing age, 
generally acquired immunological tolerance towards allergenic foods. However, many studies suggested that 
this is not true and the symptoms of hypersensitivity may persist in childhood and adulthood (Carroccio et 
al., 2000b). Any study, to date, evaluated the possible presence of CMPA in subjects who reported an 
intolerance to milk but that, normally adsorb lactose. So in subjects auto-defined milk intolerant, the abolition 
of the product assumption results in a reduced daily intake of calcium, leading in predisposition to 
osteoporosis. The use of donkey’s milk is therefore an important defence therapy in children with CMPA and 
can, consequently, be offered to adults (also with osteoporosis) whose symptoms may be due to the same 
disease. 
In the elderly, the donkey’s milk carries positive effects in the treatments of atherosclerosis, in the recovery 
of myocardial infracted, in cases of premature aging and in hypo-cholesterolemic diets. Therefore, a regular 
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intake of donkey’s milk, for its low content of saturated fatty acids and high content of polyunsaturated fatty 
acids, especially ω3 repairers of nerve cell membranes, plays a preventive action in respect of the cardio-
circulatory districts, preventing the formation of atherosclerotic plaques and reducing the risk of heart 
diseases due to increases in blood flow and pressure to the onset of heart attack (Carroccio et al., 2000a;b; 
Chiofalo, 2001; Salimei et al., 2004a; D’Amico et al., 2007). 
 
1.9.5 Use of donkey’s milk in Dermocosmetics 
 
The pool of substances contained naturally (as lysine) in donkey’s milk are used for combating and 
preventing the process of skin aging through: 
• a stimulation of metabolic activity of fibroblasts, by reactivating the process of endogenous 
production of collagen, elastin and hyaluronic acid, which form the support structure of the dermis; 
• an increase in skin hydration to give tone and firmness to the skin; 
• a protective action against free radicals which are formed continuously.  
Therefore in cosmetics, donkey’s milk is used for its cleaning and hydrating action (characteristics of any 
milk): fat’s micelles dispersed into the aqueous component of the milk reach easily the dirt particles; the 
aqueous part leaves dirt from the micelles and hydrates the treated part) combined with an antioxidant action 
(due to the presence of polyunsatured fatty acids, vitamins A, B and E, lysozyme and other active composts) 
that prevents the aging. In fact, the fat content in donkey’s milk nourishes the skin and give it softness and 
comfort, also because the essential fatty acids, such as omega 6, help the skin in the vitamin absorption. So, 
they leave the skin elastic and are useful in the prevention of cutaneous diseases, as eczema and psoriasis, 
because these fatty acids have anti-inflammatory action and are able to restore and protect the skin cellular 
membranes. The multivitamin complex A, B, C and E blocks and removes the catabolites of the skin cellular 
metabolism and begins a protector action of skin. More specifically, Vitamin C is an important antioxidant in 
cosmetics and in this way helps the slow of the skin aging and accelerates the mechanisms of healing. 
Vitamin E is known to be essentially an antioxidant which slows the skin aging and contributes to stability of 
cell structures, reducing the risk of skin diseases. The minerals contained in donkey’s milk are useful in the 
cleaning of skin, because they move away the dead cells, leaving on the skin surface only the living cells. 
They may also influence cell growth, improve the problems of capillary fragility (with anticouperose and 
anti-irritation effect) and they limit and reduce the signs of dark circles. Regarding the lysozyme, it shows 
antiviral, anti-inflammatory and healing properties and it is ideal for treatment of skin lesions, to care delicate 
skin and lips and to calm irritation symptoms (burning, itching). Lactoferrin and lactoperoxidase have instead 
bactericidal and fungicidal action useful to purify acne and oily skin, high antioxidant power which protects 
the skin against free radical attack or stress (due to chemical damage and UV radiation in the atmosphere), as 
well as having healing and lenitive properties (help skin healing and stimulate the renewal of tissues). The 
whey proteins complex contained in donkey’s milk has the ability to be absorbed and deposited gradually on 
the skin surface to form a film with a effect filler which acting on the relaxation and contraction of muscles, 
facilitates the prevention of classic skin wrinkles. The effect is developed through the formation of a very 
thin elastic film which retreating because of water evaporation exerts a tension effect on the skin, with visible 
and durable results. Even the high lactose content in donkey milk has a soothing and hydrating effect and 
draws by osmosis an increased inflow of blood to the skin tissue, improving nutrition and elasticity.    
However, in order to enhance the cleaning and moisturizing abilities of donkey’s milk, cosmetics has 
developed formulation such as soaps, creams and bubble baths where the milk is not used fresh but freeze-
dried. The freeze-drying of donkey milk for cosmetics is preferred, because it is only process which ensures 
100%  stability and preservation over time, a hygienic safety and a true integrity of active compounds in the 
finished product (Orsingher, 2011). 
 
1.9.6 Use of donkey’s milk in the daily diet 
 
The donkey’s milk is used in the common daily diet, especially in subjects at dietary regime, in sports and in 
the elderly, given its reduced lipid content. It is also used to replace the common cow’s milk in the 
production of ice creams and creams in the confectionery industry required by people with allergy or 
subjected to diet. 
The donkey’s milk not only may represent a precious source of nutrients but also of probiotic microorganism, 
able to make beneficial effects to the body and thus demonstrating the functional properties of milk. The 
probiotic microorganism isolated in donkey milk essentially belong to genus of Lactobacillus and 
Bifidobacterium (Shah, 2001), which according to the official report of FAO/WHO 2001, are living organism 
which administered in adequate amounts (106-108 UFC/ml product), are able to make a health benefit to the 
host organism”. Probiotics are microorganism resistant to the action of gastric acids and bile salts, which they 
meet along the gastrointestinal tract; thus they have the ability to adhere to the intestinal mucosa and colonize 
it, remaining so numerically dominant in relation to pathogenic or undesirable microorganisms. They are also 
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able to enhance the host body’s immune defence, at systemic and mucosal level, and produce metabolites 
with trophic effect on intestinal epithelium (butyrate) or inhibiting the growth of pathogenic microorganism 
(bacteriocins); finally, among other beneficial properties of probiotics, it is worthy mentioning the ability to 
improve the cholesterol metabolism, and to grow in milk or other fermented foods. 
For this reason, today, donkey milk (raw) is designed with the aim to isolate and identify microbial species 
with probiotic activity. In particular, a study was carried out, isolating lactic acid bacteria strains (essentially 
Lactobacillus brevis strains and Lactobacillus plantarum strains), which possess a good ability to survive in 
conditions such as the resistance to bile salts (about 70%) and simulated gastric juice (about 75%). The 
presence of probiotics in donkey milk may be, therefore, an interesting prerequisite both from healthy point 
of view and from an applicative point of view. In fact, in addition to using the isolated probiotics as 
fermentation starter for different industrial productions, it is possible to suppose the use of these starter for 
the formulation of yogurt and dairy products made with donkey milk (Kefir, koumiss). The fermentation with 
selected probiotic strains, naturally occurred in the raw food, could have positive effects on the organoleptic 
properties and texture of the final product (Nazzaro et al., 2007).     
 
1.9.7 Use of donkey milk for a fermented beverage production with lactobacilli    
 
Equid milk, as donkey milk, can be considered a good substrate for probiotic beverage production. The use of 
fermented horse milk is an ancient tradition in central Asia (Mongolia, Siberia, and Kazakhstan), where 
Koumiss or airag are considered beverages with health-promoting properties (Uniake-Lowe, 2011). A novel 
Bifidobacterium species, Bifidobacterium mongoliense sp. nov. has been isolated from airag (Watanabe et al., 
2009), while a novel Lactobacillus casei strain, Lb. casei Zhang, is under investigation for its probiotic 
potential (Guo et al., 2009). 
Bacteriocins produced by lactic acid bacteria in airag have recently been isolated and characterised by 
Batdorj et al. (2006). 
Koumiss, a lactic-alcholic beverage derived from mare’s milk, is an effective combination of raw milk and 
indigenous microbial populations, mainly Lactic Acid Bacteria LAB and yeasts, whose diversity is of 
increasing interest (Di Cagno et al., 2004). 
Koumiss is the national drink of the people in central Asia and is also quite popular in countries bordering the 
Russian federation. It has been suggested that Koumiss has probiotic properties and has even prescribed as a 
cure for patients with various diseases in Russian hospitals. It is practically unknown in the rest of Europe 
and the Western world (Chiavari et al., 2005). Koumiss is also rich in ACE-inhibitory peptides, supporting 
the clain of its beneficial effects on cardio-vascular health (Chen et al., 2010). 
The chemical-physical and microbiological properties of the raw donkey milk demonstrated that it has a high 
lactose content, a low microbial load (104 CFU/mL essentially represented by LAB which constituted about 
80% of the milk flora) and an elevated content of lysozyme which makes it somewhat selective with regards 
to the bacteria it can host (Chiavari et al., 2005). In fact, the growth of LAB (and also fungi) at 20°C 
suggested that the natural antimicrobial substances in donkey milk could not control these kinds of 
microorganism and thus this milk (for its hygienic and probiotic effects) could be used as a very good base 
ingredient for preparation of fermented probiotic and therapeutic milk beverage as suggested by Coppola et 
al. (2002).   
However, effective measures should be taken to avoid undesirable fermentative acidification of raw milk 
caused by LAB and fungi. According to Zhang et al. (2008), the refrigeration temperature (+4°C) might be 
an effective measure to control the microorganisms, mainly fungi which are not influenced either by the 
natural antimicrobial substances and by low temperature.  
Chiavari et al. (2005) and Coppola et al. (2002) underlined the possibility of producing a fermented beverage 
from donkey’s milk using the probiotic bacterial strains of Lactobacillus rhamnosus naturally present in 
donkey milk or isolated from other dairy products. According these authors, the raw milk used for the 
fermented beverage, was subjected to pasteurization (63°C for 30 min) as an additional safety measure which 
did not have any effect on the anti-microbial activity, confirming the elevated thermostability of the 
lysozyme. Pasteurized milk (after cooling at 37°C) has been inoculated with some strains of Lactobacillus 
rhamnosus, with probiotic properties. The probiotic strains of  LAB used for fermented beverage production, 
after an initial adaptation phase, must have a high growth degree (108 CFU/ml), even after fermentation and 
storage, representing almost all of bacterial content in the final beverage, even after 30 days of shelf life and 
despite the high concentration of lysozyme either in the raw milk and in the thermically treated milk. 
The fermentation provides good results, either in terms of cellular viability and in terms of presence of some 
metabolites in the final product. From a microbial growth point of view, the product is a probiotic and gives 
beneficial effects on consumers’ health, if it ensures a microbial count of about 106 -108 (Shah, 2001). 
The presence of 108 CFU/ml of probiotic lactic bacteria is sufficient to ensure the daily intake suggested by 
Vanderhoof & Young (1998), even with limited consumption of the beverage. 
It is interesting to note that Lactobacillus rhamnosus strains remained highly viable after 15 days of storage 
at 4°C and at low pH (3.7-3.8), thus demonstrating to be a good candidate for probiotic foods. The high 
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lysozyme content only partially influenced the growth of the strains tested without any significant effect on 
their acidifying activity (Coppola et al., 2002; Chiavari et al., 2005). 
Moreover, strains of Lactic Bacteria that confer pleasant sensorial traits to the fermented product are used. 
Texture and flavour of fermented horse and donkey milk, on the other hand, may be a constraint to the 
acceptability of the products, so that fortification with Na-caseinate, pectin and threonine or the addition of 
flavours can enhance the rheological and sensory quality (Di Cagno et al., 2004; Chiavari et al., 2005). The 
production of fermented milks by means of a standardised manufacturing protocol should be considered 
crucial for consumers and markets, according to Di Cagno et al. (2004). However, good quality Koumiss is 
produced when lactic and alcoholic fermentation proceed simultaneously so that the products of fermentation 
occur in definite proportion (Berlin, 1962). During fermentation, 0.7-1.8% lactic acid, 0.6-2.5% ethanol and 
0,5%-0.9% CO2, volatile acids and other compounds are formed that are important for aroma and taste. Up 
to 10% of the equine milk proteins are hydrolysed after 96h but the far remains unchanged (Berlin, 1962; 
Tamine & Marshall, 1984). Koumiss is a milky, grey, fizzy liquid with a sharp alcohol and acid taste (Berlin, 
1962; Tamine & Marshall, 1984). Products with varying amount of lactic acid and ethanol are produced and 
generally 3 categories of Koumiss, mild, medium and strong, are known, and it is thought to be more 
effective than raw milk in the treatment of various illness due to probiotics and peptides and bactericidal 
substances from microbial metabolism (Doreu & Martin-Rosset, 2002).  
Finally, donkey milk is a possible basis for a fermented beverage, as it contains several advantageous 
qualities, such as a low microbial counts and high lysozyme content, as well as being a vehicle for the 
consumption of probiotic bacteria. Further studies may be warranted in order to select other bacterial strains 
with probiotic properties that are even better adapted to donkey’s milk.   
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2 AIM of THE WORK 
 
In Europe, especially in Italy, the worry of a definitive loss of asinine species has drawn attention of the 
scientific world and local authorities, not only for its maintenance but also for productive enhancement, as 
incisive tool to ensure the “survival” of the donkey over time. So, the Community Agricultural Policy has 
allowed the revival of small donkey farms to retrieve the original strains and promote the reproduction of 
different animals avoiding, in this way, the gradual extinction of asinine species. In the last years, the loss of 
asinine genetic patrimony and the demand of a hypoallergenic and nutritionally adequate milk, have 
stimulated the interest of many breeders, mainly in the inner areas of the Italy, which have rediscovered the 
donkey breeding, as important for environment and biodiversity.  
The increasing of the donkey breeding made possible a good availability of this milk arousing the scientific 
world’s interest. In order to have a greater spread of donkey’s milk, the research is essential to orient the 
breeder towards a correct diet of animal and breeds more suitable for the milk production in respect of animal 
welfare to achieve a donkey’s milk with excellent nutritional characteristics. At the same time, it is therefore 
important the collaboration of the scientific and medical world, in order to begin an information’s campaign 
on the properties of this food.    
The preservation of asinine breeds is due to donkey’s reintegration in programs of social and economic 
interest, such as, onotherapy, onodidactics, onotourism, onocosmetic and onomilk (milk production). In fact, 
donkey’s milk, is a natural product attributable to category of pharmafood/nutraceuticals useful for children 
and adults (Gatti, 2007).  
In addition, in the production of milks for infants, the cow’s milk is humanized by decreasing the protein 
content (3.2% in cow’s milk vs 1% in human milk) and inverting the CN:WP ratio (80/20 in cow’s milk vs 
40/60 in human milk). This type of technology requires heat treatments which, nevertheless, can cause 
changes to the basic components of the milk (lactose, proteins, vitamins, minerals) resulting in alteration of 
its organoleptic characteristics and reduction of its biological and nutritional value. 
For this reason, in recent years, the interest of the scientific research was aimed at enhancing the milk of 
other species (donkey), as substitute for breast milk and bio-functional food. 
Since the knowledge about the genetic profile of donkey proteins (casein and whey proteins) of animals 
reared in Italy is very scarce, as well as there are very few experimental evidences of the expression level of 
the individual milk proteins, the present research was aimed to filling this gap and to relating it to the milk 
nutritional quality. 
The aim of this PhD thesis is placed in this context, namely the quali-quantitative characterization of protein 
fraction of donkey milk important for its use in infant feeding and in patients with cow’s milk protein allergy. 
As a potential experimental methodology for the identification and characterization of complex mixture of 
proteins, such as caseins and whey proteins extracted from individual samples of donkey milk, was proposed 
the proteomic approach. This methodology is based on the combination of analytical and instrumental 
techniques highly efficient for the separation of asinine proteome’s components, in particular: 
• Electrophoretic techniques which separate the proteins according to different principles (net charge, 
isoelectric point, molecular mass) either one-dimensional (PAGE pH 8.6, SDS-PAGE, UTLIEF) 
and two dimensional 2-DE (PAGE→UTLIEF; IPG→SDS-PAGE). The proteins separated with 
various electrophoretic system can be identified with the classic Blue Coomassie staining or by 
immunostaining with specific polyclonal antibodies produced against each protein fraction and/or 
by mass spectrometry analysis of spots excised from electrophoretic plates; 
• Chromatographic techniques with high resolution, as RP-HPLC also interfaced to mass 
spectrometry (LC-ESI-MS, MALDI-TOF-MS, ESI q-TOF/MS) for the identification of the protein 
components.   
On the basis of the advantages recognised in infant nutrition of the use of donkey milk, dietary and 
therapeutic properties of which have been known since ancient time (Oftedal & Jennes, 1988) the present 
study was carried out to examine not only qualitative but also quantitative characteristics of donkey milk. 
Thus, in the present work, the milk protein content was determined by Kjeldahl method and the CN:WP ratio 
was determined by electrophoretic technique (SDS-PAGE) coupled with densitometry, while the relative 
percentage of each individual casein and whey protein component isolated from individual milk samples was 
determined by integration of HPLC peaks.  
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3. RESULTS AND DISCUSSIONS 
 
3.1 Topic/theme 1: characterization of donkey milk caseins 
 
At present, compared with bovine milk, the characterization of donkey milk caseins is at relatively early 
stage of progress, and only limited data are related to its genetic polymorphism. In this work the 
heterogeneity of donkey “caseome” was investigated using proteomic approach. This study carried out on 
milk proteins, as caseins, is aimed to the characterization of their molecular composition (primary structure, 
disulphide bridges and other post-translational modifications as phosphorylation and glycosylation), which 
can justify both their functional properties (solubility, clotting aptitude, thermal denaturation) and nutritional 
quality (amino acid composition, digestibility, bioactivity). 
 
3.2 Materials and methods 1 
 
All chemicals were of the highest purity commercially available and were used without further purification. 
Tetra-methyl-ethylene-diamine (TEMED), 2-mercaptoethanol, ammonium persulphate, glycine, glycerol, 
TRIS (hidroxymethyl-amino methane), SDS (sodium dodecyl sulfate), acetic acid, methanol, urea, 
ammonium bicarbonate (AMBIC), HPLC grade H2O, formic acid (FA) and acetonitrile (CH3CN) were 
purchased from Carlo Erba (Milan, Italy). Trichloroacetic acid (TCA), Trifluoroacetic acid (TFA), sinapinic 
acid (SA), α-cyano-4-hydroxycinnamic acid (CHCA), iodoacetamide (IA), dithiothreitol (DTT), 3-[(3-
cholamidopropyl)-dimethylammonio]-1-propanesulfonate (CHAPS) were obtained from Aldrich (St. Louis, 
MO, USA). Modified trypsin, sequencing grade was from Promega (Madison, WI, USA), alkaline 
phosphatase (AP) was from Roche (Mannheim, Germany). Dialysis tubing with molecular weight cut off 
(MWCO) 12–14.000 Da was from Medicell International Ltd (London, UK). Amicon® Ultra centrifugal 
filters 3.000 MWCO and ZipTip™ C18 micro columns were obtained from Millipore (Bedford, MA, USA). 
Acrylamide, bis acrylamide, Ampholine buffers were from GE Healthcare Amersham Biosciences 
(Buckinghamshire, UK). Coomaassie Brilliant Blue (CBB) R250 and G250 were purchased from Bio-Rad 
(Richmond, CA, USA). 
 
3.2.1 Donkey milk sampling (sample Casein preparation)  
 
Milk samples collected from 77 donkeys reared in middle and southern Italy (Abruzzo and Sicily) were 
analysed individually. The milk was defatted by centrifugation, at 4000 rpm for 30 min. The fat layer was 
solidified at  −24°C and drawn up. The casein fraction was precipitated from skimmed milk at pH 4.6 with 
sodium acetate/acid acetic buffer and separated from the supernatant by centrifugation at 4000 rpm for 30 
min), as described by Aschaffenburg & Drewry, 1959. The sodium caseinate precipitate was washed twice 
with the buffer, dialyzed against water and finally freeze-dried and stored at −20°C before use. The 
supernatant, containing the whey proteins, after being recovered by centrifugation (4000 rpm for 30 min) at 
room temperature, was dialysed in tubing with molecular cut off 12,000–14,000 Da and subsequently freeze-
dried and stored at −20 °C before use. 
 
3.2.2 Polyacrylamide gel electrophoresis (PAGE) at pH 8.6 
Sample Preparation: Casein samples (20 g/L) for electrophoretic analysis were dissolved in 9 M urea 
solution 9 M, containing 2-mercaptoetanol (1 ml/L). At 100µl of this protein solution, 100µl glycerol 87% 
and 5µl bromophenol blue were added. 10 µl of this casein solution were loaded in the gel for the 
electrophoretic run.  
PAGE analysis at pH 8.6: polyacrylamide gel electrophoresis (PAGE) at pH 8.6 was carried out with a 
vertical electrophoretic apparatus (Protean II, Bio-Rad, Richmond, CA, USA) at 200 V and 6°C for 7h 
according to the procedure described by Chianese et al. (2010). Briefly, this electrophoretic technique 
provides a polyacrylamide gel named “stacking gel” (3% T and 1% C) containing 3.6 M Urea, 75% (w/v) 
glycerol in 0.5 M Tris-HCl at pH 6.8. The “stacking gel” is stratified on another polyacrylamide gel named 
“running gel” (7.5 % T and 2.5% C) containing 6.1M Urea and 1.5 M Tris-HCl at pH 8.6. So, the parameters 
which define the gel composition are T, sum of acrylamide and bis-acrylamide (g/100 ml solution) and C, the 
percentage ratio of the bis-acrylamide compared to T. The size of the pores is determined by T, while the 
crosslinking degree of the gel is expressed by C. Specifically, a T increase determines a reduction of the 
pores size and the separation is influenced by the size of the molecules. The polyacrylamide gels are obtained 
by co-polymerizing acrylamide and bis-acrylamide with N,N,N’,N’-tetrametiletilenediammina (TEMED) and 
ammonium persulphate (PER) added in a final concentration of 0.04% (v/v) and 0.07% (w/v), respectively, 
as activator and catalyst of polymerization reaction. The migration buffer consists of 0.19 M glycine and 
0.025 Tris with a pH 8.6. The gel staining was performed with 0.05% (w/v) CBB R-250 dissolved in a 
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mixture of 50% (v/v) methanol and 7% (v/v) acetic acid, followed by destaining in a solution containing 30% 
(v/v) methanol and 10% (v/v) glacial acetic acid. 
This technique allows to separate proteins according to their net charge, negative or positive, depending on 
the used pH. 
 
3.2.3 Ultra-thin layer isoelectric focusing UTLIEF (on polyacrylamide gels) analysis 
 
Sample Preparation: Casein samples (20 g/L) for electrophoretic analysis were dissolved in 9M urea 
solution, containing 2-mercaptoetanol (1 ml/L). 10 µl of these solutions were loaded on the gel and used for 
UTLIEF analysis. 
UTLIEF analysis:  Ultra-thin layer isoelectric focusing (UTLIEF) on polyacrylamide gels (124×258×0,25 
mm) was carried out according to the procedure of Chianese et al. (2010). Briefly, the polyacrylamide gel 
with the pH gradient in the range 4.2-6.0 was obtained by mixing 1% (v/v) Ampholine buffers 4.2-4.9 (400 
µl), 4.5-5.4 (400 µl), and 4-6 (250 µl). UTLIEF analysis was performed with LKB Multiphore II instrument  
(Pharmacia LKB, Bromma, Sweeden) at 10°C and the electrophoretic analysis consists of three steps: pre-
focusing (2000 V, 15 mA, 4 W, 30 min), focusing with the sample (2000 V, 15 mA, 4 W, 60 min), final 
focusing (3000 V, 5 mA, 20 W, 130 min). After the electrophoretic run, the fixation of the protein bands on 
the gel was carried out by gel’s immersion in 20% (v/v) trichloroacetic acid solution. The gel was stained 
with CBB G-250 as described by Krause et al. (1988). This technique allows to separate proteins according 
to their isoelectric point. 
 
3.2.4 Two-dimensional (2-DE) electrophoresis analysis (PAGE→UTLIEF) and (IPG→PAGE-SDS) 
 
The  2-DE (PAGE→UTLIEF) procedure was achieved by combining the first dimension PAGE gel with the 
second dimension UTLIEF gel; in particular, an unstained strip of gel PAGE, rinsed twice in distilled water 
and in 9M urea with mercaptoethanol 0.01% (v/v), was applied along the cathode of prefocused UTLIEF 
plate. 
For 2-DE analysis (IPG→PAGE-SDS), the first step is the rehydration phase where 330µg of casein sample 
was dissolved in 450 µL of solution containing 9M urea, 2% (w/v) 3-[(3-cholamidopropyl)-
dimethylammonio]-1-propanesulfonate (CHAPS), 65 mM dithiothreitol (DTT), ampholytes 3.5-10, 0.001% 
(w/v) bromophenol blue. 
A pre-cast immobilized pH gradient gel strip (IPG-strip) with a linear pH gradient range of 4-7 (IPG 
ReadyStrip pH 4-7, length 18 cm; Bio-Rad, Richmond, CA, USA) was placed in the Protean IEF Cell (Bio-
Rad, Richmond, CA, USA) and was rehydrated with the protein solution for 16 h at 20°C without voltage. 
For the first dimension, the focusing was performed at 20°C in three steps: in the first step a voltage of 500 V 
for 1 h was applied to remove excess salts; in the second step a voltage of 1000 V was applied for another 
hour and in the third step, a voltage of 8000 V was applied for 5 h. The current limit per IPG-strip was 50 
µA. Subsequently, IPG strips were equilibrated for 15 min in Equilibration Buffer I (0.375 M Tris-HCl pH 
8.8, containing 6M urea, 20% (v/v) glycerol, 2% (w/v) SDS, 130 mM DTT). After 15 min, the strips were 
alkylated in Equilibration Buffer II (0.375 M Tris-HCl pH 8.8, containing 6M urea, 20% (v/v) glycerol, 2% 
(w/v) SDS, 135 mM IA) and applied on 12% SDS-PAGE gels using a Protean II apparatus (Bio-Rad, 
Richmond, CA, USA) with the procedure described by Laemmli, (1970). For this second dimension, the gels 
were run at 120 Volt for 20 min and then at 200 Volt for 6-7 hours. When the gels were not submitted to 
western blotting, proteins were stained with CBB R 250. The gels were destained until the protein spots 
became evident and the gel background transparent.       
 
3.2.5 Immunoblotting analysis 
 
This analysis is based on cross-reaction between specific polyclonal antibodies produced against the 
individual casein fractions αs1-, αs2-, β- and κ-CN (or casein peptides) and their respective antigens. 
Specifically, this technique allows to identify the individual casein fractions according to the specificity 
shown by specific polyclonal antibodies produced against these casein fractions after immunization of rabbits 
with the individual caseins αs1-, αs2-, β- and κ-CN or their casein peptides.  
The reagents for immunoblotting were: PBS buffer (4.5% NaCl, 3.9% NaH2PO4, pH 7), wash buffer solution 
and saturating the membrane “blocking solution” (equine serum at 10% v/v in PBS), development buffer (0.5 
mg/ml diaminobenzidine in 10 mM Tris-HCl 0.1 M pH 7.5, 0.6 mg/ml NiCl2 1%).  
For immunoblotting analysis, the casein fraction separated either by electrophoretic analysis were transferred 
by capillary diffusion from the gel into a nitrocellulose membrane (0,45µm, Trans-Blot, Bio-Rad, Richmond, 
CA, USA). Immunodetection was carried out according to the procedure already described by Chianese et al. 
(2010), using rabbit polyclonal antibodies against donkey synthetic peptides reproducing the C-terminal 
sequence of αs1-CN (187-202), αs2-CN (206-221), β-CN (211-226) and porcine κ-CN as primary antibodies. 
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The synthetic peptides and the porcine κ-CN, the latter fractionated by RP-HPLC, were united at ovalbumin 
through the sulphydryl group of the C-terminal or N-terminal cysteine residue, according to the procedure 
described by Mattson et al. (1993). The conjugates of ovalbumin were used as antigens by Primm (Milan, 
Italy) to immune two rabbits and thus to obtain rabbit polyclonal antisera against these casein fractions. 
Finally, the antisera obtained after the animals’ death were filtered using 0.45 mm filters (Millipore, Bedford, 
MA), divided into aliquots of 1ml and stored at −20°C.  
For immunodetection, nitrocellulose membrane was incubated for 1h with specific primary antibody diluted 
in Wash Buffer. This step was followed by incubation with second antibody, preceded by washing of the 
membrane with the same wash buffer solution “ blocking solution”. As secondary antibody, the polyclonal 
antiserum produced by goats against the rabbit IgG and peroxidase-conjugated (Goat-Antirabbit antibody 
conjugated to peroxidase, Bio-Rad, Hercules, CA) was used. After 1 h of incubation with the second 
antibody and washing with “wash buffer”, the membrane is immersed in the solution for the development of 
the colorimetric reaction. This phase was carried out by adding hydrogen peroxide. 
 
3.2.6 Reversed-phase high performance liquid chromatography (RP-HPLC) analysis  
 
The HPLC system was provided by Kontron Instrument (Milan, Italy) and is constituted by two pumps 
model 420, an injector of the sample (loop 50 µL) and a DATA SYSTEM 450 for the chromatography’s 
management and for the integration of the peak areas of the chromatograms.   
The casein samples were fractionated by RP-HPLC on a 214TP54 5µm Vydac C4, 250 mm × 4.6 mm internal 
diameter column (Vydac, Hesperia, CA, USA) and the detection was at a wavelength of 220 or 280 nm with 
a UV detector Kontron (Mod. 430). The solvent used were: solvent A and solvent B. Solvent A was 0.1% 
(v/v) TFA in ultra pure water and solvent B 0.1% (v/v) TFA in acetonitrile. 50 µL of a solution containing 4 
mg (casein sample)/ mL (solvent A) were loaded into a C4 column, equilibrated with solvent A. The elution 
program involved a gradient from 34 to 42% solvent B in 35 min, then from 42% to 100% B in 2 min, with a 
flow rate of 1 mLmin−1. Each eluted casein fraction was manually collected, freeze-dried and stored at 
−20°C. 
This technique allows to separate proteins according to their hydrophobicity. 
 
3.2.7 LC-ESI-MS  analysis 
 
The molecular mass determination of native or dephosphorylated caseins (as donkey β-CNs) was carried out 
using a single quadrupole instrument LC-ESI-MS. Specifically, liquid chromatography/electrospray mass 
spectrometry (LC-ESI-MS) was performed using an HPLC modular system (HP1100-MSD, Agilent 
Technologies, Santa Clara, CA, USA) with UV detector, interfaced with a single quadrupole mass 
spectrometer equipped with a electrospray source (ESI) and monitored by HP Chem Station software for the 
acquisition, analysis and processing of  the mass spectra.  
The casein samples were fractionated by RP-HPLC on a 213TP54 5µm Vydac C3, 250 mm × 4.6 mm internal 
diameter column (Vydac, Hesperia, CA, USA) and the UV detection was at a wavelength of 220 nm. Solvent 
A was 0.1% (v/v) TFA in ultra pure water and solvent B 0.1% (v/v) TFA in acetonitrile. 20 µL of a solution 
containing 10 mg (casein sample)/ mL (solvent A) were loaded into a C3 column, equilibrated with solvent 
A. The elution program involved a gradient from 34 to 42% solvent B in 30 min, then from 42 to 55% B in 
15 min, at a flow rate of 0.4 mLmin−1. 
The ESI mass spectra were scanned in the positive ion mode, from 800-2200 m/z at a scan cycle of 5 
sec/scan. The source temperature was 120°C and the orifice voltage was 40. Mass values are reported as 
average masses. Signals recorded in the mass spectra were associated with the corresponding casein proteins 
on the basis of the molecular mass, taking into the account the reported amino acid sequences of donkey 
caseins available on database Swiss-prot (ExPASy proteomics server). 
 
3.2.8 Dephosphorylation of the casein fraction 
 
An aliquot of the casein fraction was dephosphorylated using alkaline phosphatase from bovine intestinal 
mucosa (Mamone et al., 2003). In detail, the casein fraction (casein sample or casein fraction) was dissolved 
in 0.4% NH4HCO3 aqueous solution, pH 8.5, at a concentration of 10 mg/mL and then boiled at 100°C for 3 
min to deactivate the plasmin. The enzyme was also solubilised in 0.4% NH4HCO3 aqueous solution, pH 8.5, 
at a concentration of 1 mg/mL and added at a molar enzyme/substrate ratio 1:25 to casein solution. The 
enzymatic reaction was started by addition of 60 µL of enzyme solution (1 mg/mL) to 90 µL casein solution 
(10 mg/mL). This final solution was incubated at 37°C overnight and the digestion was stopped by freezing. 
 
3.2.9 Trypsin enzymatic digestion 
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The digestion of the caseins from electrophoretic spots was carried out following the procedure reported by 
Mamone et al. (2003). Briefly, the spots from stained gel were manually excised with a clean scapel, placed 
in a Eppendorf tube and twice washed with 50 µL Milli-Q water. Each gel piece was completely destained 
(spots become white) by immersion into a solution 50 mM NH4HCO3 in 50 % (v/v) aqueous acetonitrile. The 
destained spot was dehydrated by submersion into acetonitrile, and dried under vacuum after acetonitrile 
removal. The dried gel was covered by 30 µL 50 mM NH4HCO3 containing 12 ng/µL trypsin maintained in 
an ice-cold tube. After 45 min action, the supernatant was removed and incubated overnight at 37°C. The  
resulting tryptic digest was extracted in 40 µL of acetonitrile/5% formic acid solution (1:1 v:v) and then the 
volume concentrated to a tenth in a vacuum centrifuge for the mass spectrometric analysis. Careful 
precautions are important to avoid gel contamination with foreign proteins. As regards the tryptic digestion of 
each isolated casein fraction, collected by RP-HPLC, it was dried using a Savant concentrator (Speed-Vac, 
Milan, Italy), lyophilized, denatured and alkylated before trypsin hydrolysis. Briefly, each isolated casein 
fraction (for example donkey αs1- or β-CN) was denatured at room temperature, in a guanidine buffer (6M 
guanidine in 0.5 M Tris-HCl with 1 mM EDTA) at pH 8. Subsequently, disulfide bridges were reduced by of 
10 mM/L DTT for 60 min at 56°C. SH groups were subsequently alkylated with 55 mM/L IA in the above 
guanidine buffer, and maintained for 30 min in the dark. With the aim to remove the reagents, the alkylated 
casein was ultra-filtered on Amicon® Ultra filters 3000 MWCO, centrifugated at 4000 g for 25 min and 
washed with 50 mM NH4HCO3, pH 7.4. The retentate solution containing the purified alkylated casein (as 
αs1- or β-CN), was added of trypsin (dissolved in the same solution of 50 mM NH4HCO3, pH 7.4) at 1:50 
(w/w) and incubated overnight (approximately 14 h) at 37°C. The digestion was stopped by frozen (−20°C).    
 
3.2.10 Matrix-assisted laser desorption/ionization-time-of-flight-mass spectrometry (MALDI-TOF-MS) 
analysis  
 
MALDI-TOF-MS experiments were carried out on a Voyager DE-PRO mass spectrometer (PerSeptive 
Biosystems, Framingham, MA) equipped with a N2 laser (337 nm, 3 ns pulse width) operating both in linear 
or in reflector positive ion mode, using the Delay Extraction technology. Mass spectra were acquired both in 
positive linear or in reflectron mode and using SA and CHCA dissolved in aqueous solution of 50% (v/v) 
ACN containing 0.1% (v/v) TFA, at a concentration of 10 mg/mL, as matrices for the analysis of proteins 
and peptides, respectively. MALDI-TOF-MS analysis of intact proteins were obtained in linear positive ion 
mode over the m/z range 10000-30000 and were averaged from about 150 laser shots.  
As regards peptides analysis, the mixtures of tryptic peptides were subjected to desalting/concentration step 
with Zip-Tip C18 pre-packed micro-columns (Millipore, Bedford, MA, USA) previously equilibrated with 
aqueous 0.1% TFA (v/v), prior to analysis by MALDI-TOF. Each spectrum was taken with the following 
procedure: 1µL of sample is directly loaded on a stainless steel plate together with 1µ of the matrice. Mass 
Spectra were obtained in reflectron positive ion mode over an m/z range 600-4000 and were averaged from 
about 150 laser shots. External calibration was performed by acquiring separate spectra of a mixture of 
standard peptides (PerSeptive Biosystems). 
The identification of donkey caseins and their derived peptides was carried out using the known caseins 
available on Swiss-prot database (ExPASy proteomic server) of Swiss Institute of Bioinformatics (SIB) and 
with the online software FINDPEPT (website: http://www.expasy.org/tools/findpept.html). 
 
3.2.11 Electrospray quadrupole-time of flight-mass spectrometry (ESI-Q-TOF-MS/MS) analysis 
 
Tandem MS (MS/MS) data were obtained using a hybrid quadrupole-orthogonal acceleration time of flight 
Q-STAR instrument (Applied Biosystem, Foster City, CA) equipped with a nanospray source (Protana, 
Odense, Denmark), operating in positive ion mode. Dried samples were resuspended in 0.1% TFA, purified 
from residual salts by loading into ZipTip C18 Reversed Phase pre-packed micro-columns (Millipore Bedford 
MA, USA), and introduced in the source through borosilicate needles, gold coated (Protana Odense, 
Denmark). The capillary voltage used was 800 V. Double-charged ion isotopic cluster were selected by using 
the quadrupole mass filter and the induced to fragment by collision. The collision energy was 20 to 40 eV, 
depending on the size of the peptide. The collision-induced dissociation was processed by using Analyst 5 
software (Appied Biosystems). The deconvoluted MS/MS spectrum was manually interpreted with the help 
of Analyst 5 software.  
 
3.2.12 Chymosin Hydrolysis 
 
For chymosin hydrolysis, caseins (20 mg/mL) were dissolved in 0.1 M sodium citrate buffer, pH 6.0. For 
hydrolysis reaction, the rennet’s solution was prepared adding 100 µL of HANSEN rennet in 5 mL sodium 
citrate solution 0.1M, pH 6.0. 
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30 µL of this chymosin solution was added to 1 mL protein solution, and the hydrolysis was performed at 
37°C for 2 h. To stop the reaction, the pH was decreased by adding 1 mL of 24 % (v/v) TCA. The precipitate 
obtained after adding TCA solution and centrifugation was used for the preparation of electrophoretic 
sample. 
 
3.2.13 Polyacrylamide gel electrophoresis-Sodium Dodecyl Sulphate (PAGE-SDS) analysis with 
Fluorescent Glycoprotein detection and immunoblotting 
 
Sample Preparation: donkey casein samples (before and after chymosin hydrolysis) or whey protein samples 
(20 g/L) were dissolved in 9M urea solution containing 2-mercaptoetanol (1 ml/L). 200 µL of a denaturing 
solution (0.062 M Tris-HCl, 2% (w/v) SDS, 5% (v/v) β-mercaptoethanol, pH 6.8) and 5µl bromophenol blue 
were added at 100µl of the protein solution. The protein samples, after adding the denaturing solution and 
bromophenol, were heated at 100°C for 5 min. Volumes of 10 µl of this final sample were loaded in the gels.     
PAGE-SDS analysis: PAGE-SDS was carried out with a vertical electrophoretic apparatus (Protean II, Bio-
Rad, Richmond, CA, USA) according to the procedure described by Laemmli, (1970) using a 4% 
polyacrylamide stacking gel in 0.5 M Tris-HCl buffer (pH 6.8) and  18% or 15% polyacrylamide resolving or 
running gel in 1.5 M Tris-HCl buffer (pH 8.6) in the presence of 10% SDS. The polyacrylamide gels were 
obtained by co-polymerizing acrylamide and bis-acrylamide with N,N,N’,N’-tetrametiletilenediammina 
(TEMED) and ammonium persulphate (PER) added, respectively, as activator and catalyst of polymerization 
reaction. As molecular standard, a low molecular weight standard kit (LMW Calibration kit, Amersham, GE 
Healthcare, UK) was used. Electrophoresis was performed at constant voltage 200 V (for about 6 h) in the 
migration buffer containing 0.2M glycine, 0.025 M Tris and 0.1% SDS. The gel staining was performed with 
0.1% (w/v) Coomassie Brilliant Blue CBB R-250 dissolved in a fixative solution (50% (v/v) methanol and 
7% (v/v) acetic acid), followed by destaining in a aqueous solution containing 30% (v/v) methanol and 10% 
(v/v) glacial acetic acid. 
Staining of glycoproteins fixed in the gel with an acetic/methanol solution was carried out with Fluorescent 
Glycoprotein Detection Kit (GlycoProfile III, Sigma-Aldrich, St. Louis, MO, USA), where the carbohydrates 
on the proteins are oxidized to aldehydes with periodic acid. A hydrazide dye is reacted with the aldehydes, 
forming a stable fluorescent conjugate. This allows for the specific, sensitive detection of the glycoproteins 
directly in gels. 
The immunoblotting with specific polyclonal antibodies against each donkey casein fraction was carried out 
according to the procedures described in paragraph 3.2.5.  
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3.3 Results and discussion 1 
 
3.3.1 Characterization of donkey αs1-CN by PAGE pH 8.6 and immunoblotting analysis 
 
The most representative and individual donkey casein samples Coomassie Brilliant Blue stained (Fig. 3.1A) 
were compared to cow counterparts on the basis of their relative net charge at alkaline pH by PAGE analysis. 
The results obtained after specific immunostaining with the polyclonal antibody against αs1-CN (Fig. 3.1B) 
allowed to detect this casein fraction. 
By comparing the two species each other, donkey αs1-CN exhibited a lower and reversed anodic mobility 
than its cow counterpart. The PAGE analysis of the representative donkey caseins, either with Blue Comassie 
(Fig. 3.1A) or specific polyclonal antibody staining (Fig. 3.1B) also showed a complex heterogeneity of 
donkey αs1-CN due to the detection of several immunostained components, where the main αs1-CN 
components (4-6) essentially exhibited an intermediate anodic mobility between donkey β- and αs2-CN. 
These immuno-electrophoretic results also showed an overlap between αs1-CN and αs2-CN, although minor 
αs1-CN components were essentially found at anode. 
However, the compositional heterogeneity of donkey αs1-CN could be due to different phosphorylation 
degree of its components and to the presence of deleted forms, as in mare counterparts (Milenkovic et al., 
2002; Lenasi et al., 2003; Miranda et al., 2004; Mateos et al., 2009b). 
At this regard, Cunsolo et al. (2009a) found four donkey αs1-CN components with 202, 201, 197 and 196 
amino acids (aa), whose sequences were completely characterized, using the known mare αs1-CN as 
reference (Lenasi et al., 2003). Moreover, the immuno-electrophoretic results also showed αs1-CN’s 
quantitative differences among analyzed donkey caseins, probably due to a three different expression degrees 
of the protein; at this regard, three expression levels can be detected, which allowed to classify the containing 
phenotypes as full (lanes 1, 2, 3, 4), intermediate (lane 6) and null (lane 5). 
This phenomenon of “quantitative polymorphism” was found for the first time in goat milk (Grosclaude & 
Martin, 1997), where alleles, at goat αs1-CN locus, were identified as defective mutants in terms of functional 
activity of the gene and the type of mutations is quite variable: single nucleotide substitution or deletion, or 
large insertion or deletions. So, a low αs1-CN content in donkey milk may represent an important attribute for 
its use in human allergology as reported by Bevilacqua et al. (2001) in goat milk.  
 
 
Fig 3.1: PAGE at pH 8.6 analysis of representative donkey caseins and bovine as reference (CN) after 
Coomassie Brilliant Blue staining (A) and  immunospecific staining with polyclonal antibody against αs1-CN 
(B).    
 
3.3.2 Characterization of donkey αs1-CN by UTLIEF and immunoblotting analysis 
 
The UTLIEF analysis of representative donkey caseins, either with Blue Comassie (Fig. 3.2A) or with 
specific polyclonal antibody staining (Fig. 3.2B) also showed the complexity of donkey αs1-CN. This 
phenomenon was due to the different quali-quantitative composition of donkey αs1-CN than cow counterpart, 
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together with the major resolution of this electrophoretic technique with respect to the above PAGE analysis. 
In fact, the results underlined a more complex overlapping phenomenon of αs1-CN components with other 
casein fractions due to their similar pI values. 
The detection of several αs1-CN components may be due to presence of non allelic deleted forms with 
different phosphorylation degrees, as in mare counterpart, and to proteolysis by action of endogenous 
proteases. 
However, the immunoelectrophoretic techniques did not allow to detect qualitative, but only quantitative 
differences for donkey αs1-CN, due to the identification of casein samples (5 and 6) characterized by a lower 
expression level of the allergenic protein. From a nutritional point of view, the minor content of αs1-CN in 
donkey milk can be related to the tolerance mechanism of donkey milk in the allergic patients to bovine milk. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.2: UTLIEF analysis of representative donkey caseins and bovine as reference (CN) after Coomassie 
Brilliant Blue staining (A) and  immunospecific staining with polyclonal antibody against αs1-CN (B).    
 
3.3.3 Characterization of donkey αs1-CN by two dimensional (2-DE) electrophoresis analysis (PAGE vs 
UTLIEF) and (IPG vs PAGE-SDS) 
 
One dimensional electrophoresis did not provide efficient separation of caseins, as αs1-CN, because of their 
partial overlapping. For this reason, the two dimensional electrophoresis analysis was more resolutive than 
one-dimensional electrophoresis. Specifically, in PAGE→UTLIEF analysis of an individual donkey casein, 
either after Blue Coomassie staining (Fig. 3.3A) and mainly after immunoblotting (Fig. 3.3B), the αs1-CN 
composition consisted of two doublet bands, having decreasing pI values towards the anode. According to 
Chianese et al. (2010) the compositional heterogeneity was assigned to either discrete phosphorylation (5, 6, 
7P/mol) or non allelic deleted forms generated by incorrect RNA splicing as already shown in the 
homologous goat and sheep casein. 
Instead, in IPG→PAGE-SDS analysis of individual donkey casein sample, either with Blue Coomassie 
staining (Fig. 3.4A) and immunoblotting analysis (Fig. 3.4B), αs1-CN is arranged in three level of the gel, 
having decreasing pI and molecular mass values toward the anode. These results also confirmed the data 
obtained from other authors (Cunsolo et al., 2009a; Vincenzetti et al., 2012), since of the four major levels, 
two of them C and D (197 aa with a different phosphorylation degree) would show the pentapeptide HTPRE 
deletion that decreased the molecular mass of 620 Da with respect to the other major levels A and B (202 aa 
with a different phosphorylation degree). Moreover, the absence of pentapeptide confers to deleted forms C 
and D, a more acidic nature. In our study, an additional level corresponding to αs1-CN was visible for the first 
time and showed a higher molecular mass with respect to the previous levels. Specifically, as reported in next 
paragraph 3.3.4, they could correspond to the full length αs1-CN components (210 aa for the insertion of 
octapeptide DTSNESTE encoded by exon 7) with a different phosphorylation degree. Some of these αs1-CN 
spots with a major molecular weight were never observed, probably because they are present in donkey milk 
in very small amount. 
The complexity of 2-DE pattern of donkey αs1-CN supported the hypothesis of simultaneous presence of 
potential non allelic deleted forms (leading to a variability in molecular mass) with a different 
phosphorylation degree (leading to a variability in isoelectric point). In addition, αs1-CN immunostained 
spots with a very low molecular weight could be peptide derived from αs1-CN proteolysis 
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Fig 3.3: 2-DE (PAGE→UTLIEF) analysis of individual donkey casein sample after Coomassie Brilliant Blue 
staining (A) and  immunospecific staining with polyclonal antibody against αs1-CN (B).    
 
 
 
Fig 3.4: 2-DE (IPG→PAGE-SDS) analysis of representative donkey casein sample after Coomassie Brilliant 
Blue staining (A) and  immunospecific staining with polyclonal antibody against αs1-CN (B).    
 
3.3.4 Evidences of microheterogeneity and genetic polymorphism at donkey αs1-CN locus by RP-
HPLC/MS analysis  
 
Since the majority of the mutations does not only concern charged (acid or alkaline) aa, but also neutral aa 
undetectable with respect to the above electrophoretic analysis, the individual donkey casein samples were 
also analyzed by RP-HPLC analysis. 
After a preliminary screening of individual donkey caseins, two characteristic HPLC profiles (A and B) were 
selected in (Fig. 3.5). Compositional differences between αs1-CN and β-CN fractions in the two most 
common HPLC profiles (A and B) of donkey casein samples can be deduced in (Fig. 3.5). In particular, αs1-
CN eluted in two peaks (1 and 2) characterized by a different area percentage only in sample A (peak 1 > 
peak 2), while in sample B the peaks 1 and 2 had the same area (peak 1 = peak 2). 
In order to identify the containing αs1-CN components, each eluted peak was analyzed by MS analysis before 
and after alkaline phosphatase AP action and the identified components were reported in Table 3.1 
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Fig 3.5: RP-HPLC profile of two representative donkey casein sample. 
 
Table 3.1: Molecular Masses (Mr) of αs1-CN components in the casein samples A and B determined by LC-
ESI-MS analysis. 
 
  αs1-CN components  
 
Sample 
 
Peak 
Mr 
Native (Da) 
Mr 
Dephosphorylated (Da) Lenght aa 
A 1 24888 6P 24408 202 
  24808 5P  202 
  24760 6P 24280 201 (Gln88) 
  24680 5P  201 (Gln88) 
  25833 7P 25273 210 
  25753 6P  210 
  25704 7P 25144 209 (Gln96) 
  25624 6P  209 (Gln96) 
 2 24265 6P 23785 197 
  24185 5P  197 
  24138 6P 23658 196 (Gln83) 
  24058 5P  196 (Gln83) 
     B 1 24888 6P 24408 202 
  24808 5P  202 
  24760 6P 24280 201 (Gln88) 
  24680 5P  201 (Gln88) 
  25833 7P 25273 210 
  25753 6P  210 
  25704 7P 25144 209 (Gln96) 
  25624 6P  209 (Gln96) 
  24265 6P 23785 197 
  24185 5P  197 
  24138 6P 23658 196 (Gln83) 
  24058 5P  196 (Gln83) 
 2 24874 6P 24394 202 
  24794 5P  202 
  24745 6P 24265 201 (Gln88) 
  24665 5P  201 (Gln88) 
  25819 7P 25259 210 
  25739 6P  210 
  25689 7P 25129 209 (Gln96) 
  25609 6P  209 (Gln96) 
  24250 6P 23770 197 
  24170 5P  197 
  24126 6P 23646 196 (Gln83) 
  24046 5P  196 (Gln83) 
Sample A 
β-CN 
1 
αs1-CN 
2 
5 10 15 20 30 25 
Sample B 
25 30 20 15 10 5 
αs1-CN 
β-CN 
2 1 
mV    
500 
Retentetion time  (min) 
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The results indicated that from peak 1 of sample A, in decreasing quantitative order, two proteins eluted: the 
first, the main component is 202 aa in length and the second, minor component, is 210 aa in length. In peak 2 
of sample A, only one protein with 197 aa in length eluted, since the skipping of exon 5 results in the 
pentapeptide HTPRE deletion between L33 and E34, as in mare αs1-CN (Lenasi et al., 2003), which accounts 
for the decrease of 620 Da in its molecular mass with respect to the protein with 202 aa in length. 
Each of these three protein components different in the aa length (202, 210 and 197 aa), showed a complex 
microheterogeneity either for the phosphorylation degree (5, 6 and 7P) or for a glutamine (Q) residue 
deletion (Table 3.1).  
Taking into the account the exon modular structure of αs1-CN in the other species and in the mare (Lenasi et 
al., 2003; Miranda et al., 2004), it is reasonable to assume that the existence of forms lacking a glutamine 
residue is probably related to a cryptic splice site occurring at the first codon (CAG) of exon 11, which 
explains the difference of 128 Da in their molecular masses. This phenomenon is a rather frequent, and it was 
already reported for ewe (Ferranti et al., 1995), goat (Ferranti et al., 1997), cow and water buffalo αs1-CN. 
On the other hand, the main protein component with 202 aa in length, was the same donkey αs1-CN firstly 
reported by Cunsolo et al. (2009a), while the occurrence of αs1-CN with 210 aa in length was a new finding. 
This “super long” component showed the insertion of an octapeptide DTSNESTE between K60 and E61, 
whose synthesis is encoded by exon 7 insertion as in the homologous mare’s αs1-CN (Milenkovic et al., 
2002). Moreover, the insertion of octapeptide DTSNESTE confers to αs1-CN 210 aa in length a more acidic 
nature (theoretical pI of 5.57 0P) with respect to αs1-CN 202 aa in length (theoretical pI of 5.95 0P) and αs1-
CN 197 aa in length (theoretical pI of 5.86 0P). As regarding the phosphorylation degree, the maximum 
number of phosphate groups of donkey αs1-CN agreed well with the presence of 6 potential phosphorylation 
sites involving serine (Ser) residues (Ser18, Ser73, Ser74, Ser76, Ser77 and Ser78; numbered according to the αs1-
CN with 202 aa in length) located in SerXxxGlu/SerP motifs, which are recognition sequences for bovine 
mammary gland casein kinase (Mercier, 1981). The MS analysis of the native αs1-CN isoforms revealed that 
αs1-CN was phosphorylated mainly at high level (6P or 7P) depending on the loss or conservation of exon 7. 
This suggested that the 61-68 sequence encoded by exon 7 would be systematically phosphorylated on its 2 
potential sites (Ser63 and Ser66), numbered according to the full length sequence with 210 aa (Fig. 1.1-1.2). 
 
However, all these components (202, 210 and 197 aa) with a different phosphorylation degree were also 
eluted in peak 1 of sample B (Table 3.1); in peak 2 of sample B (Fig. 3.5), instead a new series of αs1- 
“proteins” each with 14 Da lower in their molecular masses with respect to the αs1-CN component eluted in 
peak 1, were identified (Table 3.1). This molecular mass difference is due to a single point mutation that is 
Ala32→Gly32 in the novel variant found in this sample (Fig 3.6). Therefore, these results showed the 
occurrence of possible genetic polymorphism at donkey αs1-CN locus, which was confirmed by a new 
variant’s finding in the sample B. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.6: ESI-MS/MS spectrum of RP-HPLC profile of αs1-CN in the heterozygous sample with the new 
genetic variant. The amino acid substitution in the new αs1-CN variant is Ala32→Gly. 
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3.3.5 PAGE and immunoblotting analysis of donkey β-casein 
 
The casein samples from 77 donkeys were analysed individually. In Fig. 3.7, the most common individual 
donkey casein samples Coomassie Brilliant Blue stained (Fig. 3.7A) were compared to the cow counterparts 
on the basis of their relative net charge at alkaline pH by PAGE analysis. The results obtained after specific 
immunstaining (Fig. 3.7B) with polyclonal antibody against β-CN, allowed to detect donkey β-CN fraction. 
By comparing the two species each other, cow and donkey β-CN exhibited a very similar anodic mobility, 
although donkey β-CN could have a major negative net charge at pH 8.6 than cow counterparts, because 
donkey β-CN has a major number of phosphate groups and acid aminoacids than cow protein (on SWISS-
PROT database http://au.expasy.org/tools-P86273 donkey and P02666 cow). However the immunostained 
profile showed that donkey β-CN is the most abundant protein than other caseins and it was constituted at 
least by two main bands even if in some samples also a third β-CN’s band was identified. In analysed 
samples, the different number of identified bands and their different electrophoretic mobility showed that 
donkey’s β-CN heterogeneity is due to different phosphorilation level and to the presence of deleted forms of 
protein as mare’s β-CN (Girardet et al., 2006), but also to genetic polymorphism. 
Moreover the immunostained profiles showed also a proteolysis of β-CN, giving rise to peptides having a 
lower anodic mobility (β-CN derived fragments) than the parent protein. In fact considering the NNP peptide 
composition of donkey milk, consisting mainly in β-CN and αs2-CN derived peptides generated by plasmin-
like specific cleavages, it can be supposed that the same enzymes produced the above β-CN and αs2-CN 
derived insoluble peptides at pH 4.6. So the components visible to the anode after immunostaining was 
attributable to the family of donkey γ-CN, C-terminal fragment generated by plasmin enzyme on β-CN 
(Chianese et al., 2010). 
 
 
Fig. 3.7: PAGE at pH 8.6 analysis of representative donkey casein samples and bovine as reference (V) after 
Coomassie Brilliant Blue staining (A) and  immunospecific staining with polyclonal antibody against β-CN 
(B).    
 
3.3.6 UTLIEF analysis and immunoblotting of donkey β-casein 
 
The individual donkey casein samples were subjected by UTLIEF with pH gradient 4.2-6 and separated by 
isoelectric point (Fig. 3.8A). After Coomassie Brilliant Blue staining, the electrophoretic profiles of donkey 
β-CN showed a high complexity due to the highest resolution power of this technique than the above PAGE 
analysis, but also to a different quali-quantitative composition than its cow counterparts.   
The results obtained after specific immunostaining (Fig. 3.8B) with polyclonal antibody against β-CN 
allowed to detect donkey β-CN fraction. In particular, donkey and cow β-CN exhibited a very similar pI 
value, but a different compositional heterogeneity (8-9 components in donkey vs. 2-3 in cow), also 
responsible of overlapping phenomenon with other caseins, with respect to the above PAGE analysis.  
However, these donkey β-CN components focused in the central area of pH gradient and their presence is 
due to the different phosphorilation degrees of each donkey β-CN component and to the presence of deleted 
forms, as in mare counterparts (Miranda et al., 2004). At this regard, Cunsolo et al. (2009b) found three 
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phosphorylated components (5P, 6P and 7P) by MS analysis only in the full-length protein, while no 
information on the phosphorilation degree has been provided for the shorter β-CN form lacking the β-CN 
fragment (27-34) (Cunsolo et al., 2009b). According to Chianese et al. (2010) both the full-length β-CN and 
its deleted form lacking of fragment β(27-34) have 5, 6 and 7P/mole. However, the absence of the domain 
E27SITHINK34 confers to deleted form a more acidic nature (theoretical pI value 5.40 0P) with respect to the 
full-length component (theoretical pI value 5.54 0P) and also a major number of phosphate groups both on 
the full-length β-CN and on its deleted form lacking of fragment β(27-34) gives them a more acidic nature 
than the corresponding less phosphorylated forms. This result is very important and regarding donkey β-CN 
has been reported for the first time.  
Concordantly with PAGE analysis, even the hydrolysis products of donkey β-CN, probably generated by 
plasmin-like enzymatic activities, are immunostained and focused at higher pI values than their parent casein, 
respectively (Chianese et al., 2010).  
 
 
   
Fig. 3.8: UTLIEF analysis of representative donkey casein samples and bovine as reference (V) after 
Coomassie Brilliant Blue staining (A) and  immunospecific staining with polyclonal antibody against β-CN 
(B).    
 
3.3.7 Characterization of donkey β-CN by two dimensional (2-DE) electrophoresis analysis 
(PAGE→UTLIEF) and (IPG→SDS PAGE) 
 
The complex overlapping phenomenon of the full-length β-CN and its deleted form lacking of fragment 
β(27-34) with other caseins can take place in one dimensional electrophoretic analysis, as UTLIEF, because 
of their very similar pI values. 
This overlapping was partially resolved in 2-DE electrophoretic analysis. In fact, in PAGE→UTLIEF 
analysis of an individual donkey casein, after Coomassie Brilliant Blue staining (Fig. 3.9A) and mainly after 
immunoblotting with specific polyclonal antibody against β-CN (Fig. 3.9B), the number of β-CN 
components was about 6, and according Cunsolo et al. (2009b) and Chianese et al. (2010) they would 
correspond to the full-length protein, carrying from 5 to 7P as well as its shorter form, always carrying from 
5 to 7P. 
In IPG→PAGE-SDS analysis of individual donkey casein sample, either after Coomassie Brilliant Blue 
staining (Fig. 3.10A) and immunoblotting analysis (Fig. 3.10B), the complexity of β-CN was even more 
resolved than PAGE-UTLIEF analysis. In fact, in this 2-DE map β-CN components are arranged in two 
levels. A major level is associated to a higher apparent molecular mass and would correspond to the full-
length protein with 226 aa, while a minor level is associated to a lower apparent molecular mass and would 
correspond to its deleted component with 218 aa characterized by a splicing of exon 5. Cunsolo et al. (2009b) 
and Chianese et al. (2010) found that two donkey β-CN components showed a molecular mass difference of 
923 Da and differ for the presence of the domain 27SITHINK34 in the full length component, that, as 
occurring in the mare’s β-CN is absent in the deleted component (Fig. 1.3).  
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Fig 3.9: 2-DE (PAGE→UTLIEF) analysis of representative donkey casein sample after Coomassie Brilliant 
Blue staining (A) and  immunospecific staining with polyclonal antibody against β-CN  (B).    
 
 
Fig 3.10: 2-DE (IPG→PAGE-SDS) analysis of representative donkey casein sample after Coomassie 
Brilliant Blue staining (A) and  immunospecific staining with polyclonal antibody against β-CN (B).    
 
3.3.8 Evidences of genetic polymorphism at donkey β-CN locus by UTLIEF analysis 
 
The events of overlapping can be amplified by the heterogeneity of donkey β-CN due to post-translational 
phenomena (phosphorilation), non-allelic deleted forms, proteolysis by action of endogenous proteases but 
also polymorphism (one or two variants in individual samples, much more in bulk milk). 
In fact, the UTLIEF analysis of representative casein samples, either after Coomassie Brilliant Blue and 
immunoblotting (Fig. 3.11A-B) showed an high heterogeneity of donkey β-CN due to genetic polymorphism 
at this locus for the finding at least of two genetic variants, as we can see in the following individual casein 
samples: 3, 2, 4 (probably homozygous for donkey β-CN) and 8 (probably heterozygous for donkey β-CN). 
In fact, donkey β-CN focused in the central area of pH gradient and specifically in the sample 2 and 3 donkey 
β-CN variant focused in the same band X of pH gradient (calculated pI 4,82); in sample 4 and 8, donkey β-
CN focused always in the same central area of pH gradient, but specifically in this sample donkey β-CN 
variant focused in the band Y of pH gradient. The pI value of the band Y is more alkaline (calculated pI 4,91) 
than the corresponding value of band X and therefore the β-CN variant (sample 4 or 8) which focused in 
bands Y showed a lowest movement towards the anode (and could be more alkaline) than β-CN variant 
(sample 2 or 3) which focused in bands X. Moreover, the individual sample of casein 8 could be 
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heterozygous for donkey β-CN, because it contain both bands (X and Y), and thus may contain two genetic 
variants of the protein with different pI values.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.11: UTLIEF analysis of representative donkey casein samples and bovine as reference (V) after 
Coomassie Brilliant Blue staining (A) and  immunospecific staining with polyclonal antibody against β-CN 
(B).    
 
3.3.9 Evidences of genetic polymorphism at donkey β-CN locus by RP-HPLC/MS analysis 
 
The RP-HPLC UV chromatograms (Fig. 3.12) of three representative and individual donkey casein samples 
showed the presence of some main peaks. According to Chianese et al. (2010) in peak 1 β-CN fragments, 
originated by hydrolysis of both full protein length (226 aa) and from its deleted form lacking peptide (27-34) 
(Cunsolo et al., 2009b) were identified by LC/ESI/MS (Chianese et al., 2010). In peaks 2 and 3 donkey αs1-
CN components at different phosphorilation degrees (5P and 6P) as well as their non-allelic deleted forms 
generated by RNA incorrect splicing (Cunsolo et al., 2009), as in sheep and goat caseins (Ferranti et al., 
1995; 1997), eluted and were identified by Chianese et al. (2010). In peak 4 the full-length β-CN and its 
deleted form lacking of fragment (27-34), both having 5, 6 and 7P/mole, eluted (Chianese et al., 2010). These 
forms have been already detected by Cunsolo et al. (2009b) only in full-length protein.  
Regarding donkey β-CN, the comparison of the HPLC profiles of samples 4, 2 and 8 showed that in sample 
4, only one β-CN peak eluted (elution time of this peak which we named D is 20.46 min) as in sample 2, only 
one β-CN peak eluted (elution time of this peak which we named B is 21.59 min). The casein sample 8 was 
more heterogeneous than the formers, for the presence of two β-CN peaks, where the peak 4* (elution time of 
this peak which we named C is 19.94 min) eluted at shorter elution time than peak 4 (elution time of this 
peak which we named A is 20.97 min). So, in analysed casein samples, in addition to two different pI 
theoretical values of donkey β-CNs, also the different elution time of donkey β-CNs (elution time 
C<D<A<B) suggested for the first time the occurrence of genetic polymorphism at this casein locus. 
Moreover in peak 5, with higher elution time than the previous peaks, considering the known amino acid 
sequence of donkey β-CN A (Cunsolo et al., 2009b), a C-terminal β-CN fragment (56-226 with theoretical 
molecular weight of 19149 Da) probably originated by plasmin hydrolysis on Lys-X bond of full protein 
length (226 aa) was identified for the first time by LC/ESI/MS. Thus, in third casein sample with two β-CN 
peaks, in addition to the peak 5, also peak 5* eluted because this casein could be β-CN heterozygous. 
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Fig. 3.12: RP-HPLC profiles of donkey β-CN variants.  
 
3.3.10 RP-HPLC/MALDI-TOF/MS of donkey β-CN variants 
 
To evidence the possible genetic polymorphism at donkey β-CN locus, after dephosphorylation, the β-CN 
fraction of each sample was separated from casein mixture by RP-HPLC and its corresponding peaks 4 and 
4* were manually collected, freeze-dried and analysed by MALDI TOF-MS analysis. 
Fig. 3.13 shows the MALDI-TOF (MS) mass spectra of the chromatographic peaks (4 and 4*) of the 
dephosphorylated β-CN fractions. The spectra were acquired in the m/z range 10000-30000, obtained 
operating in linear positive ion mode and using SA as matrix.  
Considering the known amino acid sequence of donkey β-CN A (Cunsolo et al., 2009b), each of four 
MALDI-TOF-MS spectrum also showed, in addition to a main signal, a minor signal with an experimentally 
measured Mr of about 12760 Da, which could correspond to C-terminal β-CN fragment (114-226 2P) 
probably originated by plasmin hydrolysis on Lys-X bond of full protein length (226 aa) and was for the first 
time identified by MALDI-TOF/MS. 
Regarding donkey β-CN, the molecular masses (Mr) of a full-length (226 aa) β-CN (25526 Da) and its 
deleted form (218 aa) lacking the region 27-34 (24606 Da) (Cunsolo et al., 2009b) together with cDNA-
derived sequence of β-CN (226 aa) with a Mr 25539 Da (Di Gregorio, 2009) are known. By comparison with 
Mr of these donkey β-CNs known in literature, the MALDI-TOF MS analysis of the collected 
chromatographic peak 4 allowed to detect β-CN fraction in this peak. Specifically, in peak 4 (A) of sample 8, 
a measured Mr 25521 Da corresponded to theoretical Mr (25526 Da) of donkey β-CN known in literature 
named A variant (Cunsolo et al., 2009b), while in peak 4 (B) of sample 2, a measured Mr 25535 Da 
corresponded to theoretical Mr (25539 Da) of donkey β-CN only deduced from cDNA (Di Gregorio, 2009), 
which we named B variant.  
The MALDI-TOF MS analysis of the collected chromatographic peaks 4*(C) and 4 (D) of samples 8 and 4 
allowed even to detect two unknown components, having an experimentally measured Mr of 25546 and 
25556 Da respectively, which could correspond to two new donkey β-CN genetic variants (which we named 
C and D respectively) not yet known in literature. In this way, the occurrence of genetic polymorphism at 
donkey β-CN locus hypothesized by UTLIEF and RP-HPLC analysis of representative donkey casein 
samples was for the first time confirmed by MS methods as MALDI-TOF/MS analysis. 
 
3.3.11 Characterization of the primary structure of the new donkey β-CN variants 
 
In order to obtain additional information about the amino acid sequences of new donkey β-CN (B, C, D) 
variants, the tryptic mixture of each chromatographic peak corresponding to dephosphorylated protein was 
analyzed by MALDI-TOF and the results interpreted using the known donkey β-CN A variant as reference. 
In Table 3.2, the position, peptide sequence, theoretical and experimentally measured monoisotopic MH+ of 
selected fragments identified in the tryptic digestion mixture of donkey β-CN variants were reported. The 
sequence of  the known donkey β-CN A (Cunsolo et al., 2009b) was taken as reference. The amino acid 
substitutions with respect to the donkey’s reference β-CN A variant were red stained. 
Specifically, regarding donkey β-CN B variant, the mass spectrum signals of four peptides with 
experimentally deduced MH+ 3792.9, 4404.6, 3268.0, 4032.3 allowed the identification of two amino acid 
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substitutions in donkey β-CN B variant with respect to the corresponding known β-CN A variant. In detail, in 
comparison with β-CN A variant, the identification and characterization of peptides at m/z 3792.9 and 4032.3 
allowed us to deduce β-CN sequences which corresponded to the theoretical N-terminal (1-34) and C-
terminal (190-226) tryptic fragments, containing the same amino acids with respect to donkey β-CN A 
variant. The interpretation of mass spectra signals of the peptides at m/z 4404.06 and 3260.0, allowed use to 
deduce β-CN sequences which corresponded to the domains (1-39) and (76-105) respectively, carrying the 
amino acid substitutions Ser37→Val and Val84→Pro with respect to the donkey β-CN A variant.   
Regarding donkey β-CN D variant, the identification and characterization of peptides (signals) at m/z 
3267.81, 3806.9, 4418.78 and 4046.07 allowed use to deduce β-CN sequences which corresponded to N-
terminal (1-34), (1-39), (76-105)  and C-terminal (190-226) domains respectively, carrying the amino acid 
substitutions Asn33→Lys, Ser37→Val, Val84→Pro and Ala213→Ser, with respect to the donkey β-CN A 
variant. 
Finally, regarding donkey β-CN C variant, the identification and characterization of peptides (signals) at m/z 
4392.89 and 3268 allowed us to deduce β-CN sequences which corresponded to the theoretical tryptic 
fragments (1-39) and (76-105) respectively, also containing the same amino acid substitutions than donkey β-
CN A variant. The interpretation of mass spectra of the peptides (signals) at m/z 3806.6 and 4045.9 allowed 
us to deduce β-CN sequences corresponding to the N-terminal (1-34) and C-terminal (190-226) domains 
respectively, which contained, as β-CN D variant, the amino acid substitution Asn33→Lys and Ala213→Ser 
with respect to the donkey β-CN A variant. 
In summary, all these proteomic methods allowed the characterization of three new genetic variants of 
donkey β-CN, whose identified amino acid substitutions were reported in Table 3.3. In this table 3.3, the 
amino substitutions, pI and theoretical Mr values were reported for each donkey β-CN variant (A, B, C, D). 
These values were calculated, theoretically, on the basis of the amino acid substitutions with respect to the 
reference donkey β-CN A variant (Cunsolo et al., 2009b). Moreover, these data confirmed that donkey β-CN 
A and B variants, on the basis of their amino acid substitutions, have the same pI value (4.82). Donkey β-CN 
C and D also have the same calculated pI value (4.91), which are for the presence of Lys 33 in their amino 
acid sequences more alkaline than the corresponding value in β-CN A and B variant (4.82). 
However, these theoretical pI values of the four β-CN variants allowed us to identify them on the UTLIEF 
profile, where β-CN A and B variants focused at the same lower pH gradient than C and D variants (Fig. 
3.14).  
 
 
 
 
Fig. 3.13: MALDI-TOF-MS spectra of four chromatographic peaks containing the corresponding 
dephosphorylated β-CN variants.   
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Table 3.2: β-CN tryptic peptides identified by MALDI TOF MS analysis 
 
Peptide Theoretical  
Mass (Da) 
Reference sequence β-CN A B D C A 
1-34 3790.77 REEKELNVSSETVESLSSNEPDSSSEESITHINK 3792.90 3806.90 
 (+14) 
3806.66 
(+14) 
3792.75 
1-39 4392.64 REEKELNVSSETVESLSSNEPDSSSEESITHINKEKSQK 4404.12 
(+12) 
4418.78  
(+14) 
(+12) 
4392.89 4392.54 
76-105 3269.96 AVVPQNILVLAQPPIVPFLQPEIMEVSQAQ 3268.01 3267.81 - - 
190-
226 
4029.10 DTPVQAFLLYQDPQLGLTGEFDPATQPIVPVHNPVIV 4032.33 4046.07  
(+14) 
4045.99 4032.55 
 
Table 3.3: Amino acid substitutions, theoretical molecular mass and pI values of different β-CN variants 
 
β-CN 33 37 84 213 Theoretical Molecular Mass (Da) pI 
B Asn Val Pro Ala 25539 4.82 
D Lys Val Pro Ser 25570 4.91 
C Lys Ser Val Ser 25558 4.91 
A Asn Ser Val Ala 25526 4.82 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.14: UTLIEF analysis of representative donkey casein samples and bovine as reference (V) after 
Coomassie Brilliant Blue staining (A) and  immunospecific staining with polyclonal antibody against β-CN 
(B).    
 
3.3.12 Characterization of the phosphorylation level of the new donkey β-CN variants 
 
The molecular mass determination for the phosphate-free form of the β-CN variants and their deleted forms 
∆5 enabled a precise determination of the maximum degree of phosphorylation to be made. It corresponded 
to 7P (Chianese et al., 2010) per molecule and specifically, analysis of the new phosphorylated β-CNs 
demonstrated that each full length variant (B, C, D), as donkey β-CN A variant (Cunsolo et al., 2009b) 
consists of three isoforms carrying from 5 to 7P. This same phosphorylation degree was also found for each 
corresponding deleted isoform (B ∆5, C ∆5, D ∆5) as for β-CN A ∆5 Chianese et al. (2010).   
This result is important because emphasizes that amino acid deletions or substitutions between the different 
donkey β-CN variants do not affect serine residue which can phosphorylated. Moreover, for each new β-CN 
variants (B, C, D) as well as for their corresponding β-CNs ∆5 (lacking the region encoded by exon 5), the 
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isoform carrying 6P and 7P occur with comparable abundances, whereas the 5P protein is present as a minor 
component. This is in agreement with the results obtained for donkey β-CN A (Cunsolo et al., 2009b) and 
donkey β-CN ∆5 (Chianese et al., 2010). 
These results, however, reveals that donkey β-CN is more phosphorylated than the homologous mare’s β-
CN, in which the predominant phosphorylated isoforms carries 5P, despite 7 phosphorylation sites are 
available. Instead, the human protein, which is also phosphorylated at different levels, carries up to 5P. Thus, 
the donkey β-CNs could also be more phosphorylated than both bovine (a fully phosphorylated protein with 
5P) and the human β-CN, the major isoform of which are β-CN 2P and 4P (Sood & Slattery, 2000). 
It is difficult to explain the high phosphorylation level of donkey β-CN, but this phenomenon, as mare’s β-
CN, could be due to the presence of an additional exon 4’,only observed in equidae, which encodes a region 
(21-26) containing a phosphorylation cluster (Miranda et al., 2004). Thus, the presence of at most seven 
group bond to donkey β-CN agrees with the protein primary structure which contains six potential 
phosphorilation sites (Ser9, Ser15, Ser18, Ser23, Ser24 and Ser25), located in a Ser-Xxx-Glu/SerP motif, and one 
Ser (Ser17) in a Ser-Xxx-Xxx-Glu motif,    together with two other potential phosphorilation sites located at 
Thr12 and Thr207, located in a Thr-Xxx-Glu motif, analogously to the homologous mare’s β-CN. The Ser-
Xxx-Glu/SerP and Ser-Xxx-Xxx-Glu motifs are the recognition sequences characterized for cow mammary 
gland casein Kinase I (Mercier, 1981) and II (Kuenzel et al., 1987), whereas studies on the specificity of 
mammary gland casein kinase have shown that the sequence motif Thr-Xxx-Glu is a poor substrate for the 
mammary gland enzyme and is usually not phosphorylated (Bingham & Groves, 1979; Sorensen & Petersen, 
1994).  
 
3.3.13 Primary structure comparison of the donkey’s and cow’s β-CNs 
 
Studies of large population of patients allergic to CMA (cow’s milk allergy) show that β-CN, the second 
most abundant protein in cow’s milk, where it constitutes about 28% of the total milk proteins, represents one 
of the major cow’s milk allergens (Monaci et al., 1998). In human milk, the casein fraction is essentially 
composed by β-CN.  
β-CN is a phosphoprotein with a distributed proline content but with a lack of cysteine amino acids. So, in 
bovine β-CN disulphide bonds are absent and therefore it possesses virtually no secondary structure and 
shows a  reduced rigidity of the tertiary structure (Kumosinski et al., 1991). As a consequence, these factors 
increase the likelihood that the important allergenic epitopes of this protein are linear rather than 
conformational. As results of several investigations, six major (AA 1-16, AA 45-54, AA 55-70, AA 83-92, 
AA 107-120 and AA 135-144) and three minor (AA149-164, AA167-178 and AA 185-208) IgE binding 
regions on bovine β-CN were identified. Among these, three epitopes (AA 1-16, AA 83-92 and AA 135-144) 
were the most frequently recognised epitopes while two minor epitopes (AA 149-164, and AA 167-178) are 
recognised only by older patients but not by the younger age. Instead, eight major epitopes (AA 1-14, AA 23-
34, AA 55-68, AA79-92, AA 107-120, AA 135-144, AA 149-160 and AA 183-208) and one minor (AA 169-
184) IgG binding regions on bovine β-CN were identified. Among these, two epitopes (AA 135-144 and AA 
183-208) were recognised by all patients (Chatchatee et al., 2001). 
Therefore, the knowledge about the allergenic epitopes of bovine β-CN, together with the determination of 
the primary structure of different donkey β-CN variants and their internally deleted isoforms (here reported) 
provide the basis for some comparison of their sequences. According to Cocco (2007), the substitutions or 
deletions of one or more amino acids in a protein as donkey β-CN could result in a partial reduction or 
elimination of IgE binding regions in majority of patients. 
However, the best alignment of the bovine and donkey’s β-CN variant A reveals that these two proteins share 
a low sequence homology (58% of identity). In particular, alignment reveals that the IgE- and IgG- binding 
linear epitopes of cow’s β-CN and the corresponding domains present in donkey β-CN have remarkable 
differences in their amino acid sequences. Moreover, it is interesting to note that the amino acid sequence 
E27SITHINK34 absent in the internally deleted β-CN∆5 isoform from donkey is a trait of an important IgE- 
and IgG-binding epitopes of bovine β-CN; thus, its deletion from the full-length β-CN sequence together 
with the considerable differences between the primary structure of donkey and bovine β-CNs could be 
related to the already demonstrated low allergenic properties of donkey’s milk and could contribute to 
explain its better tolerance also with respect to goat’s milk for children suffering CMPA (Vita et al., 2007). In 
fact, it should also be noted that goat’s and cow’s β-CNs show 91% of identity and that anaphylactic 
reactions to goat’s milk in children with CMPA have been reported (Pessler, 2004).  
Although these considerations seem reasonable, further biochemical studies and clinical experiences are 
needed to establish precise relationship between donkey’s milk protein structures and its low allergenic 
properties. 
 
3.3.14 PAGE Analysis and Immunoblotting of donkey αs2-CN 
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Regarding donkey αs2-CN, the results of PAGE analysis at pH 8.6 on representative individual casein 
samples, obtained after CBB (Fig. 3.15A) staining and mainly specific immunostaining with polyclonal 
antibody against αs2-CN (Fig. 3.15B), allowed to detect this casein fraction, which seemed to be one of the 
less abundant casein in donkey milk. By comparing cow and donkey casein, each other, donkey αs2-CN 
exhibited a higher and reversed anodic mobility than its cow counterpart. The immunostained profiles also 
showed an overlap between αs1- and αs2-CN components, although the latter showed an higher anodic 
mobility compared to some of the major αs1-CN components. In donkey caseins analyzed, this 
immunoelectrophoretic technique revealed a variability in the protein’s migration, suggesting also a genetic 
polymorphism at donkey αs2-CN locus. 
Moreover, the presence of more immunostained αs2-CN components could be due to its different 
phosphorylation degree (10-12 P), as reported by Chianese et al. (2010) and to the presence of its deleted 
forms, as reported by Saletti et al. (2012). In fact, at this regard Saletti et al. (2012), using the aa sequence of 
the known full length αs2-CN as reference (Chianese et al., 2010), detected four αs2-CN deleted forms which 
were produced from differential splicing events involving exon 4, 5, 6 and part of exon 17 in the gene 
encoding for the asinine protein (Fig.1.4). 
 
 
Fig 3.15: PAGE at pH 8.6 analysis of representative donkey casein samples and bovine as reference (CN) 
after Coomassie Brilliant Blue staining (A) and  immunospecific staining with polyclonal antibody against 
αs2-CN (B).    
 
3.3.15 UTLIEF Analysis and Immunoblotting of donkey αs2-CN 
 
UTLIEF profiles of representative donkey caseins, either with Blue Coomassie (Fig. 3.16A) and mainly with 
polyclonal antibodies against αs2-CN (Fig. 3.16B) showed the compositional heterogeneity of the asinine αs2-
CN. 
For donkey αs2-CN this phenomenon may be due to qualitative and, above all, quantitative polymorphism, 
because there are casein samples characterized by αs2-CN content much more lower than the others. 
Moreover, the detection of different αs2-CN components may be due to the presence of non allelic deleted 
forms (Saletti et al., 2012) with a different phosphorylation degree, and to the proteolysis by action of 
endogenous proteolytic enzymes (Chianese et al., 2010). 
Specifically, regarding the phosphorylation degree, the high number of phosphate groups of donkey αs2-CN, 
agreed well with the presence of 11 phosphorylation sites involving  serine (Ser) residues (Ser8, Ser9, Ser10, 
Ser17, Ser32, Ser65, Ser66, Ser67, Ser70, Ser142, Ser154) and Thr141 or Thr165, numbered according to the full 
length αs2-CN with 221 aa located in SerXxxGlu/SerP and ThrXxxGlu motifs, which are recognition 
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sequences for mammary gland casein kinase. The phosphorylation sites were determined using the program 
NetPhos 2.0, available at www.expasy.ch proteomic server in donkey αs2-CN (Accession No. B7VGF9)   
However, these results underlined a more complex overlapping phenomenon, due to the similar pI values of 
casein components, with respect to the above PAGE analysis. In particular, αs2-CN components (5-6) for the 
presence of many acid amino acids and phosphate groups (10-12) focused at more acid pH gradient than the 
main αs1-CN components, even if they partially overlapped β-CN and other minor αs1-CN components.  
 
 
 
Fig 3.16: UTLIEF analysis of representative donkey caseins and bovine as reference (CN) after Coomassie 
Brilliant Blue staining (A) and  immunospecific staining with polyclonal antibody against αs2-CN (B).  
 
3.3.16 Characterization of donkey αs2-CN by two dimensional (2-DE) electrophoresis (IPG→PAGE-
SDS) 
 
The complexity of donkey αs2-CN was also responsible of the overlapping phenomenon with other casein 
fractions. This phenomenon was partially resolved in 2-DE (IPG→PAGE-SDS) electrophoretic analysis of 
an individual donkey casein sample, either after Coomassie Brilliant Blue staining (Fig. 3.17A) and mainly 
after immunoblotting with specific polyclonal antibody against αs2-CN (Fig. 3.17B). In fact, in this 2-DE 
map αs2-CN components were arranged in two levels. A major level is associated  to a greater apparent 
molecular mass and would correspond to the full-length protein with 221 aa, while a minor level is associated 
a very low apparent molecular mass and would correspond to its deleted component characterized by a 
splicing of many exons which encoded for this protein. At this regard, Cosenza et al. (2010) cloned, 
sequenced and analyzed the gene with 19 exons which encodes for the entire protein of 221 aa, but also a 
second gene (16 exons) characterized by the lack of the sequences that in the entire gene correspond to exons 
6, 7, 8, 10,11,12, which encodes for a predicted peptide of 145 aa.  
 
3.3.17 Characterization of donkey αs2-CN by RP-HPLC/MS  
 
As for αs1-CN, to simplify the compositional heterogeneity of donkey αs2-CN and subsequently to determine 
its mean expression level (paragraph 3.13.3), the individual donkey casein samples were analyzed by RP-
HPLC. The identification of the eluted components, after AP action, was carried out using a mass detector 
coupled to an electrospray source (LC/ESI/MS) (table 3.4). After a screening of individual donkey caseins, a  
characteristic HPLC profiles was selected in (Fig.  3.18), and specifically in peak with elution time of  20 min 
the eluted protein corresponded to the full-length αs2-CN component, with a molecular weight of 26027 Da, 
as reported by Chianese et al. (2010). The identification of αs2-CN in this chromatographic peak will allow, 
in the chapter of the proteins quantitative analysis (paragraph 3.13.3), to determine the average amount of 
αs2-CN in donkey milk by RP-HPLC.  
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Fig 3.17: 2-DE (IPG→PAGE-SDS) analysis of representative donkey casein sample after Coomassie 
Brilliant Blue staining (A) and  immunospecific staining with polyclonal antibody against αs2-CN (B).    
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.18: RP-HPLC of an individual donkey casein sample where αs2-CN chromatographic peak was 
identified. 
 
Table 3.4: Molecular masses (Da) of casein fractions identified in a individual donkey casein samples by 
LC-ESI-MS. 
 
 Measured Mr (Da) 
 Dephosphorylated 
Theoretical Mr (Da) 
 Dephosphorylated 
αs1 24408.2 24406 
αs2 26027.5 26029 
β 25552.7 25558 (C variant) 
 25537.6 25539 (B variant) 
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3.3.18 PAGE Analysis and Immunoblotting of donkey  κ-CN 
 
As far as donkey κ-CN, it was very difficult to detect its components only in CBB, likely depending either on 
the low amount of this fraction in the milk or on its lower reactivity to CBB staining (Fig. 3.19A). The results 
of this immuno-electrophoretic technique (Fig. 3.19B) showed the lowest mobility of κ-CN towards the 
anode compared to the other casein fractions and a different electrophoretic mobility of κ-CN in the different 
analyzed samples, probably due to the occurrence of genetic polymorphism also at this locus. 
 
 
 
Fig 3.19: PAGE at pH 8.6 analysis of representative donkey casein samples and bovine as reference (CN) 
after Coomassie Brilliant Blue staining (A) and  immunospecific staining with polyclonal antibody against κ-
CN (B).    
 
3.3.19 UTLIEF Analysis and Immunoblotting of donkey κ-CN 
 
UTLIEF profiles of representative donkey caseins, either with Blue Coomassie (Fig. 3.20A) and mainly with 
polyclonal antibodies against κ-CN (Fig. 3.20B) showed the compositional heterogeneity of the asinine κ-
CN. 
In fact, all these casein fractions (αs1-, β-, αs2-CN) were overlapped by κ-CN components, which, as in 
ruminants, is the most heterogeneous casein fraction for the detection of components (10-12) focalizing 
throughout the pH gradient and probably this phenomenon is generated from a different glycosylation degree 
of the protein. In fact, considering the cDNA amino acid sequence of donkey κ-CN (without the first 20 aa of 
signal peptide), 12 Thr residues (Thr86, Thr109, Thr116, Thr119, Thr123, Thr127, Thr131, Thr149, Thr152, Thr153, 
Thr154, Thr158) may be glycosylated, as in mare counterpart, by using the program NetOGlyc 3.1, available at 
www.expasy.ch proteomic server in donkey κ-CN (without 20 aa of signal peptide) (Accession No. 
FOV6V5).  
Many glycosides linked to the protein, giving it a more acidic nature. Therefore κ-CN forms which focused 
at cathode would correspond to the less glycosylated κ-CN components, which would also appear to be more 
abundant compared to the glycosylated κ-CN components, which focused at anode. 
Even for κ-CN, a different intensity and migration of immunostained bands suggested not only quantitative, 
but also a qualitative polymorphism at its locus, and thus, the presence of more κ-CN variants. 
No direct information is available on the phosphorylation state of donkey κ-CN. However, three putative 
phosphorylation sites, namely Thr119, Thr127 and Thr149, may be suggested based on the sequence similarity 
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studies with mare’s κ-CN and on prediction analysis. The phosphorylation sites were determined using the 
program NetPhos 2.0, available at www.expasy.ch proteomic server in donkey κ-CN (without 20 aa of signal 
peptide) (Accession No. FOV6V5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.20: UTLIEF analysis of representative donkey casein samples and bovine as reference (CN) after 
Coomassie Brilliant Blue staining (A) and  immunospecific staining with polyclonal antibody against κ-CN 
(B).    
 
3.3.20 Characterization of donkey κ-CN by two dimensional (2-DE) electrophoresis (IPG→PAGE-
SDS) 
 
Concordantly with UTLIEF analysis (paragraph 3.3.19), all casein fractions (αs1-, αs2-, β-CN) were 
overlapped by κ-CN. In fact in the 2-DE map (PAGE→UTLIEF) analysis of an individual donkey casein, the 
most heterogeneous casein fraction was κ-CN, since at least 11 components were specifically immunostained 
in the 2-DE map, focalising throughout the entire working pH range (Fig. 3.21A-B).  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.21: 2-DE (PAGE→UTLIEF) analysis of representative donkey casein sample after Coomassie Brilliant 
Blue staining (A) and  immunospecific staining with polyclonal antibody against κ-CN (B).  
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3.3.21 Characterization of donkey caseins by PAGE-SDS and Immunoblotting analysis with 
fluorescent glycoprotein detection 
 
An individual sample of donkey CN, before and after chymosin hydrolysis, was analyzed by PAGE-SDS and 
was shown in Fig. 3.22A after Blue Coomassie staining; with the aim to identify each donkey casein fraction 
it was immunostained using specific polyclonal antibodies against each donkey casein fraction (αs1-, αs2-, β-, 
and κ-CN) (Fig. 3.22B). The electrophoretic profile obtained for donkey casein fraction is shown to be very 
similar to that reported by Miranda et al. (2004) for mare and goat caseins. In fact, in the casein zone, the 
heaviest electrophoretic band was that corresponding to αs2-CN, followed by αs1-CN. For the latter, two main 
bands were separated, which probably could correspond to its two deleted forms resulting from the skipping 
of exon 7 and 5; instead β-CN has migrated into the intermediate zone between these two αs1-CN 
components. The results of this immuno-electrophoretic technique also showed the fastest mobility of κ-CN 
towards the anode compared to the other casein fractions, suggesting, therefore, its lower molecular weight 
between asinine caseins. In addition, κ-CN migrated as a more or less extensive smear because of 
considerable variation in the level of post-translational glycosylation. This electrophoretic behaviour had 
previously been highlighted by Miranda et al. (2004) with respect to mare’s milk.  
The presence of κ-CN also in whey protein used as reference and corresponding to the casein zone, suggested 
that this smear would include highly glycosylated κ-CN forms, which could be either the heaviest and less 
abundant forms. 
Moreover, this immuno-electrophoretic technique showed that β- and αs1-CN are the most abundant casein 
fractions followed by αs2- and κ-CN, and this feature makes donkey milk more similar to human milk, in 
which αs2-CN has not yet been identified. Also peptides derived essentially from β- and αs1-CN hydrolysis 
by endogenous enzymes of donkey milk were showed in the immunostained profiles. 
The results obtained by this immuno-electrophoretic technique were also confirmed by Fluorescent 
Glycoprotein Detection (Fig 3.22C). In fact, the κ-CN band was more fluorescent than the other casein bands 
with a major molecular weight, thus suggesting its high glycosylation degree. It should be mentioned that the 
migration zone of donkey κ-CN spanned all the other casein bands. 
Donkey κ-CN seems to be more glycosylated (about 12 glycosides) than bovine κ-CN which has six 
glycosylated Thr residues and considering the preferential peptide bond of donkey κ-CN susceptible to 
chymosin hydrolysis, it could probably be Phe97-Ile98 and not Phe105-Met106 bond (which would reflect 
differences in the mechanism of clotting of milk in ruminant and non ruminant mammals). In this way, 
donkey κ-CN, showing more similarities to equine and human κ-CN, compared to bovine κ-CN may belong 
to the κ-CN group II.   
 
 
 
 
         
 
      
 
 
 
 
 
 
 
 
 
   
 
 
Fig 3.22: Characterization of donkey casein, before and after chymosin hydrolysis, by PAGE-SDS analysis 
(A) and immunoblotting with specific polyclonal antibodies against each casein fraction (B) with fluorescent 
glycoprotein detection (C).  
WPD: whey protein donkey; CNC: casein cow; CNC+chim.: casein cow + chymosin; CND+chim.: casein 
donkey + chymosin. 
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Conclusions 1 
 
The proteomic approach allowed the identification of the four casein fractions (αs1-, αs2-, β- e κ-CN) in 
donkey milk together with their related heterogeneity due to post-translational phenomena such as the 
different phosphorylation degree of the caseins (αs1-, αs2-, β-CN) and the high glycosylation level of κ-CN, 
incorrect splicing of primary transcript in mRNA (non allelic deleted forms of αs1-, αs2-, β-CN) and genetic 
polymorphism of αs1- and β-CN (one or more variants in individual samples). 
Specifically 
• αs1-CN was composed at least of three protein components, characterized by a different length of 
their amino acid sequence (210, 202, 197 aa) and also expressed at different intensity 
(202>197>210), where the minor component with 210 aa was found for the first time. This means, 
that unlike αs1-CN mare, all exons are expressed in donkey αs1-CN gene. The incorrect splicing of 
the primary transcript (210) determining the single and/or contemporary elimination of exons 7 and 
5 gave rise to the two deleted components with 202 and 197 aa, respectively. Each of these three 
components (210, 202, 197) showed a microheterogeneity due both to the different phosphorylation 
degree (5, 6 e 7P) that the glutamine residue deletion. The screening carried out on the samples by 
RP-HPLC and MS analysis also revealed a qualitative polymorphism at αs1-CN locus for the finding 
of a new αs1-CN variant, in addition to the protein already known in literature (Cunsolo et al., 
2009a), but also a quantitative polymorphism at this locus (paragraph 3.13.3), for the detection of 
samples characterized by the presence of αs1-CN only in traces, as in goat milk.  
• β-CN is always present in donkey milk as in human milk (paragraph 3.13.3). The immuno-
electrophoretic and chromatographic analysis of analyzed samples showed three new genetic 
variants at this locus, each 226 aa long, which we named B, C, e D, while the mass spectrometry 
allowed to identify the characterizing amino acid substitutions. The structural study has indicated for 
each new variant the same phosphorylation degree of β-CN A reference (Cunsolo et al., 2009b), 
indicating that the involved mutations do not affect serine residues in the delegated code sequences. 
Each new variant, therefore, was heterogeneous for the presence of three phosphorylated 
components (5, 6, 7P) and for the contemporary presence of a non allelic deleted form lacking the 
peptide E27SITHINK34, encoded by exon 5, always with the same three phosphorylation degrees.  
• αs2-CN was identified and characterized in donkey milk by Chianese et al. (2010). Its heterogeneity 
is due to its high phosphorylation degree (10, 11, 12 P) and to the presence of deleted forms 
(Cosenza et al., 2010; Saletti et al., 2012). The electrophoretic and chromatographic analysis also 
suggested the existence of a possible quali-quantitative polymorphism at αs2-CN locus (paragraph 
3.13.3). The absence of αs2-CN in some samples of donkey milk, as in the human milk, together 
with a lower expression level of αs1-CN and β-Lg, confirm the compositional similarity of two 
milks and represent a scientific basis for donkey milk’s use in nutrition of infants with CMP allergy. 
• To date, for κ-CN only partial data on its cDNA sequence exist. We have experimental evidences of 
κ-CN presence in DM only after specific immunostaining, likely depending either on the low 
amount of this fraction in the milk or on its lower reactivity to Blue Coomassie staining. As in 
ruminants, κ-CN is the most heterogeneous casein fraction and probably this phenomenon is 
generated from its high glycosylation degree. In fact the fluorescent glycoproteins detection showed 
that κ-CN is not only the casein with the lowest molecular weight but also the most fluorescent, 
being a highly glycosylated protein. For this reason, it could have more similarity with human and 
equine κ-CN than other species. Finally, the immunoelectrophoretic profiles also showed the 
occurrence of a possible genetic polymorphism at this locus and the non-susceptibility of κ-CN to 
chymosin hydrolysis compared to αs1- and αs2-CN is due to the non para-κ-CN formation. This 
result is in agreement with cDNA κ-CN sequence which would lack of the specific site for 
chymosin action.  
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3.6 Topic/theme 2: characterization of donkey milk whey proteins 
 
At present, while the investigation of casein components is still at a relatively early stage of progress, more 
scientific data are available on donkey whey proteins consisting of α-La, β-Lg, serum albumin, lactoferrin 
and lysozyme as in ruminants and horse milk. The particularity of donkey milk is to contain two β-Lgs (β-Lg 
I and β-Lg II) because the donkey has two genes which encodes for this protein, absent in human milk and 
therefore, considered the principal milk allergen in neonates and children. This study carried out on donkey 
whey proteins of animals reared in Italy, is aimed to the characterization of their molecular composition 
(primary structure, disulphide bridges) and also to identification of possible new genetic variants, as for β-Lg 
II which, according to data reported in literature, showed a greater heterogeneity compared the other whey 
components. The heterogeneity of this protein, (due to its qualitative and quantitative polymorphism) could 
influence the milk composition and its allergenic properties, while the positive presence of minor whey 
proteins, lysozyme and lactoferrin, may influence nutritional, functional and biological properties of donkey 
milk. 
  
3.7 Materials and methods 2 
 
All chemicals were of the highest purity commercially available and were used without further purification. 
Tetra-methyl-ethylene-diamine (TEMED), 2-mercaptoethanol, ammonium persulphate, glycine, glycerol, 
TRIS (hidroxymethyl-amino methane), SDS (sodium dodecyl sulfate), acetic acid, methanol, urea, 
ammonium bicarbonate (AMBIC), HPLC grade H2O, formic acid (FA) and CH3CN were purchased from 
Carlo Erba (Milan, Italy). Trichloroacetic acid (TCA), Trifluoroacetic acid (TFA), sinapinic acid (SA), α-
cyano-4-hydroxycinnamic acid (CHCA), iodoacetamide (IA), dithiothreitol (DTT) were obtained from 
Aldrich (St. Louis, MO, USA). Modified trypsin, sequencing grade was from Promega (Madison, WI, USA), 
alkaline phosphatase (AP) was from Roche (Mannheim, Germany). Dialysis tubing with molecular weight 
cut off (MWCO) 12–14000 Da was from Medicell International Ltd (London, UK). Amicon® Ultra 
centrifugal filters 3.000 MWCO and ZipTip™ C18 micro columns were obtained from Millipore (Bedford, 
MA, USA). Acrylamide, bis-acrylamide, Ampholine buffers were from GE Healthcare Amersham 
Biosciences (Buckinghamshire, UK). Coomaassie Brilliant Blue (CBB) R250 and G250 were purchased 
from Bio-Rad (Richmond, CA, USA). 
 
3.7.1 Donkey milk sampling (sample whey protein preparation)  
 
Individual donkey milk samples (77) were collected from two breeds reared in Italy (Sicilia and Abruzzo) 
and the whey proteins fraction was isolated by acidification at pH 4.6 of defatted milk (Aschaffenburg & 
Drewry, 1959). The supernatant, containing the whey proteins, was recovered by centrifugation (4000 rpm 
for 30 min) at room temperature and subsequently dialysed in tubing with molecular cut off 12000-14000 Da, 
individual whey protein samples were freeze-dried and stored at −20 °C before use. 
 
3.7.2 Ultra-thin layer isoelectric focusing UTLIEF (on polyacrylamide gels) analysis 
 
Sample Preparation: lyophilized whey protein samples (20 g/L) for electrophoretic analysis were dissolved 
in 9M urea solution, containing 2-mercaptoetanol (1 ml/L), respectively. 10 µl of these solutions were loaded 
on the gel. 
UTLIEF analysis:  Ultra-thin layer isoelectric focusing (UTLIEF) on polyacrylamide gels (124×258×0,25 
mm) was carried out according to the procedure of Chianese et al. (2010). Briefly, the polyacrylamide gel in 
a 4.2-9.0 pH gradient was obtained mixing 1% (v/v) Ampholine buffers: 4.2–4.9 (350 µL), 4.5–5.4 (350 µL), 
5.0–7.0 (150 µL), 7.0–9.0 (150 µL). UTLIEF analysis was performed with LKB Multiphore II instrument  
(Pharmacia LKB, Bromma, Sweeden) at 10°C and the electrophoretic analysis consists of three steps: pre-
focusing (2000 V, 15 mA, 4 W, 30 min), focusing with the sample (2000 V, 15 mA, 4 W, 60 min), final 
focusing (3000 V, 5 mA, 20 W, 130 min). After the electrophoretic run, the fixation of the protein bands on 
the gel was carried out by gel’s immersion in 20% (v/v) trichloroacetic acid solution. The gel was stained 
with CBB G-250 as described by Krause et al. (1988) and destained with two solutions of the same volume: 
aqueous solution containing 20% (v/v) acetic acid and aqueous solution containing 50% (v/v) methanol. This 
technique allows to separate whey proteins according to their isoelectric point values. 
 
3.7.3 Immunoblotting analysis 
 
This analysis is based on cross-reaction between specific polyclonal antibodies produced against the main 
whey proteins α-La and β-Lg and their respective antigens. Therefore, this technique allows to identify the 
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main whey proteins according to the specificity shown by specific polyclonal antibodies produced against 
these proteins after immunization of rabbits with the individual whey proteins α-La and β-Lg.  
The reagents for immunoblotting were: PBS buffer (4.5% NaCl, 3.9% NaH2PO4, pH 7), wash buffer solution 
and saturating the membrane “blocking solution” (equine serum at 10% v/v in PBS), development buffer (0.5 
mg/ml diaminobenzidine in 10 mM Tris-HCl 0.1 M pH 7.5, 0.6 mg/ml NiCl2 1%).  
For immunoblotting analysis, the main whey proteins separated by UTLIEF analysis were transferred by 
capillary diffusion from the gel into a nitrocellulose membrane (0.45 µm, Trans-Blot, Bio-Rad, Richmond, 
CA, USA) and immunostained using polyclonal antibodies against bovine α-La and β-Lg as primary 
antibodies. These were prepared according to the following procedure: bovine α-La and β-Lg, fractionated 
by RP-HPLC, were used as antigen by Primm (Milan, Italy) to prepare rabbit polyclonal antisera against 
bovine α-La and β-Lg. Finally, the antisera were filtered using 0.45 mm filters (Millipore, Bedford, MA), 
divided into aliquots of 1 mL and stored at −20°C.   
The immunoblotting analysis was conducted according to the procedure described in 3.2.5 paragraph for the 
recognition of the casein components in donkey milk. 
 
3.7.4 Reversed-phase high performance liquid chromatography (RP-HPLC) analysis 
 
The HPLC system was provided by Kontron Instrument (Milan, Italy) and is constituted by two pumps 
model 420, an injector of the sample (loop 50 µL) and a DATA SYSTEM 450 for the chromatography’s 
management and for the integration of the peak areas of the chromatograms.   
The whey protein samples were fractionated by RP-HPLC on a 214TP54 5µm Vydac C4, 250 mm × 4.6 mm 
internal diameter column (Vydac, Hesperia, CA, USA) and the detection was at a wavelength of 220 nm with 
a UV detector Kontron (Mod. 430). The solvent used were: solvent A and solvent B. Solvent A was 0.1% 
(v/v) TFA in ultra pure water and solvent B 0.1% (v/v) TFA in acetonitrile. 50 µL of a solution containing 10 
mg (whey protein sample)/ mL (solvent A) were loaded into a C4 column, equilibrated with solvent A. The 
elution program involved an isocratic step with 30% solvent B for 5 min and a linear gradient from 30 to 
50% solvent B in 45 min, then from 50% to 100% solvent B in 2 min, with a flow rate of 1 mLmin−1. Each 
eluted whey protein fraction was manually collected, freeze-dried and stored at −20°C. 
This technique allows to separate proteins according to their hydrophobicity. 
 
3.7.5 LC-ESI-MS analysis 
 
The molecular mass determination of the main whey proteins (donkey α-La, β-Lg I and β-Lg II) and of the 
minor whey proteins with biological activity (donkey lysozyme, serum albumin and lactoferrin) was carried 
out using a single quadrupole instrument LC-ESI-MS. Also the screening on individual whey samples to 
discriminate β-Lg II A from B variant, otherwise comigrating in UTLIEF analysis, was carried out using LC-
ESI-MS instrument.    
Specifically, liquid chromatography/electrospray mass spectrometry (LC-ESI-MS) was performed using an 
HPLC modular system (HP1100-MSD, Agilent Technologies, Santa Clara, CA, USA) with UV detector, 
interfaced with a single quadrupole mass spectrometer equipped with a electrospray source (ESI) and 
monitored by HP Chem Station software for the acquisition, analysis and processing of  the mass spectra.  
The whey protein samples were fractionated by RP-HPLC on a 214TP54 5µm Vydac C4, 250 mm × 2.1 mm 
internal diameter column (Vydac, Hesperia, CA, USA) and the UV detection was at a wavelength of 220 nm. 
Solvent A was 0.1% (v/v) TFA in ultra pure water and solvent B 0.1% (v/v) TFA in acetonitrile. 100 µL of a 
solution containing 5 mg (casein sample)/ mL (solvent A) were loaded into a C4 column, equilibrated with 
solvent A. The elution program involved a gradient from 37 to 50% solvent B in 30 min, at a flow rate of 0.2 
mLmin−1. 
The ESI mass spectra were scanned in the positive ion mode, from 800-2400 m/z at a scan cycle of 5 
sec/scan. The source temperature was 120°C and the orifice voltage was 40. Mass values are reported as 
average masses. Signals recorded in the mass spectra were associated with the corresponding whey proteins 
on the basis of the molecular mass, taking into the account the reported amino acid sequences of mare and 
donkey whey proteins available on database Swiss-prot (ExPASy proteomics server). 
 
3.7.6 β-Lg alkylation and trypsin enzymatic digestion  
 
The digestion of the whey proteins from electrophoretic spots was carried out following the procedure 
reported by Mamone et al. (2003) in paragraph 3.2.9. As regards the tryptic digestion of the isolated β-Lg II, 
collected by RP-HPLC, it was dried using a Savant concentrator (Speed-Vac, Milan, Italy), lyophilized, 
denatured and alkylated before trypsin hydrolysis. Briefly, each isolated whey protein fraction (for example 
donkey β-Lg II) was denatured at room temperature, in a guanidine buffer (6M guanidine in 0.5 M Tris-HCl 
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with 1 mM EDTA) at pH 8. Subsequently, disulfide bridges were reduced by of 10 mM/L DTT for 60 min at 
56°C. SH groups were subsequently alkylated with 55 mM/L IA in the above guanidine buffer, and 
maintained for 30 min in the dark. With the aim to remove the reagents, the alkylated whey protein was ultra-
filtered on Amicon® Ultra filters 3000 MWCO, centrifugated at 4000 g for 25 min and washed with 50 mM 
NH4HCO3, pH 7.4. The retentate solution containing the purified alkylated whey protein (as β-Lg II), was 
added of trypsin at 1:50 (w/w) and incubated overnight (approximately 14 h) at 37°C. The digestion was 
stopped by frozen (−20°C).    
 
3.7.7 Matrix-assisted laser desorption/ionization-time-of-flight-mass spectrometry (MALDI-TOF-MS) 
analysis  
 
MALDI-TOF-MS experiments were carried out on a Voyager DE-PRO mass spectrometer (PerSeptive 
Biosystems, Framingham, MA) equipped with a N2 laser (337 nm, 3 ns pulse width) operating in linear or in 
reflector positive ion mode, using the Delay Extraction technology. Mass spectra were acquired both in 
positive linear or in reflectron mode and using SA and CHCA dissolved in aqueous solution of 50% (v/v) 
CAN containing 0.1% (v/v) TFA, at a concentration of 10 mg/mL, as matrices for the analysis of proteins 
and peptides, respectively. MALDI-TOF-MS analysis of intact proteins were obtained in linear positive ion 
mode over the m/z range 10000-30000 and were averaged from about 150 laser shots.  
As regards peptides analysis, the mixtures of tryptic peptides were subjected to desalting/concentration step 
with Zip-Tip C18 pre-packed micro-columns (Millipore, Bedford, MA, USA) previously equilibrated with 
aqueous 0.1% TFA (v/v) prior to analysis by MALDI-TOF. Spectra were obtained in reflectron positive ion 
mode over an m/z range 600-4000 and were averaged from about 150 laser shots. External calibration was 
performed by acquiring separate spectra of a mixture of standard peptides (PerSeptive Biosystems). 
The identification of donkey whey proteins and their derived peptides was carried out using the known whey 
proteins available on Swiss-prot database (ExPASy proteomic server) of Swiss Institute of Bioinformatics 
(SIB) and with the online software FINDPEPT (website: http://www.expasy.org/tools/findpept.html). 
 
3.7.8 Electrospray quadrupole-time of flight-mass spectrometry (ESI-Q-TOF-MS/MS) analysis  
 
Tandem MS (MS/MS) data were obtained using a hybrid quadrupole-orthogonal acceleration time of flight 
Q-STAR instrument (Applied Biosystem, Foster City, CA) equipped with a nanospray source (Protana, 
Odense, Denmark), operating in positive ion mode. Dried samples were resuspended in 0.1% TFA, purified 
from residual salts by loading into ZipTip C18 Reversed Phase pre-packed micro-columns (Millipore Bedford 
MA, USA), and introduced in the source through borosilicate needles, gold coated (Protana Odense, 
Denmark). The capillary voltage used was 800 V. Double-charged ion isotopic cluster were selected by using 
the quadrupole mass filter and the induced to fragment by collision. The collision energy was 20 to 40 eV, 
depending on the size of the peptide. The collision-induced dissociation was processed by using Analyst 5 
software (Appied Biosystems). The deconvoluted MS/MS spectrum was manually interpreted with the help 
of Analyst 5 software.  
 
3.8 Results and discussion 2 
 
3.8.1 Characterization of donkey whey proteins by UTLIEF and immunoblotting analysis 
   
The most representative UTLIEF profiles of individual donkey whey proteins were shown in Fig. 3.23; after 
Comassie Brilliant Blue staining (Fig. 3.23A), the main whey proteins α-La and β-Lg, were identified 
according to known theoretical pI value and after immunoblotting with α-La and β-Lg specific polyclonal 
antibodies (B). With the exception of lysozyme which focused at alkaline zone of pH gradient, on the basis of 
the increasing pI value β-Lg II, β-Lg I and α-La focalized in A, B and C (acid) zone of UTLIEF pH gradient, 
respectively. The composition of each electrophoretic zone was heterogeneous for the presence of almost two 
components recognised by each specific polyclonal antibody. This was the case of B and C zones where β-Lg 
I and α-La were “excorted” by a and b satellite bands, respectively. While, both α-La and β-Lg I presented 
the same pI value in all analyzed samples, four different β-Lg II phenotypes were discriminated on the basis 
of their pI value. In particular, these latter were numbered in order of decreasing pI value (bands 1, 2, 3, 4) 
and occurred in homozygous (lanes 4, 5 and 6) and heterozygous form (lanes 1, 2, 3 and 8) (Fig. 3.23). 
Taking into account the known theoretical pI values (Table 1.14), A and B genetic variants of β-Lg II 
focalized in band 2 (pI=4.70), β-Lg II C in band 1 (pI=4.72) and β-Lg II D (pI=4.64) in band 4. Since, to 
date, none genetic variant having a pI value intermediate between B and D β-Lg II was reported, the 
occurrence of a new variant E was supposed in band 3. Moreover, a defective coding allele for β-Lg II 
determined the absence of expressed protein in lane 7. A similar milk sample was found in Sicilian 
(Criscione et al., 2009) and Sardinian (Conti et al., 1989) donkey breeds. In conclusion, from a genetic point 
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of view, in examined donkey milk samples, α-La and β-Lg I were monomorphic and β-Lg II polymorphic, 
since known (B, C and D), new (E) variants and a defective quantitative allele occurred at this locus.  
 
 
 
 
Fig 3.23: UTLIEF in pH gradient 4.2-9.0 of individual whey protein samples containing representative 
donkey phenotypes detected by double staining with Coomassie Brilliant Blue (A) and polyclonal antibodies 
against α-La and β-Lg (B).    
 
3.8.2 Identification of donkey whey proteins, as β-Lg II genetic variants, by RP-HPLC coupled to 
LC/MS analysis  
 
The screening, carried out by RP-HPLC analysis, on individual donkey whey protein samples, allowed to 
select the a and b representative chromatograms (Fig. 3.24). Each chromatogram consisted of five peaks. By 
LC/MS analysis, Lyz, SA/Lf, α-La, β-Lg II and β-Lg I, in increasing order of elution time, were identified in 
each of these five chromatographic peaks (Table 3.5). 
In donkey, two variants of lysozyme, named A (Godovac-Zimmermann et al., 1988b) and B (Herrouin et al., 
2000) were reported, whereas the sequences of minor components of whey fraction, as serum albumin and 
lactoferrin were only deduced from the corresponding cDNA sequences in donkey (Li et al., 2004) and mare 
(Sharma et al., 1999), respectively. No information is available for the primary structure of donkey 
lactoferrin. At this regard the identification of some antimicrobial proteins in donkey milk samples, such as 
lysozyme B and lactoferrin, could be responsible for the low microbial load found in this milk and may be 
useful to prevent intestine infections in infants.  
However, comparing a and b chromatographic profiles (Fig. 3.24), a different quantitative expression of β-
Lgs and α-La can be observed; in particular, β-Lg II was lacking in b, while a different quantitative ratio α-
La/β-Lg I was assessed in each profile (a=1 and b=2, approximately). 
The use of LC/MS allowed to identify the four β-Lg II variants (B, C, D and E), otherwise co-eluting in the 
same chromatographic peak 4 or co-focalising at the same pI value of UTLIEF pH gradient, as β-Lg II A and 
B (Table 3.5).  
These results indicated β-Lg II B as the most common phenotype at donkey β-Lg II locus compared to β-Lg 
II A and confirmed the monomorphism of α-La and β-Lg I due to the occurrence of A and B variants, 
respectively. We found a more complex polymorphism of β-Lg II for the occurrence of known (B, C and D) 
new (E) variants and null allele at this locus. 
Furthermore, the HPLC analysis of whey samples containing B, C and D β-Lg II variants (Fig. 3.25) showed 
a different peak area in the following decreasing order: (BB) < (CC) < (DD); therefore these genetic variants 
could be expressed by quantitative alleles (strong, intermediate, weak and null). It was well known that a 
similar quali-quantitative polymorphism was found at goat αs1-CN locus and the related scientific studies 
reported in numerous research papers (Martin et al., 2002; Caroli et al., 2006; Marletta et al., 2007). 
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Fig 3.24: RP-HPLC profiles of representative donkey           Fig: 3.25: RP-HPLC profiles of individual whey  
whey protein samples (profiles a and b) containing a             protein from donkey milk samples containing β- 
different quantitative level of β-Lgs and α-La.                       Lg II B, C, D variants. 
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Table 3.5: Identified donkey whey proteins by LC/MS analysis. 
 
Retentetion time  
(min) 
Peak Molecular Mass (Da) Protein identification 
  Measured Theoretical  
17,6 1 14.626 14.631 Lysozyme B 
24,4 2 65.601 65.597 Serum Albumin 
  75.536 75.420a Lactoferrin 
27,5 3 14.210 14.214 α-La A variant 
28,6 4 18.221, 18.239,  
18.314, 18.256b 
18.227, 18.241, 
18.311 
β-Lg II B, C, D, Eb  
variants 
30,3 5 18.505 18510 β-Lg I B 
a
 Horse Molecular Mass 
b
 present research 
 
3.8.3 Characterization of the new β-Lg II E variant by MALDI/TOF/MS analysis and ESI-Q-TOF-
MS/MS analysis  
 
To characterize the new β-Lg II E variant, the whey proteins of sample containing the variant, were separated 
by RP-HPLC (Fig. 3.26) and the eluted peak 4 manually collected, was submitted to LC/MS analysis.  
 
 
 
Fig 3.26: RP-HPLC profile of donkey whey sample containing D and E β-Lg II variants.    
 
Two components at Mr 18314 and Mr 18256 Da, were determined in the peak sample. Of these, the first 
corresponded to expected β-Lg II D variant (Table 3.5) while the other one was assigned to the new genetic 
β-Lg II E variant. To identify the amino acid substitutions, β-Lg II D and E variants (co-eluted in peak 4) 
were digested by trypsin before MALDI TOF analysis. The obtained mass spectra (Fig. 3.27) gave rise to 
peptides with measured masses reported in Table 3.6; as expected, all signals were assigned to D variant 
except two new T1 (E) and T2 (E) peptides at Mr 2001.2 Da and 2356.8 Da, displayed in insets a and b. These 
peptides presented a molecular weight lower of 29 and 28 Da than T1 (D) and T2 (D) respectively. These 
achieved data were in close agreement with the 57 Da molecular mass difference measured between β-Lg II 
D and β-Lg II E. 
The peptides T1 (E) and T2 (E) were submitted to ESI-Q-TOF-MS/MS analysis for sequencing and thus, 
determine the amino acid substitutions between them (Fig. 3.28): the peptide T1 (E) corresponded to the 
sequence 1-18 with two amino acid substitutions D2→N2 and the C-terminal R18→K18, while the peptide T2 
(E) corresponded to the sequence 19-40 and exchanged respected to peptide T2 (D) for amino acid 
substitution V25→A25. Overall, the β-Lg II E amino acid substitutions experimentally observed in this work 
were all confined in the N-terminal area of the protein sequence that was known to be conserved among the 
other β-Lg II genetic variants. 
 
 
 
 
 
 
 
Lyz 
β-Lg II DE 
α-La β-Lg I 
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Fig 3.27: MALDI-TOF mass spectrum of tryptic digest of β-Lg II DE. Inset in panel a: peptide 1-18 T1(D) 
and T1 (E) in m/z range 1990-2050. Inset in panel b: peptides 19-40, T2(D) and T2(E) recorded in mass 
range 2360-2420. 
  
Table 3.6: MALDI-TOF MS identification of RP-HPLC peak 4 eluted at 28.6 min (Fig 3 o 4) digested with 
trypsin. 
 
Fragment Position Molecular Mass, Da Peptide Sequences β-Lg II 
variants 
  Theoretical Measured   
T1 1-18 2029.9 2030.6 TDIPQTMQLDDLQEVQGR D 
T1 1-18 2000.2 2001.2 
(−29Da) 
TNIPQTMQLDDLQEVQGK E 
T2 19-40 2384.2 2384.8 WHSVAMVASDISLLDSESAPLR D 
T2 19-40 2355.8 2356.8 
(−28Da) 
WHSVAMAASDISLLDSESAPLR E 
T3 41-59 2240.2 2240.8 VYVEELRPTPEGNLEIILR D, E 
T4 60-69 1112.5  EGANHVCVER D, E 
T5 70-75 671.4  NIVAQK D, E 
T6 76-90 1724.8 1725.4 TEDPAVFTVNYQGER D, E 
T8 92-125 3831.8 3945.7a ISVLDTDYAHYMFFCVGPPLPSAEHGMV D, E 
T6+T8 91-125 3959.8 4091.6a KISVLDTDYAHYMFFCVGPPLPSAEHGMV D, E 
T10 129-136 977.4  VDEEVMEK D, E 
T10+T11 129-139 1368.5  VDEEVMEKFSR D, E 
T12 140-160 2240.2  ALQPLPGHVQIIQDPSGGQER D, E 
 
b
2387.8
2356.8
2384.8
2385.8
2356.8
2360 2380 2420
Mass (m/z)
2357.8
2358.8
T2(D)
T2(E)
2030.6
2029.6
2031.6
2032.6
2001.2
1990                    2020
030.6
2029.6
2031.6
2032.6
2001.2
1990         2020        2050
Mass (m/z)
T1(E)
T1(D)
a
 84
  
Fig 3.28: ESI-Q-TOF-MS/MS fragmentation of T1 (1-18) and T2 (19-40) tryptic peptides of β-Lg II E 
variant.  
 
3.9 Conclusions 2 
  
The proteomic characterization of the whey fraction in individual donkey milk samples allowed, together 
with the identification of already known whey proteins such as lysozyme B, α-La A and β-Lg I B, the 
detection of minor components (serum albumin and lactoferrin), whose sequences were only deduced from 
corresponding cDNA sequences in donkey and mare, respectively. 
The application of proteomic methodology to the donkey whey proteins has also led to the identification of a 
novel β-Lg II genetic variant, which we named E, in addition to already known β-Lg II variants (A, B, C, D) 
in literature. The presence of these different molecular forms of β-Lg II explains its greater heterogeneity 
compared to other donkey whey proteins, as the monomorphic α-La A and β-Lg I B.      
Three amino acid substitutions characterized β-Lg II E variant in comparison with D variant: D β-Lg II 
Asp2→ E β-Lg II Asn2, D β-Lg II Arg18→ E β-Lg II Lys18 and D β-Lg II Val25→ E β-Lg II Ala25. These 
results indicated a direct phylogenic origin of E from D variants. Moreover, since the percentage area of β-Lg 
II DE was very close to CD HPLC profile counterpart, it can be hypothesized that β-Lg II E is expressed by 
an intermediate alleles.  
From a nutritional point of view the minor content of β-Lgs in donkey milk in addition to quantitative genetic 
polymorphism occurred at donkey β-Lg II locus can be related to the tolerance mechanism of donkey milk in 
the allergic patients to bovine milk.  
Thus, the proteomic methodology is a powerful tool to underline the genetic biodiversity inter and/or intra 
species. In particular, the sensibility of  based separative technique as UTLIEF was very high and able to 
discriminate between β-Lg II D and E variants and between β-Lg II C and B/A variants differing each other 
for 0.01 pH unit.  
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3.11 Topic/theme 3: quantitative characterization of donkey milk proteins (caseins and whey proteins) 
 
Donkey’s milk may be considered a valid alternative, for infant nutrition, to powdered milks, soybean milk 
or other formulas, since its composition in lactose and proteins is very close to human milk. So, recent 
clinical studies confirm donkey milk feeding as a safe e valid treatment of most complicated cases of 
multiple food allergies compared other infant formulae. However, information on the donkey milk 
composition is more limited than that on mare’s milk, which has also been studied as an infant food. The aim 
of the this part of the study is to characterize “donkey milk” product, especially with regard to the amount of  
protein fractions. In fact, although the mechanism of donkey milk’s tolerance has not been fully clarified, it is 
reasonable to hypothesize that the hypoallergenic properties of donkey’s milk can be related to structural and 
quantitative differences of its protein components with respect to bovine milk.  
 
3.12 Materials and methods 3 
 
All chemicals were of the highest purity commercially available and were used without further purification. 
Tetra-methyl-ethylene-diamine (TEMED), 2-mercaptoethanol, ammonium persulphate, glycine, glycerol, 
TRIS (hidroxymethyl-amino methane), SDS (sodium dodecyl sulfate), hydrochloric acid (HCl), sulphuric 
acid, sodium hydroxide (NaOH), boric acid, acetic acid, methanol, urea, potassium sulphate (K2SO4), 
ammonium bicarbonate (AMBIC), HPLC grade H2O, formic acid (FA) and CH3CN were purchased from 
Carlo Erba (Milan, Italy). Trichloroacetic acid (TCA), Trifluoroacetic acid (TFA), sinapinic acid (SA), α-
cyano-4-hydroxycinnamic acid (CHCA), iodoacetamide (IA), dithiothreitol (DTT) were obtained from 
Aldrich (St. Louis, MO, USA). Modified trypsin, sequencing grade was from Promega (Madison, WI, USA), 
alkaline phosphatase (AP) was from Roche (Mannheim, Germany). Dialysis tubing with molecular weight 
cut off (MWCO) 12–14,000 Da was from Medicell International Ltd (London, UK). Amicon® Ultra 
centrifugal filters 3.000 MWCO and ZipTip™ C18 micro columns were obtained from Millipore (Bedford, 
MA, USA). Acrylamide, bis acrylamide, Ampholine buffers were from GE Healthcare Amersham 
Biosciences (Buckinghamshire, UK). Coomaassie Brilliant Blue R250 and G250 were purchased from Bio-
Rad (Richmond, CA, USA). 
 
3.12.1 Quantitative determination of the milk’s nitrogen fractions (TN, SN, NPN) by Kjeldahl method   
  
Eight significant donkey milk samples were selected in relation to the identification of quali-quantitative 
polymorphisms, and used for the determination of the nitrogen substance according to the FIL-IDF (1983) 
procedure with the Kjeldahl method. 
The Kjeldahl method (FIL-IDF, 1993) is an analytical method for determining the nitrogen content of organic 
and inorganic substances. It includes three step: 
• mineralization;  
• distillation; 
• titration. 
The mineralization phase consists in the oxidation of the sample and in the processing of protein nitrogen in 
inorganic nitrogen with sulphuric acid. In order to accelerate the reaction, K2SO4 is added as catalyst which 
increases the boiling point of sulphuric acid and then the oxidation temperature. This phase lasts several 
hours and is completed when the solution is clear. 
After mineralization, the cooled sample is added distilled water and 40% (w/v) NaOH to release NH3. For 
direct injection of water vapor in the sample, the NH3 is distilled in a vapor stream and transported to 
condenser, where it condenses together with water vapor. In a flask containing boric acid and a mixed methyl 
red-green bromocresol indicator (weakly reddish solution), the distillate is collected (blue solution). Finally, 
the distillate is titrated with 0.1N HCl. The titration is concluded at the turning of the indicator, that is when 
the indicator becomes colourless. 
The % nitrogen is the result of the following ratio: 
mL HCl × N HCl × 1.4007 
sample weight  
The protein content (%) is obtained by multiplying the nitrogen content (%) for a conversion factor, which, 
for milk proteins is equal to 6.38.  
 
3.12.2 Preparation of the milk’s nitrogen fractions (TN, SN, NPN)  
 
The total nitrogen (TN) was determined directly in the milk; the nitrogen content of milk, soluble at pH 4.6 
(SN) refers to the nitrogen content obtained after the precipitation of the casein fraction with acetic 
acid/acetate buffer. After the extraction of the precipitate by filtration, the filtrate contains pH 4.6 soluble 
nitrogen and was used for analysis according to the procedure described for total nitrogen. 
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It is possible to calculate the casein nitrogen content as difference between the total nitrogen and the pH 4.6 
soluble nitrogen content. 
The non protein nitrogen (NPN) refers to nitrogen content obtained after the precipitation of the proteins 
(caseins and whey proteins) in the sample by the addition of TCA solution to achieve a final concentration of 
TCA of 12% in the mixture. Extraction of the precipitate by filtration, with the filtrate containing NPN which 
was used for analysis according to the procedure described for total nitrogen. It is possible to calculate the 
true protein nitrogen as the difference between the total nitrogen and the non protein nitrogen content. 
 
3.12.3 Sodium Dodecyl Sulphate-Polyacrylamide gel electrophoresis (SDS-PAGE) analysis 
 
Sample Preparation: donkey milk samples (1 mL), after skimming by centrifugation at 4000 rpm for 30 min, 
were added of a denaturing solution (0.062 M Tris-HCl, 2% (w/v) SDS, 5% (v/v) β-mercaptoethanol, pH 6.8) 
using about 90% of its water in donkey milk. The milk samples, after adding the denaturing solution, were 
added of 10 µl bromophenol blue, as tracer of electrophoretic run and then heated at 100°C for 5 min. 
Volumes of 10 µl of this final sample were loaded in the gels.     
SDS-PAGE analysis: SDS-PAGE was carried out with a vertical electrophoretic apparatus (Protean II, Bio-
Rad, Richmond, CA, USA) according to the procedure described by Laemmli, (1970), by using a 4%  
polyacrylamide stacking gel in 0.5 M Tris-HCl buffer (pH 6.8) and a 18% or 15% polyacrylamide resolving 
or running gel in 1.5 M Tris-HCl buffer (pH 8.6) in the presence of 10% SDS. The polyacrylamide gels were 
obtained by co-polymerizing acrylamide and bis-acrylamide with N,N,N’,N’-tetrametiletilenediammina 
(TEMED) and ammonium persulphate (PER) added, respectively, as activator and catalyst of polimerization 
reaction. As molecular standard, a low molecular weight standard kit (LMW Calibration kit, Amersham, GE 
Healthcare, UK) was used. Electrophoresis was performed at constant voltage 200 V (for about 6 h) in the 
migration buffer containing 0.2M glycine, 0.025 M Tris and 0.1% SDS. The gel staining was performed with 
0.1% (w/v) Coomassie Brilliant Blue CBB R-250 dissolved in a fixative solution (50% (v/v) methanol and 
7% (v/v) acetic acid), followed by destaining in a aqueous solution containing 30% (v/v) methanol and 10% 
(v/v) glacial acetic acid. 
This technique allows to separate proteins according their molecular weight. 
 
3.12.4 Densitometry 
 
The densitometric analysis of the electrophoretic SDS-PAGE profiles of the individual donkey milk samples 
were carried out with a scanning laser densitometer (LKB 2202 UltoScan XL Enhanced Laser) equipped with 
an integration program gel-Scan 2,0 and connected to an IBM computer PC/PS2. Gel image analysis 
(recognition of the bands, calculation of the molecular weight and amount of each band) were automatically 
performed by the software. The densitometry is based on the measurement of the transmitted light when a 
laser beam is made to pass through the gel allowing a quantitative evaluation of individual bands. The 
intensity of transmitted light when a laser beam is passed through the gel is inversely proportional to the 
amount of protein present in the band. The intensity of the bands is expressed in the form of peaks in 
“densitogramma”, where the optical density detected by the instrument, for each single spot, is expressed as a 
percentage of the optical density of all spots corresponding to the different stained fractions to Coomassie 
Brilliant Blue. The densitometry should be used with caution, since the range of protein concentrations in 
which there is a linear relationship between transmitted light and concentration is very restricted and in 
addition, the proteins are often stained in a different way.    
 
3.12.5 Quantitative analysis of donkey caseins and whey proteins by RP-HPLC 
 
After the fractionation of donkey caseins and whey proteins by RP-HPLC, a quantitative analysis of 
components was performed by integration of the peak areas corresponding to each individual protein 
fraction. 
 
3.13 Results and discussion 3 
 
3.13.1 Quantitative determination of donkey milk proteins by Kjeldahl method  
 
In eight individual donkey milks analyzed, the average protein content, consistent with data reported by 
Salimei et al. (2004) and Guo et al. (2007), was 1.48% ± 0.2, varying from a minimum (1.10%) to maximum 
value (1.81%) (Table 3.7-Fig. 3.29). 
The reasons for this variability have aroused the interest in studying the quantitative distribution of the 
individual protein fractions in donkey milk. 
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The average percentages of casein, whey protein and NPN (contents) were 34.61%, 49.80% and 15.55% 
(Table 3.7-Fig. 3.29), respectively. These results showed remarkable differences compared with other 
mammalian milks and were within the range of variability reported in literature on donkey milk (Salimei et 
al., 2004; Guo et al., 2007), with the exception of measured CN content which was lower than that reported 
by Guo et al. (2007) for Chinese donkey milk. 
The average NPN content is resulted very close to the values for human and mare’s milk (Malacarne et al., 
2002). The nutritional and biological significance of this milk fraction is still far from being completely 
understood, but seems to be related to the development of infant (Emmet & Rogers, 1997). In donkey milks 
analyzed, the whey protein content was more similar to human milk (defined typically as albuminex) than 
cow’s milk (defined as a caséinoux milk) (Malacarne et al., 2002), while casein content was intermediate 
between human and ruminant milk casein (Travia, 1986).  
The richness in whey protein content of donkey’s milk, as mare’s milk, make it more favourable to human 
nutrition than cow’s milk, because of the relatively higher supply of essential amino acids (Hambraeus, 
1994). 
 
Table 3.7-Fig. 3.29: the average composition of proteins and nitrogenous fractions in analyzed donkey milk 
samples.  
 
  
Proteins (% NT × 6.38) 
 (g ×100 mL-1) 
% 
 Whey proteins (WP) 
%       
Caseins (CN) 
% 
 NPN 
Mean 1.48 49.80 34.61 15.55 
S.D. 0.21 7.49 6.89 2.32 
Min. 1.10 40.38 21.33 11.71 
Max. 1.81 63.33 41.03 18.82 
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3.13.2 Determination of casein: whey protein (CN:WP) ratio by SDS-PAGE analysis and Densitometry  
 
The evaluation of the CN:WP ratio is important, since a milk with a reduced protein content, but especially 
with a ratio comparable to human milk (40:60), is less allergenic than cow’s milk (80:20), and thus, could be 
a valid alternative non only for nutrition of infants with CMPA, but also a valid substitute if human milk is 
unavailable. Although it is not clear what are the major allergens in cow’s milk, several studies demonstrated 
that most children with CMPA synthesize antibodies mainly against α-casein and β-Lg (Bevilacqua et al., 
2001; Ametani et al., 2003). Even goat milk with a lower amount of αs1-CN, may be responsible for the soft 
curd produced in the infant stomach and is less allergenic than cow’s milk (Lara-Villoslada et al., 2004). In 
fact it has been previously demonstrated that goat’s milk defective α-CN decreases sensitization to β-Lg, also 
ensuring its better digestion (Bevilacqua et al., 2001).  
The mechanism by which a milk with a lower casein content can be less allergenic is unknown, but could be 
related to the biochemical interactions between casein and β-Lg. The digestion of β-Lg, a protein known to 
be resistant to gastric pepsin, might be facilitated by lower casein content, as it is known that caseins and β-
Lg are tightly linked into the casein micelles. In this sense, the absence or reduction of α-CN content might 
inhibit the initiation of the allergenic course to other milk proteins, such as β-Lg (Lara-Villoslada et al., 
2005). Moreover, using this scientific evidences, a milk with a minor content of caseins than whey proteins 
may be particularly suitable for human consumption, since the whey proteins are proteins with high 
biological and nutritional value and therefore, source of essential amino acids.      
In order to enhance the donkey milk as a natural substitute of human milk, the CN:WP ratio was determined 
in the examined donkey population.  
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The most representative donkey milk samples, analyzed by SDS-PAGE, were shown in Fig. 3.30, after CBB 
staining. In the electrophoretic profiles, three areas were separated: A, in which proteins, with a high 
molecular weight (MW) are migrated, a central area B, in which proteins with an intermediate MW are 
migrated and a C zone, in which low-MW proteins are migrated. 
By recognition of the protein marker bands and by comparing protein migration patterns with those 
previously published for mare (Miranda et al., 2004) and donkey (Salimei et al., 2004; Guo et al., 2007), it 
was possible to identify the following proteins Immunoglobulin IG (approximate relative molecular mass Mr 
94 KDa), lactoferrin Lf (approximate Mr 75 KDa), serum albumin SA (approximate Mr 60 KDa), casein CN 
(approximate Mr of 21 to 35 KDa), β-Lg (approximate Mr 18 KDa), lysozyme Lyz (approximate Mr 15 KDa) 
and α-La (approximate Mr 14 KDa). 
The casein fraction, with intermediate MW, has migrated in the central area and is well separated from whey 
proteins. After all, the whey proteins with high MW (Ig, Lf and SA) are quite distinct from those with low 
MW (β-Lg, α-La and Lyz), whereas the two β-Lg components (β-Lg I and β-Lg II) do not separate between 
them. 
 
 
Fig. 3.30: determination of CN/WP ratio by SDS-PAGE analysis of  representative donkey milk samples.   
 
Since the casein fraction was separated from the whey proteins with SDS-PAGE analysis, the quantitative 
determination of these two protein fractions was carried out by densitometry in order to evaluate the CN:WP 
ratio in donkey milk samples. The data of densitometry (expressed as percentage of total protein) were shown 
in Table 3.8-Fig.3.31. It showed has shown that the average casein content was 39.08% ± 7.54, varying from 
a minimum of 23.11% to maximum value of 63.68% resulting, however, a lower value than that of cow’s 
milk. The average whey proteins content was 60.91% ± 7.54 resulting a higher value than that of cow’s milk 
and very close to human milk. It varied from a minimum of 36.32% to maximum value of 76.89%. 
In this way, in analyzed donkey population the mean CN:WP ratio value was calculated to be 0.67 ± 0.24, 
resulting similar to that found in human milk, and specifically, it was intermediate between the lower value 
of human milk (0.60) and the higher value of cow’s milk (4), consistent with the findings reported by Travia 
(1986). Moreover, this ratio value (0.67) was lower compared to that found in donkeys bred in China (1.4) 
indicating in the latter a major casein level as reported by Guo et. (2007). 
In donkey milks analyzed, the values of CN:WP ratio indicated a high variability in the expression of 
individual protein fractions; in fact about 19% of analyzed donkey population exhibited a CN:WP ratio ≤ 
0.5% and only 7% of the population exhibited a CN:WP ratio > 1. This result could be important for future 
genetic selection of donkeys producing “hypocaseinic” milk, because the casein and whey protein (as β-Lg) 
content influences milk’s allergenicity.   
 
Table 3.8-Fig. 3.31: determination of CN/WP ratio in examined donkey milk samples. 
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3.13.3 Determination of expression level of donkey caseins by RP-HPLC 
 
For the quantitative determination of donkey caseins, the individual casein samples were 
chromatographically separated by RP-HPLC (Fig. 3.32) and identified by mass spectrometry methods. 
Subsequently, the average expression level of donkey caseins  (αs1-, αs2-, β-CN) was determined through the 
integration of chromatographic peaks. The data (expressed as percentage of total caseins) were shown in 
Table 3.9-Fig.3.33. 
 
Table 3.9-Fig.3.33: determination of donkey casein content (% of the total caseins) in examined casein 
samples by RP-HPLC analysis. 
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The results showed that the most abundant casein fraction in analyzed samples was β-CN (66.99 % ± 7.93), 
followed by αs1-CN (25.34% ± 5.85) and αs2-CN (1.82 ± 1.50), highlighting a high individual variability in 
the expression level of each casein fraction. Specifically, the mean content of β-CN in analyzed donkey 
caseins was about 66.99% (∼ 3.87 mg/mL) of the total caseins, varying from a minimum 45.92 % to 
maximum value of 84.55%. This result obtained for donkey milk is in good agreement with the β-CN content 
in human (4.00 mg/mL) milk but is very low compared to mare (11 mg/mL) and cow (10 mg/ mL) β-CN 
content (Miranda et al., 2004).  
The mean content of  donkey αs1-CN was about 25.34% (∼ 1.5 mg/mL) of the total caseins varying, however, 
from a minimum of 3.42% to maximum of 34.56% and showing thus, a high variability in the expression 
level of the asinine protein. In fact, the HPLC analysis of individual caseins showed different peak areas for 
αs1-CN (Fig. 3.32), in the following decreasing order (Table 3.10-Fig. 3.34): A (32.27%) (∼ 2.00 mg/mL), B 
(24.05%) (∼ 1.4 mg/mL) and C (3.42%) (∼ 0,2 mg/mL); therefore the donkey αs1-CN could be expressed by 
quantitative alleles (strong, intermediate, weak and/or null). 
 
 
 
 
Fig. 3.32: expression level of donkey αs1-CN by RP-HPLC analysis.  
 
These results confirmed the quantitative polymorphism at donkey αs1-CN locus and suggested that there are 
donkeys, as goats, which produce milk with a minor content of this allergenic protein. At this regard, the 
possible use of donkey milk for patients with CMPA could be encouraged by αs1-CN expression level, 
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mainly for weak and intermediate phenotypes more similar to human (0.8 mg/mL) milk and much lower than 
cow αs1-CN content (10.0 mg/mL) (Miranda et al., 2004). 
 
Table 3.10-Fig. 3.34: expression level (%) of donkey αs1-CN by RP-HPLC analysis.  
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In analyzed samples, the αs2-CN was the less abundant casein fraction (1.82%) (∼0.11 mg/mL) compared to 
αs1-CN and β-CN, varying however from minimum of 0.00% to maximum value of 6.42% (Table 3.9-Fig. 
3.33). In analyzed donkey milk samples, the mean value of αs2-CN content was very close to that of mare’s 
milk (0.2 mg/mL) and much lower compared to cow’s milk (3.7 mg/mL), whereas the presence of αs2-CN in 
human milk has not been demonstrated (Miranda et al., 2004). 
As for donkey αs1-CN, the HPLC analysis of individual caseins showed different peak areas for αs2-CN (Fig. 
3.32), in the following decreasing order (Table 3.11-Fig. 3.35): C (4.04%) (∼ 0.2 mg/mL), B (1.78%) (∼ 0.1 
mg/mL) and A (0.53%) (∼ 0.03 mg/mL); therefore the donkey αs2-CN could also be expressed by 
quantitative alleles (strong, intermediate, weak and/or null). 
Thus, a lower expression level or the absence of αs2-CN in some samples of donkey milk, as in human milk, 
together with minor content of αs1-CN and β-Lg confirm the compositional similarity of two milks and 
represent a scientific basis for donkey milk’s use in nutrition of infants with CMPA. 
 
Table 3.11-Fig. 3.35: expression level (%) of donkey αs1-CN by RP-HPLC analysis.  
 
 
 
The relatively low level of caseins, as αs1-CN in donkey milk (1.5-2.00 mg/mL) compared with bovine milk 
(10 mg/mL) may be significant and, coupled with the low protein content, may be responsible for the soft 
curd produced in the infant stomach and foal. Goat milk lacking αs1-CN has poor coagulation properties 
compared with milk containing αs1-CN and also ensures a better β-Lg digestion. 
These data, together with a greater homology of donkey caseins primary structure with human compared to 
cow’s αs1-CN represent a scientific basis to explain the higher digestibility and lower allergenicity of donkey 
milk than other species’ milk (Table 3.12). 
 
Table 3.12: Homology’s percentage of donkey caseins in comparison with other species (expasy.org)  
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 Human Donkey Mare Cow Goat Sheep 
αs1-CN 40% 100% 90% 36% 36% 36% 
αs2-CN  100% 89% 60% 60% 60% 
β-CN 54% 100% 90% 49% 49% 49% 
 
3.13.4 Determination of expression level of donkey whey proteins by RP-HPLC 
 
For the quantitative determination of each donkey whey protein, the individual whey samples were 
chromatographically separated by RP-HPLC (Fig. 3.36) and identified by mass spectrometry methods (Table 
3.5).  
 
 
Fig 3.36: RP-HPLC of donkey whey proteins. 
 
Subsequently, the average expression level of each donkey whey protein was determined through the 
integration of chromatographic peaks. The data (expressed as percentage of total whey proteins) were shown 
in Table 3.13-Fig.3.37. 
 
Table 3.13-Fig. 3.37: determination of content of each donkey whey protein (% of the total whey protein) in 
examined whey samples by RP-HPLC analysis. 
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The mean content of Lyz in analyzed donkey whey proteins was about 23.54% (∼ 2mg/mL), showing a 
considerable variability from a minimum (14.57%) to maximum value of 33.91%. The percentage of 
lysozyme in donkey whey proteins (23.54%) (∼ 2mg/mL) was much higher than in human (0.50 mg/mL) and 
mare (1.10 mg/mL) milk, whereas only traces were found in cow’s milk (Solaroli et al., 1993; Miranda et al., 
2004). The large amount of Lyz in donkey milk was also confirmed by Salimei et al. (2004) and Guo et al. 
(2007) and may be responsible for its low bacterial count and could be useful to prevent intestinal diseases in 
infants. Many authors have shown interest in the large amount of Lyz in donkey milk, and according to 
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Coppola et al. (2002), donkey milk represents an optimal growth medium for certain strains of useful lactic 
acid bacteria. It must be noted that lysozyme can be also considered as an indirect “bifidogen factor”. 
The lactoferrin and serum albumin together accounted, on average, 2.88% (∼ 0.25 mg/mL) of the total whey 
proteins, varying from a minimum 0.00% to maximum value of 15.23%. The determination of percentages of 
these two biological whey proteins represented our important result. In fact, the donkey lactoferrin, although 
representing together with SA a minor component than other whey proteins, not only in donkey, but also in 
other mammalian species, such as mare (0.82 mg/mL), human (2.3 mg/mL) and cow (0.47 mg/mL) 
(Malacarne et al., 2002), display many biological functions: regulation of iron homeostasis, cellular growth, 
anti-microbial and anti-viral functions, and protection against cancer development and metastasis 
(Vincenzetti et al., 2012). 
The mean content of α-La in donkey whey proteins analyzed was about 33.18% (∼ 3 mg/mL), varying from a 
minimum 23.20 % to maximum value of 46.80%. This result obtained for donkey milk is in good agreement 
with the α-La content in mare (3.30 mg/mL) milk but is very high compared to human (1.6 mg/mL) and cow 
(1.2 mg/ mL) α-La content (Miranda et al., 2004).  
Regarding donkey β-Lg, in this study we were able to separate the two components of the protein (β-Lg I and 
II) by RP-HPLC, something that to date no one had been able to do. The mean content of β-Lg I in donkey 
whey samples analyzed was about 36.03% (∼ 3.2 mg/mL), varying from minimum of 31.58% to maximum 
value of 47.05%. The mean content of donkey β-Lg I was very close to that of cow’s milk (3.3 mg/mL) and 
mare’s milk (3.0 mg/mL), whereas in human milk β-Lg is absent (Miranda et al., 2004). 
The donkey β-Lg II was separated from β-Lg I by RP-HPLC analysis, which allowed to determine its mean 
content. Subsequently, the LC-MS analysis of individual whey proteins allowed to identify four β-Lg II 
variants (B, C, D and E) otherwise co-eluting in the same chromatographic peak or co-focalising at the same 
pI value of the UTLIEF pH gradient, as β-Lg II A and B. 
We found a complex polymorphism of β-Lg II for the occurrence of different variants and null allele at this 
locus. Furthermore, the HPLC analysis of whey samples containing B, C, and D β-Lg II variants showed a 
different peak area in the following decreasing order: BB (3.34%), CC (1.66%) and DD (0.54%). The whey 
samples heterozygous for β-Lg II also showed a different peak area in the following order: BC (3.34%), BD 
(2.94%), DE (1.73%) and DC (1.53%). Donkey whey proteins with a lower or zero β-Lg II content (0.50-
0.00%) were also identified in donkey population analyzed.  
These results confirmed the quali-quantitative polymorphism at donkey β-Lg II locus and therefore the 
possibility that β-Lg II variants could be expressed by quantitative alleles (strong, intermediate, weak and 
null) as at goat αs1-CN locus. Since the percentage area value of β-Lg II DE was very close to that of CD 
counterpart, it can be hypothesized that β-Lg II E (new variant) is expressed by an intermediate allele.  
In donkey milk, the total β-Lg, absent in human milk, accounted for approximately 40% of the whey 
proteins, equal to the level in mare milk and lower than that in cow’s milk, where β-Lg can account for up to 
50% of the total whey proteins (Solaroli et al., 1993; Miranda et al., 2004). Other authors found a low β-Lg 
content in mare’s milk compared with cow’s and donkey milk (Malacarne et al., 2002). 
However, from these analytical data, it appears that a high lysozyme content together with other 
antimicrobial proteins in donkey milk can be important from an immunological point of view and for the 
shelf life of the same milk. The two main whey proteins (α-La and β-Lg) are expressed at the same level, but 
with a prevalence of β-Lg and for this latter, β-Lg I is expressed at higher level than β-Lg II as known in 
literature (Godovac-Zimmermann et al., 1988; 1990). Moreover, the quali-quantitative polymorphism at 
donkey β-Lg II locus highlighted the possibility that β-Lg could be expressed at low level in donkey milk and 
this, may affect its composition and therefore, its allergenic properties. 
These findings, together with the low casein content, are probably related to the hypoallergenic 
characteristics for both donkey and mare milk (Businco et al., 2000; Carroccio et al., 2000); β-Lg is, in fact, 
the probable major milk allergen not only in adults but also in children (Carroccio et al., 1999). This protein 
is absent in human milk and thus may react as an allergen. In fact, its particular folding makes β-Lg resistant 
to peptic digestion at low pH, even after denaturation (Dalgalarrondo et al., 1995). Conversely at pH 7.2, β-
Lg is very susceptible to the pancreatic enzymes which completely hydrolyze it. The surviving peptides from 
β-Lg digestion can cross the gut mucosal barrier to sensitise the immune system and/or elicit an allergic 
response, acting as epitopes (Wall, 2004). 
With respect to bovine β-Lg, seven IgE epitopes (AA 1-16, AA 31-48, AA 47-60, AA 67-78, AA 75-86 AA 
127-144 and AA 144-151) were identified (Jarvinen et al., 2001). Among these, two the fragments 47-60 and 
127-144 were identified as the main IgE binding immunoreactive epitopes. The knowledge about the 
allergenic epitopes of bovine β-Lg, together with the determination of the primary structure of different 
donkey β-Lgs provide the basis for some comparison of their sequences. According to Cocco (2007), the 
substitutions or deletions of one or more amino acids in a protein as donkey β-Lg could result in a partial 
reduction or elimination of IgE binding regions in majority of patients. 
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Comparison of the bovine β-Lg with donkey β-Lg I and II  reveals that these proteins share a low sequence 
homology (56% and 51%) respectively. In particular, alignment reveals that the IgE-binding epitopes of 
cow’s β-Lg and the corresponding domains present in donkey β-Lg have remarkable differences in their 
amino acid sequences. In fact, it is interesting to note that one of the strongest β-Lg epitope (125-135) is 
located in the 127-144 region, which is highly hydrophilic for the presence of five acidic residue and one Pro 
over total 11 residues, which also make it very resistant to proteolysis. An alignment of the 125-135 epitope 
of β-Lg from bovine with donkey showed 5 amino acid substitutions which lowering the acidic character of 
the donkey peptide (Table 3.14), drastically changes its susceptibility to proteolysis and therefore its 
allergenicity (Picariello et al., 2010). 
 
Table 3.14: sequence alignment of the β-Lf f(125-135) from milk of cow and donkey species. 
 
Cow 125TPEVDDEALEK135 
Donkey β-Lg I 125TQMVDKEIMEK135 
Donkey β-Lg II 125TQKVDKEVMEK135 
 
3.14 Conclusions 3 
 
The quantitative results indicated that the examined donkey milk samples were shown to be poor in protein, 
resulting more similar to mare and human milk than to other mammalian milks as cow’s milk. 
The analyzed donkey milk samples were also shown to be poor in caseins with allergenic properties, and rich 
in whey proteins with high biological and nutritional value, with a CN/WP ratio < 1. The richness and pattern 
of whey proteins and NPN of donkey’s milk make it more favourable than cow’s milk for human nutrition. 
Specifically, regarding donkey caseins, the most abundant casein fraction was β-CN, followed by αs1-CN and 
αs2-CN; human milk is characterized by a prevalence of β-CN, as donkey milk, while cow casein is relatively 
rich in αs1-CN, which is believed to be responsible for the onset of allergic forms in nursing infants. 
The determination of αs1-CN content in individual donkey milk samples also showed a quantitative 
polymorphism at this locus, for the presence, only in traces, of the protein. 
For donkey whey proteins, the quantitative results showed an high level of lysozyme, which, together with 
other antimicrobial components of donkey milk, as lactoferrin, is responsible for the low bacterial count of 
this milk and could be useful to prevent intestine infections in infants. α-La and β-Lg content is similar with 
a β-Lg prevalence. Moreover, the detection of donkey milk samples characterized by a low β-Lg II content 
also suggested a quali-quantitative polymorphism at this locus.  
The low casein (αs1-CN) and β-Lg contents are probably related to the hypoallergenic characteristics reported 
in literature for donkey milk.  
Finally, in analyzed donkey milk samples, an individual variability of either caseins and whey proteins 
amount suggests further studies in this direction aimed at a selection of animals producing milk with a 
composition “qualitatively and quantitatively” more similar to human milk, and “functionalized” for infant 
feeding. 
The achieved results, confirming the biological and nutritional value of donkey’s milk, similar to human 
milk, solicit detailed and analytic knowledge of donkey’s milk, which could be used not only as a breast milk 
substitute but also as a new dietetic/bio-functional food. Moreover, the production and the wider use of 
donkey milk suggest the potential economic value of asinine breeding, providing an economic justification 
for breeding donkeys and preserving their natural environment, mostly represented by  marginal and hilly 
areas, helping to protect certain donkey breeds from extinction in industrialised countries.    
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3.16 Glossary 
 
Mr                              Molecular Mass 
Aa                              amino acid 
UTR                           untraslated region 
Cys                            cysteine 
Ser                             serine 
Thr                             threonine 
SerP                           serine phosphorylated 
Glu                             glutamic acid 
NANA                        N-acetyl neuraminic acid 
GMP                          glycomacropeptide 
FA                              fatty acids 
SFAs                          saturated fatty acids 
MCFAs                      medium chain fatty acids 
LCFAs                       long chain fatty acids 
UFAs                         unsaturated fatty acids 
EPA                           eicosapentanoic acid 
DHA                          docosahesaenoic acid 
TAGs                         triglycerides 
MCT                          medium chain triglycerides 
Lyz                            lysozyme 
Lf                              lactoferrin 
SA                             serum albumin 
Ig                               immunoglobulin 
CMP                          cow’s milk protein 
CMPA                       cow’s milk protein allergy 
eHF                           extensively hydrolyzed formulas 
AAF                          amino acid formulas 
AD                            atopic dermatitis 
LAB                          lactic acid bacteria 
EFAs                         essential fatty acids 
PAGE                        polyacrylamide gel electrophoresis 
UTLIEF                     Ultra-thin layer isoelectric focusing 
PAGE-SDS               polyacrylamide gel electrophoresis-sodium dodecyl sulphate  
MS                            mass spectrometry 
MALDI TOF            matrix assisted laser desorbtion/ionization time-of-flight 
RP-HPLC                  reversed phase- high performance liquid chromatography  
LC-ESI-MS               liquid chromatography-electrospray ionization-mass spectrometry 
ESI-q-TOF-MS/MS  electrospray quadrupole-time of flight-tandem-mass spectrometry  
GRAVY                    grand average of hydropathicity 
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